6-K 1 a0570u.htm HALF-YEAR RESULTS a0570u
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
 
 
FORM 6-K
 
 
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13A-16 OR 15D-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
 
July 28, 2022
 
Barclays PLC
(Name of Registrant)
 
1 Churchill Place
London E14 5HP
England
(Address of Principal Executive Office)
 
Indicate by check mark whether the registrant files or will file annual reports
under cover of Form 20-F or Form 40-F.
 
Form 20-F x Form 40-F
 
Indicate by check mark whether the registrant by furnishing the information
contained in this Form is also thereby furnishing the information to the
Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
 
Yes No x
 
If "Yes" is marked, indicate below the file number assigned to the registrant
in connection with Rule 12g3-2(b):
 
This Report on Form 6-K is filed by Barclays PLC.
 
This Report comprises:
 
Information given to The London Stock Exchange and furnished pursuant to
General Instruction B to the General Instructions to Form 6-K.
 
 
EXHIBIT INDEX
 
 
 


 

 SIGNATURES
 
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
 
BARCLAYS PLC
 
 
(Registrant)
 
 
 
 
Date: July 28, 2022
 
 
 
By: /s/ Garth Wright
--------------------------------
 
 
Garth Wright
 
 
Assistant Secretary
 
 

 
 
 
Barclays PLC
 
Interim Results Announcement
 
30 June 2022
 
 
 
Table of Contents
 
Results Announcement
 
Page
 
 
 
Notes
 
1
 
 
 
Performance Highlights
 
3
 
 
 
Group Finance Director’s Review
 
7
 
 
 
Results by Business
 
 
 
 
Barclays UK
 
10
 
 
 
Barclays International
 
14
 
 
 
Head Office
 
19
 
 
 
Quarterly Results Summary
 
21
 
 
 
Quarterly Results by Business
 
22
 
 
 
Performance Management
 
 
 
 
Margins and Balances
 
29
 
 
 
Risk Management
 
 
 
 
Risk Management and Principal Risks
 
31
 
 
 
Credit Risk
 
33
 
 
 
Market Risk
 
57
 
 
 
Treasury and Capital Risk
 
58
 
 
 
Statement of Directors' Responsibilities
 
74
 
 
 
Independent Review Report to Barclays PLC
 
75
 
 
 
Condensed Consolidated Financial Statements
 
77
 
 
 
Financial Statement Notes
 
87
 
 
 
Appendix: Non-IFRS Performance Measures
 
115
 
 
 
Shareholder Information
 
125
 
 
 
 
 
BARCLAYS PLC, 1 CHURCHILL PLACE, LONDON, E14 5HP, UNITED KINGDOM. TELEPHONE: +44 (0) 20 7116 1000. COMPANY NO. 48839.
 
 
Notes
 
This document contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014 (as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018, as amended).
 
The terms Barclays or Group refer to Barclays PLC together with its subsidiaries. Unless otherwise stated, the income statement analysis compares the six months ended 30 June 2022 to the corresponding six months of 2021 and balance sheet analysis as at 30 June 2022 with comparatives relating to 31 December 2021 and 30 June 2021. The historical financial information used for the purposes of such analysis has been restated. Please refer to Note 1 to the condensed consolidated interim financial statements contained herein for further information. The abbreviations ‘£m’ and ‘£bn’ represent millions and thousands of millions of Pounds Sterling respectively; the abbreviations ‘$m’ and ‘$bn’ represent millions and thousands of millions of US Dollars respectively; and the abbreviations ‘€m’ and ‘€bn’ represent millions and thousands of millions of Euros respectively.
 
There are a number of key judgement areas, for example impairment calculations, which are based on models and which are subject to ongoing adjustment and modifications. Reported numbers reflect best estimates and judgements at the given point in time.
 
Relevant terms that are used in this document but are not defined under applicable regulatory guidance or International Financial Reporting Standards (IFRS) are explained in the results glossary.
 
The information in this announcement, which was approved by the Board of Directors on 27 July 2022, does not comprise statutory accounts within the meaning of Section 434 of the Companies Act 2006. Statutory accounts for the year ended 31 December 2021, which contained an unmodified audit report under Section 495 of the Companies Act 2006 (which did not make any statements under Section 498 of the Companies Act 2006) have been delivered to the Registrar of Companies in accordance with Section 441 of the Companies Act 2006.
 
These results will be furnished on Form 6-K with the US Securities and Exchange Commission (SEC) as soon as practicable following their publication. Once furnished with the SEC, a copy of the Form 6-K will be available from the SEC’s website at www.sec.gov.
 
Barclays is a frequent issuer in the debt capital markets and regularly meets with investors via formal road-shows and other ad hoc meetings. Consistent with its usual practice, Barclays expects that from time to time over the coming quarter it will meet with investors globally to discuss these results and other matters relating to the Group.
 
Non-IFRS performance measures
 
Barclays’ management believes that the non-IFRS performance measures included in this document provide valuable information to the readers of the financial statements as they enable the reader to identify a more consistent basis for comparing the businesses’ performance between financial periods and provide more detail concerning the elements of performance which the managers of these businesses are most directly able to influence or are relevant for an assessment of the Group. They also reflect an important aspect of the way in which operating targets are defined and performance is monitored by Barclays’ management. However, any non-IFRS performance measures in this document are not a substitute for IFRS measures and readers should consider the IFRS measures as well. Refer to the appendix on pages 115 to 123 for further information and calculations of non-IFRS performance measures included throughout this document, and the most directly comparable IFRS measures.
 
 
 
 
Forward-looking statements
 
This document contains certain forward-looking statements within the meaning of Section 21E of the US Securities Exchange Act of 1934, as amended, and Section 27A of the US Securities Act of 1933, as amended, with respect to the Group. Barclays cautions readers that no forward-looking statement is a guarantee of future performance and that actual results or other financial condition or performance measures could differ materially from those contained in the forward-looking statements. Forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward-looking statements sometimes use words such as ‘may’, ‘will’, ‘seek’, ‘continue’, ‘aim’, ‘anticipate’, ‘target’, ‘projected’, ‘expect’, ‘estimate’, ‘intend’, ‘plan’, ‘goal’, ‘believe’, ‘achieve’ or other words of similar meaning. Forward-looking statements can be made in writing but also may be made verbally by members of the management of the Group (including, without limitation, during management presentations to financial analysts) in connection with this document. Examples of forward-looking statements include, among others, statements or guidance regarding or relating to the Group’s future financial position, income levels, assets and liabilities, impairment charges, provisions, capital, leverage and other regulatory ratios, capital distributions (including dividend pay-out ratios and expected payment strategies), projected levels of growth in banking and financial markets, projected expenditures, costs or savings, any commitments and targets (including, without limitation, environmental, social and governance (ESG) commitments and targets), business strategy, plans and objectives for future operations, group structure, IFRS impacts and other statements that are not historical or current facts. By their nature, forward-looking statements involve risk and uncertainty because they relate to future events and circumstances. Forward-looking statements speak only as at the date on which they are made. Forward-looking statements may be affected by a number of factors, including, without limitation: changes in legislation, regulation and the interpretation thereof, the development of IFRS and other accounting standards, evolving practices with regard to the interpretation and application of accounting standards, emerging and developing ESG reporting standards, the outcome of current and future legal proceedings and regulatory investigations and any related impact on provisions, the policies and actions of governmental and regulatory authorities, the Group’s ability along with governments and other stakeholders to measure, manage and mitigate the impacts of climate change effectively, environmental, social and geopolitical risks and incidents or similar events beyond the Group’s control, and the impact of competition. In addition, factors including (but not limited to) the following may have an effect: capital, leverage and other regulatory rules applicable to past, current and future periods; UK, US, Eurozone and global macroeconomic and business conditions; volatility in credit and capital markets; market related risks such as changes in interest rates and foreign exchange rates; changes in valuation of credit market exposures; changes in valuation of issued securities; changes in credit ratings of any entity within the Group or any securities issued by such entities; changes in counterparty risk; changes in consumer behaviour; the direct and indirect consequences of the Russia-Ukraine War on European and global macroeconomic conditions, political stability and financial markets; direct and indirect impacts of the coronavirus (COVID-19) pandemic; instability as a result of the UK’s exit from the European Union (EU), the effects of the EU-UK Trade and Cooperation Agreement and the disruption that may subsequently result in the UK and globally; the risk of cyber-attacks, information or security breaches or technology failures on the Group’s reputation, business or operations; the Group’s ability to access funding; and the success of acquisitions, disposals and other strategic transactions. A number of these influences and factors are beyond the Group’s control. As a result, the Group’s actual financial position, future results, capital distributions, capital, leverage or other regulatory ratios or other financial and non-financial metrics or performance measures or ability to meet commitments and targets may differ materially from the statements or guidance set forth in the Group’s forward-looking statements. Additional risks and factors which may impact the Group’s future financial condition and performance are identified in Barclays PLC’s filings with the SEC (including, without limitation, Barclays PLC’s Annual Report on Form 20-F, as amended, for the financial year ended 31 December 2021), which are available on the SEC’s website at www.sec.gov.
 
Subject to Barclays’ obligations under the applicable laws and regulations of any relevant jurisdiction (including, without limitation, the UK and the US), in relation to disclosure and ongoing information, we undertake no obligation to update publicly or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
 
 
Performance Highlights
 
 
 
Barclays delivered profit before tax of £3.7bn and return on tangible equity (RoTE) of 10.1%, with a half year dividend of 2.25p per share and intends to initiate a further share buyback of up to £500m
C. S. Venkatakrishnan, Group Chief Executive, commented
“This has been a strong first half with Group income up 17%1 to £13.2bn and a RoTE of 10.1%.
The broad-based income growth that we achieved in the first quarter continued across all three operating businesses into the second quarter.
Our performance in the first half shows the resilience and advantage that diversification at all levels brings, both across the bank and within our businesses. It also underlines the value of investment into our three strategic priorities in next generation consumer finance, sustainable growth across the Corporate and Investment Bank (CIB), and the transition to a low-carbon economy.
Profit before tax was £3.7bn, and attributable profit was £2.5bn, after absorbing charges net of tax of £0.6bn relating to the Over-issuance of Securities.
We are alert to the pressure that the rising cost of living will have on our customers and colleagues. We have a range of measures in place to help and are looking to do more. With our resilient income growth and balance sheet strength, we can provide that support while distributing excess capital, having announced a half year dividend of 2.25p per share and an intention to initiate a further share buyback of £500m.”
 
 
Key financial metrics:
 
Income
Cost: income ratio
Profit before tax
Attributable profit
RoTE
EPS
CET1 ratio
TNAV per share
Total capital return
H122
£13.2bn
69%
£3.7bn
£2.5bn
10.1%
14.8p
13.6%
297p
c.5.25p equivalent
Q222
£6.7bn
75%
£1.5bn
£1.1bn
8.7%
6.4p
 
 
H122 performance2:
 
Attributable profit was £2.5bn (H121: £3.8bn) and RoTE was 10.1% (H121: 16.1%) having reflected a £0.6bn net of tax impact for the Over-issuance of Securities in the US (Over-issuance of Securities3). Excluding this impact, RoTE was 12.5%
 
£0.6bn impact of Over-issuance of Securities is comprised of:
 
£0.4bn post tax expected net impact of the rescission offer losses, driven by £1.3bn of costs as a result of market movements and interest, substantially offset by £0.8bn of income from hedging arrangements
 
£0.2bn of costs relating to an estimated monetary penalty from the SEC
 
Excluding the impact of Over-issuance of Securities:
 
Group income was £12.4bn, up 10% year-on-year, driven by strong client activity in Markets, recovery in both Consumer, Cards and Payments (CC&P) and Barclays UK more than offsetting the impact of a weak fee pool in Investment Banking
 
Group costs were £7.7bn (H121: £7.2bn) including other litigation and conduct charges of £0.4bn (H121: £0.1bn), with operating costs (excluding litigation and conduct) up 2% year-on-year
 
On a statutory basis, including the impacts of Over-issuance of Securities:
 
Group income was £13.2bn, up 17% year-on-year, including the £0.8bn of income from hedging arrangements related to the Over-issuance of Securities
 
Credit impairment charges were £0.3bn (H121: £0.7bn net release) with provision levels broadly retained in light of an uncertain macroeconomic backdrop
 
Group costs were £9.1bn (H121: £7.3bn), including litigation and conduct charges of £1.9bn (H121: £0.2bn), including £1.5bn estimated impact of rescission offer losses in relation to the Over-Issuance of Securities and associated estimated monetary penalty from the SEC 
 
Capital: Common Equity Tier 1 (CET1) ratio of 13.6% (December 2021: 15.1% and March 2022: 13.8%) and tangible net asset value (TNAV) per share of 297p (December 2021: 291p and March 2022: 294p)
 
Increased capital distributions: total capital return equivalent of c.5.25p per share, including a half year dividend of 2.25p per share. Intend to initiate a further share buyback of up to £0.5bn, which is expected to have a c.15bps CET1 ratio impact 
 
 
1
Excluding the Q222 income benefit of £0.8bn from hedging arrangements related to the Over-issuance of Securities, Group income was up 10% to £12.4bn.
2
2021 financial and capital metrics have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 65 and Restatement of financial statements (Note 1) on page 87 for more information.
3
Denotes the Over-issuance of Securities under Barclays Bank PLC’s US shelf registration statements on Form F-3 filed with the SEC in 2018 and 2019.
 
Outlook:
 
Returns: Barclays continues to target a RoTE of greater than 10% in 2022
 
Income: Barclays’ diversified income streams position the Group well for the current economic and market environment and rising interest rates
 
Costs: given £1.3bn of litigation and conduct charges in Q222 and the appreciation of average USD against GBP, Barclays now expects FY22 total operating expenses to be around £16.7bn1 versus previous outlook of £15.0bn2
 
Impairment: while acknowledging macroeconomic uncertainty, the impairment charge is expected to remain below pre-pandemic levels in coming quarters given reduced unsecured lending balances and existing coverage ratios
 
Capital: Barclays continues to target a CET1 ratio within the range of 13-14%
 
Capital returns: Barclays' capital distribution policy incorporates a progressive ordinary dividend, supplemented with buybacks as appropriate. Dividends will continue to be paid semi-annually, with the half year dividend expected to represent, under normal circumstances, around one-third of the total dividend for the year
 
 
 
1
Group cost outlook is based on an average USD/GBP FX rate of 1.23 across H222 and subject to foreign currency movements.
2
Previous FY22 Group cost outlook was based on an average USD/GBP FX rate of 1.31 throughout 2022.
Barclays Group results
for the half year ended
 
 
 
30.06.22
 
Restated1
30.06.21
 
 
 
£m
£m
% Change
Net interest income
4,763
3,903
22
Net fee, commission and other income
 
8,441
7,412
14
Total income
13,204
11,315
17
Credit impairment (charges)/releases
(341)
742
 
Net operating income
12,863
12,057
7
Operating costs
(7,270)
(7,132)
(2)
Litigation and conduct
(1,857)
(176)
 
Total operating expenses
(9,127)
(7,308)
(25)
Other net (expenses)/ income
(3)
153
 
Profit before tax
3,733
4,902
(24)
Tax charge
(823)
(742)
(11)
Profit after tax
2,910
4,160
(30)
Non-controlling interests
(21)
(19)
(11)
Other equity instrument holders
(414)
(389)
(6)
Attributable profit
2,475
3,752
(34)
 
 
 
 
Performance measures
 
 
 
Return on average tangible shareholders' equity
10.1%
16.1%
 
Average tangible shareholders' equity (£bn)
48.9
46.5
 
Cost: income ratio
69%
65%
 
Loan loss rate (bps)
17
 
Basic earnings per share
14.8p
21.9p
 
Dividend per share
2.25p
2.0p
 
Share buyback announced (£m)
500
500
 
Total payout equivalent per share
c.5.25p
4.9p
 
Basic weighted average number of shares (m)
16,684
17,140
(3)
Period end number of shares (m)
16,531
16,998
(3)
 
 
 
 
 
As at 30.06.2
Restated1 As at 31.12.21 
Restated1 As at 30.06.21 
Balance sheet and capital management2
£bn
£bn
£bn
Loans and advances at amortised cost
395.8
361.5
348.5
Loans and advances at amortised cost impairment coverage ratio
1.4%
1.6%
1.8%
Total assets
1,589.2
1,384.3
1,376.3
Deposits at amortised cost
568.7
519.4
500.9
Tangible net asset value per share
297p
291p
280p
Common equity tier 1 ratio
13.6%
15.1%
15.0%
Common equity tier 1 capital
46.7
47.3
46.2
Risk weighted assets
344.5
314.1
307.4
UK leverage ratio
5.1%
5.2%
5.0%
UK leverage exposure
1,151.2
1,137.9
1,154.9
Average UK leverage ratio
4.7%
4.9%
4.8%
Average UK leverage exposure
1,233.5
1,229.0
1,192.7
 
 
 
 
Funding and liquidity
 
 
 
Group liquidity pool (£bn)
343
291
291
Liquidity coverage ratio
156%
168%
162%
Loan: deposit ratio
70%
70%
70%
 
 
1
2021 financial and capital metrics have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 65 and Restatement of financial statements (Note 1) on page 87 for more information.
2
Refer to pages 55 to 62 for further information on how capital, Risk Weighted Assets (RWAs) and leverage are calculated.
 
 
 
Group Finance Director's Review
 
 
Group performance1, 2
 
 
Barclays' diversified model delivered a profit before tax of £3,733m (H121: £4,902m), RoTE of 10.1% (H121: 16.1%), and earnings per share (EPS) of 14.8p (H121: 21.9p)
 
Total income increased to £13,204m (H121: £11,315m). Barclays UK income increased 5%. Barclays International income increased 21%, with CIB income up 21% and CC&P income up 20%. Excluding the income benefit of £758m from hedging arrangements related to the Over-issuance of Securities, total Group income was £12,446m, up 10% year-on-year, Barclays International income was £9,182m, up 12% year-on-year and CIB income was £7,213m, up 10% year-on-year
 
Credit impairment charges were £341m (H121: £742m net release) reflecting low flows to delinquency and an improved UK employment outlook, partially offset by a day one charge relating to the acquisition of the GAP Inc. US credit card portfolio (the GAP portfolio). Expert judgement post-model adjustments have been maintained to incorporate customer affordability and inflationary headwinds
 
Total operating expenses increased to £9,127m (H121: £7,308m). Operating costs increased 2% to £7,270m, reflecting continued investment and business growth, the impact of inflation and the appreciation of average USD against GBP, partially offset by efficiency savings and the non-recurrence of structural cost actions, primarily relating to the real estate review in June 2021. Litigation and conduct charges were £1,857m (H121: £176m) including £1,304m estimated impact of rescission offer losses in relation to the Over-Issuance of Securities and £165m associated estimated monetary penalty from the SEC, £181m of customer remediation costs relating to a legacy loan portfolio in CC&P and £165m related to settlements in principle in respect of industry-wide devices investigations by the SEC and the Commodity Futures Trading Commission (CFTC)3. This resulted in a cost: income ratio of 69% (H121: 65%)
 
The effective tax rate (ETR) was 22.0% (H121: 15.1%). The tax charge included a £346m charge recognised for the re-measurement of the Group’s UK deferred tax assets (DTAs) due to the enactment of legislation in Q122 which will result in the UK banking surcharge rate being reduced from 8% to 3% effective from 1 April 2023. The ETR excluding the impact of this downward re-measurement of UK DTAs was 12.8% which included a 5.8% benefit relating to adjustments in respect of prior years
 
Attributable profit was £2,475m (H121: £3,752m) including the net impact of the Over-issuance of Securities net of tax, of £581m, of which £341m was in Q222
 
Total assets increased to £1,589bn (December 2021: £1,384bn) primarily due to an increase in client and trading activity, and growth in the liquidity pool
 
TNAV per share increased to 297p (December 2021: 291p) primarily reflecting 14.8p of EPS, partially offset by net negative reserve movements driven by higher interest rates
 
Group capital and leverage1
 
The CET1 ratio decreased by c.150bps to 13.6% (December 2021: 15.1%) as capital decreased by £0.6bn to £46.7bn and RWAs increased by £30.4bn to £344.5bn
 
c.80bps reduction to the CET1 ratio due to the expected impact of regulatory change on 1 January 2022 as CET1 capital decreased £1.7bn and RWAs increased £6.6bn
 
c.30bps reduction due to the £1bn buyback announced with FY21 results, which is well progressed
 
c.40bps reduction due to the impact of the Over-issuance of Securities. c.20bps due to the £0.6bn net of tax impact reducing CET1 capital and c.20bps due to a £4.5bn temporary increase in RWAs reflecting the hedging arrangements designed to manage the risk of the rescission offer. The hedging related RWAs are expected to reverse after the rescission offer is completed in Q322
 
Excluding the impacts above, an increase in CET1 capital of £2.7bn was offset by a £19.3bn increase in RWAs:
 
The £2.7bn increase in CET1 capital reflects profits and an increase in the currency translation reserve, offset by an accrual toward a FY22 dividend, equity coupons paid, and a decrease in the fair value through other comprehensive income reserve
 
The £19.3bn increase in RWAs was primarily due to the appreciation of USD against GBP, increased client activity within CIB and higher CC&P balances mainly driven by the GAP portfolio acquisition. This was marginally offset by the partial disposal of Barclays' equity stake in Absa Group Limited (Absa) in April 2022
 
The UK leverage ratio decreased to 5.1% (December 2021: 5.2%) primarily due to an increase in the leverage exposure of £13.3bn to £1,151.2bn
 
 
1
2021 financial and capital metrics have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 65 and Restatement of financial statements (Note 1) on page 87 for more information.
2
The 6% appreciation of average USD against GBP positively impacted income and profits and adversely impacted credit impairment charges and total operating expenses.
3
See 'Other matters' on page 6 for further details.
 
 
Group funding and liquidity
 
The liquidity pool was £343bn (December 2021: £291bn) and the liquidity coverage ratio (LCR) remained significantly above the 100% regulatory requirement at 156% (December 2021: 168%), equivalent to a surplus of £119bn (December 2021: £116bn). The increase in the liquidity pool was driven by deposit growth and an increase in wholesale funding, which were partly offset by an increase in business funding consumption
 
Wholesale funding outstanding, excluding repurchase agreements, was £181.5bn (December 2021: £167.5bn). The Group issued £3.5bn equivalent of minimum requirement for own funds and eligible liabilities (MREL) instruments from Barclays PLC (the Parent company) in the year to date. The Group has a strong MREL position with a ratio of 30.9% of RWAs which is in excess of its regulatory requirement of 28.5%, excluding the confidential institution specific PRA buffer. The Group remains above its MREL regulatory requirement including the PRA buffer
 
 
Other matters
 
Over-issuance of Securities: since 31 March 2022, the following developments should be noted with respect to the Over-issuance of Securities:
 
On 23 May 2022, Barclays PLC and Barclays Bank PLC filed amendments to their respective Annual Reports on Form 20-F to, among other matters, restate the financial statements for the financial year ended 31 December 2021 to reflect certain impacts of the Over-issuance of Securities
 
On 23 May 2022, Barclays Bank PLC filed a shelf registration statement on Form F-3 with the SEC, which was automatically effective and under which an unlimited amount of securities may be registered, on the basis that Barclays Bank PLC is a “well-known seasoned issuer” (the “2022 F-3”). Barclays PLC also has an automatic shelf registration statement on Form F-3 filed with the SEC on 1 March 2021
 
On 1 August 2022, Barclays Bank PLC intends to launch an offer to rescind the purchase of securities that were issued in excess of Barclays Bank PLC’s shelf registration statement on Form F-3 declared effective by the SEC in 2019 (2019 F-3) and the predecessor US shelf registration statement filed in 2018 (Predecessor Shelf) by certain purchasers who purchased such securities in a distribution from Barclays Bank PLC during certain relevant periods (the rescission offer)
 
Following the launch of the rescission offer, Barclays Bank PLC is expected to resume issuances and sales of series of iPath ETNs that were not affected by the rescission offer. Barclays Bank PLC further expects to resume issuances and sales of the remaining series of iPath ETNs when the rescission offer has been completed and settlement of the rescission offer with respect to the relevant series has occurred
 
Barclays has recognised a H122 attributable profit impact of £581m relating to this matter net of tax, including a £1,304m charge recognised in costs, substantially offset by hedging arrangements which generated income of £758m, as well as an estimated monetary penalty from the SEC of £165m
 
The total balance sheet provision as at 30 June 2022 was £1,757m, of which: £1,592m relates to the estimated rescission offer losses and £165m relates to an estimated SEC monetary penalty. Barclays also expects temporary RWAs of £4.5bn, which translates to a c.20bps reduction in the CET1 ratio, from the hedging arrangements to reverse after the rescission offer has been completed in Q322
 
Barclays also expects the Review (see pages 25-26 for more detail), assisted by external counsel, of the facts and circumstances related to this matter to conclude shortly and will continue to engage with regulators
 
SEC and CFTC devices investigation: in July 2022, Barclays Bank PLC and Barclays Capital Inc. (BCI) reached an agreement in principle with the staff of the SEC's Division of Enforcement and the staff of CFTC in connection with investigations by the SEC and the CFTC of Barclays Bank PLC, BCI and other financial institutions as part of a financial industry sweep regarding compliance with record-keeping obligations in connection with business-related communications sent over unapproved electronic messaging platforms (the Devices Settlements In Principle). The SEC and the CFTC found that Barclays Bank PLC and BCI failed to comply with their respective record keeping and supervisory obligations, where such communications were sent or received by employees over electronic messaging channels that had not been approved by the bank for business use by employees. The proposed resolution with the SEC and the CFTC will include Barclays Bank PLC and BCI paying a combined $125m civil monetary penalty to the SEC and a $75m civil monetary penalty to the CFTC. Subject to final agreement of the terms of the settlements and related documentation, as well as the SEC's and CFTC's approval, the civil monetary penalties are expected to be paid during the third quarter of 2022
 
GAP portfolio acquisition: on 21 June 2022, Barclays completed the acquisition of a US credit card portfolio of $3.3bn of receivables, in partnership with GAP Inc. The acquisition reduced the Group CET1 ratio by approximately 15bps. The partnership broadens Barclays product offering in the retail sector and store cards, advancing our strategy and growth ambitions in the United States
 
Kensington Mortgage Company acquisition: on 24 June 2022 Barclays PLC announced that Barclays Bank UK PLC has agreed to acquire UK specialist mortgage lender Kensington Mortgage Company Limited, thereby broadening Barclays' capabilities and product offering in the UK mortgage market. The transaction is subject to regulatory approval and is expected to complete in late Q422 or early Q123
  
Legacy Loan Portfolio: a customer remediation provision of £181m was recognised in Q122 in relation to a legacy timeshare loan portfolio brokered by Azure Services Limited (ASL). The provision represents the best estimate as at 30 June 2022. Barclays continues to review complaints regarding legacy partner finance loans, however it is not currently possible to predict the outcome of this review
 
Absa sale: on 21 April 2022, Barclays sold 63m ordinary shares in Absa (7.4% of Absa’s issued share capital) at a price of ZAR 164.0 per share, raising aggregate gross sale proceeds of ZAR 10.3bn (£516m1)
 
Pensions: during 2019 and 2020, the UK Retirement Fund (UKRF), the Group’s main pension scheme, subscribed for non-transferable listed senior fixed rate notes for £1.25bn. Following the PRA's statement on 13 April 2022, Barclays is planning to unwind these transactions, which would result in a c.30bps reduction to the CET1 ratio, being accelerated to Q422 from 2023, 2024 and 2025. For more details, see note 16 on page 103
 
Capital distributions
 
Barclays is committed to maintaining an appropriate balance between delivering attractive total cash returns to shareholders, investment in the business and maintaining a strong capital position. Barclays pays a progressive ordinary dividend, taking into account these objectives and the earnings outlook of the Group. The Board will also continue to supplement the ordinary dividends as appropriate, including with share buybacks
 
Announced a half year dividend of 2.25p per share and intention to initiate a further share buyback of up to £500m
 
Dividends will continue to be paid semi-annually, with the half year dividend expected to represent, under normal circumstances, around one-third of the total dividend for the year
 
The £1.0bn buyback programme announced in FY21 results is expected to complete before the end of September 2022

Group targets
 
Barclays continues to target the following over the medium term:
 
Returns: RoTE of greater than 10%

Cost efficiency: cost: income ratio below 60%
 
Capital adequacy: CET1 ratio in the range of 13-14%
 
 
Anna Cross, Group Finance Director
 
 
1
Exchange rate GBP/ZAR 20.04 as of 21 April 2022.
 
 
Results by Business
 
 
 
Barclays UK
Half year ended
 
Half year ended
 
 
 
30.06.22
 
30.06.21
 
 
Income statement information
£m
£m
% Change
Net interest income
2,732
2,586
6
Net fee, commission and other income
641
613
5
Total income
3,373
3,199
5
Credit impairment (charges)/releases
(48)
443
 
Net operating income
3,325
3,642
(9)
Operating costs
(2,083)
(2,114)
1
Litigation and conduct
(25)
(22)
(14)
Total operating expenses
(2,108)
(2,136)
1
Other net income
 
Profit before tax
1,217
1,506
(19)
Attributable profit
 
854
 
1,019
 
(16)
 
 
 
 
 
 
As at 30.06.22
 
As at 31.12.21
 
As at 30.06.21
 
Balance sheet information
£bn
£bn
£bn
Loans and advances to customers at amortised cost
205.9
208.8
207.8
Total assets
318.8
321.2
311.2
Customer deposits at amortised cost
261.5
260.6
255.5
Loan: deposit ratio
85%
85%
87%
Risk weighted assets
72.2
72.3
72.2
Period end allocated tangible equity
9.9
10.0
9.9
 
 
 
 
 
Half year ended
Half year ended
 
Key facts
 
30.06.22
30.06.21
 
Average loan to value of mortgage portfolio1
51%
51%
 
Average loan to value of new mortgage lending1
69%
69%
 
Number of branches
593
755
 
Mobile banking active customers
10.1m
9.4m
 
30 day arrears rate - Barclaycard Consumer UK
1.0%
1.4%
 
 
 
 
 
Performance measures
 
 
 
Return on average allocated tangible equity
17.0%
20.6%
 
Average allocated tangible equity (£bn)
10.0
9.9
 
Cost: income ratio
62%
67%
 
Loan loss rate (bps)
4
 
Net interest margin
 
2.67%
 
2.54%
 
 
 
 
 
1
Average loan to value of mortgages is balance weighted and reflects both residential and buy-to-let mortgage portfolios within the Home Loans portfolio.
 
 
Analysis of Barclays UK
Half year ended
 
Half year ended
 
 
30.06.22
 
30.06.21
 
 
Analysis of total income
£m
£m
% Change
 
Personal Banking
2,099
1,910
10
Barclaycard Consumer UK
541
605
(11)
Business Banking
733
684
7
Total income
3,373
3,199
5
 
 
 
 
Analysis of credit impairment (charges)/releases
 
 
 
Personal Banking
(21)
50
 
Barclaycard Consumer UK
40
398
(90)
Business Banking
(67)
(5)
 
Total credit impairment (charges)/releases
(48)
443
 
 
 
 
 
 
As at 30.06.22
 
As at 31.12.21
 
As at 30.06.21
 
Analysis of loans and advances to customers at amortised cost
£bn
 
£bn
 
£bn
 
Personal Banking
167.1
165.4
162.4
Barclaycard Consumer UK
8.8
8.7
8.8
Business Banking
30.0
34.7
36.6
Total loans and advances to customers at amortised cost
205.9
208.8
207.8
 
 
 
 
Analysis of customer deposits at amortised cost
 
 
 
Personal Banking
197.0
196.4
191.0
Barclaycard Consumer UK
0.1
Business Banking
64.5
64.2
64.4
Total customer deposits at amortised cost
261.5
260.6
255.5
 
 
 
 
Barclays UK delivered a RoTE of 17.0% (H121: 20.6%), and a lower cost: income ratio of 62% (H121: 67%), reflecting improved income performance across Personal Banking and Business Banking, alongside reduced total operating expenses, while impairment returned to a charge following a net release in H121. Barclays UK remains well positioned, with a strong focus on supporting customers in an increasingly difficult and uncertain environment.
 
Income statement - H122 compared to H121
 
Profit before tax decreased to £1,217m (H121: £1,506m). RoTE was 17.0% (H121: 20.6%) reflecting the non-recurrence of a prior year credit impairment release, partially offset by the rising rate environment in the UK
 

●     Total income increased 5% to £3,373m. Net interest income increased 6% to £2,732m with a net interest margin (NIM) of 2.67% (H121: 2.54%) primarily driven by the rising interest rate environment in the UK. Net fee, commission and other income increased 5% to £641m
 
Personal Banking income increased 10% to £2,099m, driven by rising interest rates and the benefit of strong mortgage origination in 2021, partially offset by mortgage margin compression
 
Barclaycard Consumer UK income decreased 11% to £541m as higher transaction based revenues from improved customer spend volumes were more than offset by lower interest earning lending (IEL) balances. Lower IEL balances were impacted by higher customer repayments and reduced borrowing
 
Business Banking income increased 7% to £733m driven by rising interest rates alongside improved transaction based revenues, partially offset by lower government scheme lending income as repayments continue
 
Credit impairment charge of £48m (H121: £443m net release) driven by low flows to delinquency, improved UK employment data and reduced uncertainty around the possible effects of COVID-19, offset by increased concerns around customers' vulnerability to high inflation. As at 30 June 2022, 30 and 90 day arrears rates in UK cards were 1.0% (H121: 1.4%) and 0.2% (H121: 0.6%) respectively. The credit card and consumer loan businesses maintain appropriate provision levels in light of affordability headwinds, as reflected in a total coverage ratio of 9.2% (December 2021: 10.9%)
 
Total operating expenses decreased 1% to £2,108m driven by lower operational costs and efficiency savings, partially offset by increased investment spend and the impact of inflation
 
 
Balance sheet - 30 June 2022 compared to 31 December 2021
 
Loans and advances to customers at amortised cost decreased 1% to £205.9bn as £1.5bn of mortgage growth was more than offset by a £4.7bn decrease in Business Banking balances due to the repayment of government scheme lending and the yield curve impact from rising interest rates on the Education, Social Housing and Local Authority portfolio carrying value
 
Customer deposits at amortised cost remained broadly stable at £261.5bn, maintaining a strong loan: deposit ratio of 85% (December 2021: 85%)
 
RWAs remained stable at £72.2bn (December 2021: £72.3bn)
 
 
 
 
Barclays International
Half year ended
 
Restated1
Half year ended
 
 
 
30.06.22
 
30.06.21
 
 
Income statement information
£m
£m
% Change
 
Net interest income
1,965
1,559
26
Net trading income
5,212
3,389
54
Net fee, commission and other income
2,763
3,270
(16)
Total income
9,940
8,218
21
Credit impairment (charges)/releases
(310)
293
 
Net operating income
9,630
8,511
13
Operating costs
(5,042)
(4,606)
(9)
Litigation and conduct
(1,832)
(161)
 
Total operating expenses
(6,874)
(4,767)
(44)
Other net income
 
13
22
(41)
Profit before tax
2,769
3,766
(26)
Attributable profit
2,083
2,638
(21)
 
 
 
 
 
As at 30.06.22
 
As at 31.12.21
 
As at 30.06.21
 
Balance sheet information
£bn
 
£bn
 
£bn
 
Loans and advances at amortised cost
167.3
133.8
121.9
Trading portfolio assets
126.9
146.9
147.1
Derivative financial instrument assets
343.5
261.5
255.4
Financial assets at fair value through the income statement
209.3
188.2
190.4
Cash collateral and settlement balances
128.5
88.1
108.5
Other assets
275.1
225.6
223.5
Total assets
1,250.6
1,044.1
1,046.8
Deposits at amortised cost
307.4
258.8
245.4
Derivative financial instrument liabilities
321.2
256.4
246.9
Loan: deposit ratio
54%
52%
50%
Risk weighted assets
263.8
230.9
223.2
Period end allocated tangible equity
38.0
33.2
31.8
 
 
 
 
 
Half year ended
 
Restated1
Half year ended
 
 
Performance measures
30.06.22
 
30.06.21
 
 
Return on average allocated tangible equity
11.5%
16.3%
 
Average allocated tangible equity (£bn)
36.2
32.3
 
Cost: income ratio
69%
58%
 
Loan loss rate (bps)
37
 
Net interest margin
4.34%
3.95%
 
 
 
 
 
1
2021 financial and capital metrics have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 65 and Restatement of financial statements (Note 1) on page 87 for more information.
 
 
Analysis of Barclays International
 
 
 
Corporate and Investment Bank
Half year ended
 
Restated1
Half year ended
 
 
 
30.06.22
 
30.06.21
 
 
Income statement information
£m
£m
% Change
Net interest income
795
640
24
Net trading income
5,188
3,411
52
Net fee, commission and other income
1,988
2,522
(21)
Total income
7,971
6,573
21
Credit impairment (charges)/releases
(32)
272
 
Net operating income
7,939
6,845
16
Operating costs
(3,791)
(3,509)
(8)
Litigation and conduct
(1,632)
(79)
 
Total operating expenses
(5,423)
(3,588)
(51)
Other net income
1
 
Profit before tax
2,516
3,258
(23)
Attributable profit
1,895
2,252
(16)
 
 
 
 
 
As at 30.06.22
 
As at 31.12.21
 
As at 30.06.21
 
Balance sheet information
£bn
£bn
£bn
Loans and advances at amortised cost
125.8
100.0
91.0
Trading portfolio assets
126.7
146.7
147.0
Derivative financial instrument assets
343.4
261.5
255.3
Financial assets at fair value through the income statement
209.2
188.1
190.3
Cash collateral and settlement balances
127.7
87.2
107.7
Other assets
237.2
195.8
192.5
Total assets
1,170.0
979.3
983.8
Deposits at amortised cost
229.5
189.4
178.2
Derivative financial instrument liabilities
 
321.2
256.4
246.8
Risk weighted assets
227.6
200.7
194.3
 
 
 
 
 
Half year ended
 
Restated1
Half year ended
 
 
Performance measures
30.06.22
30.06.21
 
Return on average allocated tangible equity
11.9%
15.9%
 
Average allocated tangible equity (£bn)
31.8
28.3
 
Cost: income ratio
68%
55%
 
 
 
 
 
 
 
 
 
Analysis of total income
£m
£m
% Change
FICC
3,173
2,099
51
Equities
2,463
1,709
44
Global Markets
5,636
3,808
48
Advisory
421
381
10
Equity capital markets
84
469
(82)
Debt capital markets
697
882
(21)
Investment Banking fees
1,202
1,732
(31)
Corporate lending
78
244
(68)
Transaction banking
1,055
789
34
Corporate
1,133
1,033
10
Total income
7,971
6,573
21
 
 
 
 
1
2021 financial and capital metrics have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 65 and Restatement of financial statements (Note 1) on page 87 for more information.
 
Analysis of Barclays International
 
 
 
Consumer, Cards and Payments
Half year ended
 
Half year ended
 
 
 
30.06.22
 
30.06.21
 
 
Income statement information
£m
£m
% Change
Net interest income
1,170
919
27
Net fee, commission, trading and other income
799
726
10
Total income
1,969
1,645
20
Credit impairment (charges)/releases
(278)
21
 
Net operating income
1,691
1,666
2
Operating costs
(1,251)
(1,097)
(14)
Litigation and conduct
(200)
(82)
 
Total operating expenses
(1,451)
(1,179)
(23)
Other net income
13
21
(38)
Profit before tax
253
508
(50)
Attributable profit
188
386
(51)
 
 
 
 
 
As at 30.06.22
 
As at 31.12.21
 
As at 30.06.21
 
Balance sheet information
£bn
£bn
£bn
Loans and advances at amortised cost
41.5
33.8
30.9
Total assets
80.6
64.8
63.0
Deposits at amortised cost
77.9
69.4
67.2
Risk weighted assets
36.2
30.2
29.0
 
 
 
 
 
Half year ended
 
Half year ended
 
 
Key facts
30.06.22
30.06.21
 
30 day arrears rate – Barclaycard US
1.4%
1.6%
 
US cards customer FICO score distribution
 
 
 
<660
10%
10%
 
>660
90%
90%
 
Total number of Barclaycard payments clients
c.391,000
c.372,000
 
Value of payments processed (£bn)1
190
160
 
 
 
 
 
Performance measures
 
 
 
Return on average allocated tangible equity
8.5%
19.1%
 
Average allocated tangible equity (£bn)
4.4
4.0
 
Cost: income ratio
74%
72%
 
Loan loss rate (bps)
128
 
 
 
 
 
Analysis of total income
£m
£m
% Change
 
International Cards and Consumer Bank
1,229
1,050
17
Private Bank
459
393
17
Payments
281
202
39
Total income
1,969
1,645
20
 
 
 
 
 
 
 
 
 
1
Includes £145bn (H121: £129bn) of merchant acquiring payments.
 
 
Barclays International delivered a RoTE of 11.5% reflecting the benefits of being a diversified business. CIB delivered a RoTE of 11.9% reflecting a strong performance in FICC, partially offset by a decrease in Investment Banking fees, against a strong prior year comparative, and provisions for litigation and conduct. CC&P RoTE decreased to 8.5% as an increase in income was offset by a provision for higher customer remediation costs relating to a legacy loan portfolio and continued investment in the business.
 
Income statement - H122 compared to H1211
 
Profit before tax decreased 26% to £2,769m with a RoTE of 11.5% (H121: 16.3%), reflecting a RoTE of 11.9% (H121: 15.9%) in CIB and 8.5% (H121: 19.1%) in CC&P
 
The 6% appreciation of average USD against GBP positively impacted income and profits and adversely impacted impairment charges and total operating expenses
 
Total income increased to £9,940m (H121: £8,218m)
 
CIB income increased 21% to £7,971m reflecting the benefit of a diversified business model and impact of hedging arrangements
 
Global Markets income increased 48% to £5,636m. FICC income increased 51% to £3,173m, mainly in macro, reflecting higher levels of activity as we supported our clients through a period of market volatility. Equities income increased £754m to £2,463m including £758m of income related to hedging arrangements in relation to managing the risks from the rescission offer to be launched by Barclays Bank PLC in relation to the Over-issuance of Securities
 
Investment Banking fees income decreased 31% to £1,202m due to the reduced fee pool, particularly in Equity capital markets2, and a strong prior year comparative
 
Within Corporate, Transaction banking income increased 34% to £1,055m driven by deposit balance growth, improved margins and higher payments volumes. Corporate lending income decreased 68% to £78m due to losses on certain fair value lending positions and higher costs of hedging and credit protection, partially offset by the non-recurrence of a prior year fair value loan write-off on a single name
 
CC&P income increased 20% to £1,969m
 
International Cards and Consumer Bank income increased 17% to £1,229m as higher average cards balances were partially offset by higher customer acquisition costs
 
Private Bank income increased 17% to £459m, reflecting client balance growth and improved margins partially offset by the non-recurrence of a gain on a property sale in the prior year
 
Payments income increased 39% to £281m driven by turnover growth following the easing of lockdown restrictions in the past year
 
Credit impairment charges were £310m (H121: £293m net release)
 
CIB credit impairment charge of £32m (H121: £272m net release) was driven by a net increase in modelled impairment whilst there continue to be limited material single name wholesale loan charges, with the prior year including a net release resulting from an improved macroeconomic outlook scenario refresh
 
CC&P credit impairment charges increased to £278m (H121: £21m net release) driven by higher balances in US cards, including the day one impact of acquiring the GAP portfolio, partially offset by lower provisions held for uncertainty. As at 30 June 2022, 30 and 90 day arrears in US cards were 1.4% (H121: 1.6%) and 0.7% (H121: 0.9%) respectively. The US cards business continues to maintain appropriate provision levels in light of affordability headwinds
 
Total operating expenses increased 44% to £6,874m
 
CIB total operating expenses increased 51% to £5,423m. Operating costs increased 8% to £3,791m driven by investment in talent, systems and technology, and the impact of inflation. Litigation and conduct charges were £1,632m (H121: £79m) including £1,304m estimated impact of rescission offer losses in relation to the Over-Issuance of Securities and £165m associated estimated monetary penalty from the SEC, and £165m provision relating to the Devices Settlements in Principle
 
CC&P total operating expenses increased 23% to £1,451m primarily driven by £200m of litigation and conduct costs, including a provision for higher customer remediation costs relating to a legacy loan portfolio. Operating costs increased 14% driven by higher investment spend reflecting an increase in marketing and costs for existing and new partnerships
 
 
1
2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page 87 for more information.
2
Data source: Dealogic for the period covering 1 January to 30 June 2022.
 
 
Balance sheet - 30 June 2022 compared to 31 December 2021
 
Loans and advances at amortised cost increased £33.5bn to £167.3bn due to increased lending across CIB and CC&P, inclusive of the £2.7bn GAP portfolio acquisition and appreciation of USD against GBP, and increased investment in debt securities
 
Trading portfolio assets decreased £20.0bn to £126.9bn due to a reduction in equity securities driven by facilitation of client activity, partially offset by increased trading activity in debt securities
 
Derivative assets and liabilities increased £82.0bn and £64.8bn respectively to £343.5bn and £321.2bn driven by market volatility and increased activity in FICC and Equities
 
Financial assets at fair value through the income statement increased £21.1bn to £209.3bn driven by increased secured lending
 
Deposits at amortised cost increased £48.6bn to £307.4bn primarily due to an increase in short-term money market deposits and growth in Corporate deposits
 
RWAs increased to £263.8bn (December 2021: £230.9bn) resulting from the impact of the appreciation of USD against GBP, regulatory changes that took effect from 1 January 2022, increased client activity within CIB, an increase in respect of hedging arrangements designed to manage the risks of the rescission offer relating to the Over-issuance of Securities and higher CC&P balances driven mainly by the GAP portfolio acquisition
 
 
 
 
Head Office
Half year ended
 
Half year ended
 
 
 
30.06.22
 
30.06.21
 
 
Income statement information
£m
£m
% Change
 
Net interest income
66
(242)
 
Net fee, commission and other income
(175)
140
 
Total income
(109)
(102)
(7)
Credit impairment releases
17
6
 
Net operating income
(92)
(96)
4
Operating costs
(145)
(412)
65
Litigation and conduct
7
 
Total operating expenses
(145)
(405)
64
Other net (expenses)/income
(16)
131
 
Loss before tax
(253)
(370)
32
Attributable (loss)/profit
(462)
95
 
 
 
 
 
 
As at 30.06.22
 
Restated1
As at 31.12.21
 
Restated1
As at 30.06.21
 
Balance sheet information
£bn
 
£bn
 
£bn
 
Total assets
19.8
19.0
18.3
Risk weighted assets
8.6
11.0
12.0
Period end allocated tangible equity
1.1
5.5
5.9
 
 
 
 
 
Half year ended
 
Half year ended
 
 
Performance measures
30.06.22
 
30.06.21
 
 
Average allocated tangible equity (£bn)
2.7
4.3
 
 
 
 
Income statement - H122 compared to H121
 
Loss before tax was £253m (H121: £370m)
 
Total income was an expense of £109m (H121: £102m expense) which primarily reflected hedge accounting, funding costs on legacy capital instruments, treasury items as well as a £42m loss on sale from the partial disposal of Barclays’ equity stake in Absa in April 2022. This was partially offset by a one-off gain of £86m from the sale and leaseback of UK data centres and the recognition of dividends on Barclays’ equity stake in Absa
 
Total operating expenses reduced to £145m (H121: £405m) reflecting the non-recurrence of the £266m charge related to structural cost actions taken as part of the real estate review in June 2021
 
Other net income was an expense of £16m (H121: £131m income) driven by a fair value loss in Barclays associate investment holding in the Business Growth Fund
 
 
Balance sheet - 30 June 2022 compared to 31 December 2021
 
RWAs reduced to £8.6bn (December 2021: £11.0bn) reflecting the partial sale of Barclays' equity stake in Absa in April 2022. The sale resulted in an increase to Barclays' CET1 ratio of c.10bps
 
 
 
1
2021 financial and capital metrics have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 65 and Restatement of financial statements (Note 1) on page 87 for more information.
 
 
Quarterly Results Summary
 
Barclays Group
 
 
 
 
 
 
 
 
 
 
 
 
Q222
 
Q122
 
 
Q4211
 
Q3211
 
Q2211
 
Q121
 
 
Q420
 
Q320
 
Income statement information
 
£m
 
£m
 
 
£m
 
£m
 
£m
 
£m
 
 
£m
 
£m
 
Net interest income
2,422
2,341
 
2,230
1,940
2,052
1,851
 
1,845
2,055
Net fee, commission and other income
4,286
4,155
 
2,930
3,525
3,363
4,049
 
3,096
3,149
Total income
6,708
6,496
 
5,160
5,465
5,415
5,900
 
4,941
5,204
Credit impairment (charges)/releases
(200)
(141)
 
31
(120)
797
(55)
 
(492)
(608)
Net operating income
6,508
6,355
 
5,191
5,345
6,212
5,845
 
4,449
4,596
Operating costs
(3,682)
(3,588)
 
(3,514)
(3,446)
(3,587)
(3,545)
 
(3,480)
(3,391)
UK bank levy
 
(170)
 
(299)
Litigation and conduct
(1,334)
(523)
 
(92)
(129)
(143)
(33)
 
(47)
(76)
Total operating expenses
(5,016)
(4,111)
 
(3,776)
(3,575)
(3,730)
(3,578)
 
(3,826)
(3,467)
Other net income/(expenses)
7
(10)
 
13
94
21
132
 
23
18
Profit before tax
1,499
2,234
 
1,428
1,864
2,503
2,399
 
646
1,147
Tax charge
(209)
(614)
 
(104)
(292)
(246)
(496)
 
(163)
(328)
Profit after tax
1,290
1,620
 
1,324
1,572
2,257
1,903
 
483
819
Non-controlling interests
(20)
(1)
 
(27)
(1)
(15)
(4)
 
(37)
(4)
Other equity instrument holders
(199)
(215)
 
(218)
(197)
(194)
(195)
 
(226)
(204)
Attributable profit
1,071
1,404
 
1,079
1,374
2,048
1,704
 
220
611
 
 
 
 
 
 
 
 
 
 
 
Performance measures
 
 
 
 
 
 
 
 
 
 
Return on average tangible shareholders' equity
8.7%
11.5%
 
9.0%
11.4%
17.6%
14.7%
 
1.8%
5.1%
Average tangible shareholders' equity (£bn)
49.0
48.8
 
48.0
48.3
46.5
46.5
 
47.6
48.3
Cost: income ratio
75%
63%
 
73%
65%
69%
61%
 
77%
67%
Loan loss rate (bps)
20
15
 
13
6
 
56
69
Basic earnings per share
6.4p
8.4p
 
6.4p
8.0p
11.9p
9.9p
 
1.3p
3.5p
Basic weighted average number of shares (m)
16,684
16,682
 
16,985
17,062
17,140
17,293
 
17,300
17,298
Period end number of shares (m)
16,531
16,762
 
16,752
16,851
16,998
17,223
 
17,359
17,353
 
 
 
 
 
 
 
 
 
 
 
Balance sheet and capital management2
£bn
 
£bn
 
 
£bn
 
£bn
 
£bn
 
£bn
 
 
£bn
 
£bn
 
Loans and advances at amortised cost
395.8
371.7
 
361.5
353.0
348.5
345.8
 
342.6
344.4
Loans and advances at amortised cost impairment coverage ratio
1.4%
1.5%
 
1.6%
1.7%
1.8%
2.2%
 
2.4%
2.5%
Total assets
1,589.2
1,496.1
 
1,384.3
1,406.5
1,376.3
1,379.7
 
1,349.5
1,421.7
Deposits at amortised cost
568.7
546.5
 
519.4
510.2
500.9
498.8
 
481.0
494.6
Tangible net asset value per share
297p
294p
 
291p
286p
280p
267p
 
269p
275p
Common equity tier 1 ratio
13.6%
13.8%
 
15.1%
15.3%
15.0%
14.6%
 
15.1%
14.6%
Common equity tier 1 capital
46.7
45.3
 
47.3
47.2
46.2
45.9
 
46.3
45.5
Risk weighted assets
344.5
328.8
 
314.1
307.7
307.4
313.4
 
306.2
310.7
UK leverage ratio
5.1%
5.0%
 
5.2%
5.1%
5.0%
5.0%
 
5.3%
5.2%
UK leverage exposure
1,151.2
1,123.5
 
1,137.9
1,162.7
1,154.9
1,145.4
 
1,090.9
1,095.1
Average UK leverage ratio
4.7%
4.8%
 
4.9%
4.9%
4.8%
4.9%
 
5.0%
5.1%
Average UK leverage exposure
1,233.5
1,179.4
 
1,229.0
1,201.1
1,192.7
1,174.9
 
1,146.9
1,111.1
 
 
 
 
 
 
 
 
 
 
 
Funding and liquidity
 
 
 
 
 
 
 
 
 
 
Group liquidity pool (£bn)
343
320
 
291
293
291
290
 
266
327
Liquidity coverage ratio
156%
159%
 
168%
161%
162%
161%
 
162%
181%
Loan: deposit ratio
70%
68%
 
70%
69%
70%
69%
 
71%
70%
 
 
 
1
The comparative capital and financial metrics relating to Q221 - Q421 have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 65 and Restatement of financial statements (Note 1) on page 87 for more information.
2
Refer to pages 55 to 62 for further information on how capital, RWAs and leverage are calculated.
 
Quarterly Results by Business 

 
 
Barclays UK
 
 
 
 
 
 
 
 
 
 
 
Q222
 
Q122
 
 
Q421
 
Q321
 
Q221
 
Q121
 
 
Q420
 
Q320
 
Income statement information
£m
 
£m
 
 
£m
 
£m
 
£m
 
£m
 
 
£m
 
£m
 
Net interest income
1,393
1,339
 
1,313
1,303
1,305
1,281
 
1,317
1,280
Net fee, commission and other income
331
310
 
386
335
318
295
 
309
270
Total income
1,724
1,649
 
1,699
1,638
1,623
1,576
 
1,626
1,550
Credit impairment (charges)/releases
(48)
 
59
(137)
520
(77)
 
(170)
(233)
Net operating income
1,724
1,601
 
1,758
1,501
2,143
1,499
 
1,456
1,317
Operating costs
(1,085)
(998)
 
(1,202)
(1,041)
(1,078)
(1,036)
 
(1,134)
(1,095)
UK bank levy
 
(36)
 
(50)
Litigation and conduct
(16)
(9)
 
(5)
(10)
(19)
(3)
 
4
(25)
Total operating expenses
(1,101)
(1,007)
 
(1,243)
(1,051)
(1,097)
(1,039)
 
(1,180)
(1,120)
Other net (expenses)/income
 
(1)
1
 
6
(1)
Profit before tax
623
594
 
514
451
1,046
460
 
282
196
Attributable profit
458
396
 
420
317
721
298
 
160
113
 
 
 
 
 
 
 
 
 
 
 
Balance sheet information
£bn
 
£bn
 
 
£bn
 
£bn
 
£bn
 
£bn
 
 
£bn
 
£bn
 
Loans and advances to customers at amortised cost
205.9
207.3
 
208.8
208.6
207.8
205.7
 
205.4
203.9
Total assets
318.8
317.2
 
321.2
312.1
311.2
309.1
 
289.1
294.5
Customer deposits at amortised cost
261.5
260.3
 
260.6
256.8
255.5
247.5
 
240.5
232.0
Loan: deposit ratio
85%
85%
 
85%
86%
87%
88%
 
89%
91%
Risk weighted assets
72.2
72.7
 
72.3
73.2
72.2
72.7
 
73.7
76.2
Period end allocated tangible equity
9.9
10.1
 
10.0
10.0
9.9
10.0
 
9.7
10.0
 
 
 
 
 
 
 
 
 
 
 
Performance measures
 
 
 
 
 
 
 
 
 
 
Return on average allocated tangible equity
18.4%
15.6%
 
16.8%
12.7%
29.1%
12.0%
 
6.5%
4.5%
Average allocated tangible equity (£bn)
10.0
10.1
 
10.0
10.0
9.9
9.9
 
9.8
10.1
Cost: income ratio
64%
61%
 
73%
64%
68%
66%
 
73%
72%
Loan loss rate (bps)
9
 
24
14
 
31
43
Net interest margin
2.71%
2.62%
 
2.49%
2.49%
2.55%
2.54%
 
2.56%
2.51%
 

 
 
Analysis of Barclays UK
Q222
 
Q122
 
 
Q421
 
Q321
 
Q221
 
Q121
 
 
Q420
 
Q320
 
Analysis of total income
£m
 
£m
 
 
£m
 
£m
 
£m
 
£m
 
 
£m
 
£m
 
Personal Banking
1,077
1,022
 
983
990
987
923
 
895
833
Barclaycard Consumer UK
265
276
 
352
293
290
315
 
354
362
Business Banking
382
351
 
364
355
346
338
 
377
355
Total income
1,724
1,649
 
1,699
1,638
1,623
1,576
 
1,626
1,550
 
 
 
 
 
 
 
 
 
 
 
Analysis of credit impairment (charges)/releases
 
 
 
 
 
 
 
 
 
 
Personal Banking
(42)
21
 
8
(30)
72
(22)
 
(68)
(48)
Barclaycard Consumer UK
84
(44)
 
114
(108)
434
(36)
 
(78)
(106)
Business Banking
(42)
(25)
 
(63)
1
14
(19)
 
(24)
(79)
Total credit impairment (charges)/releases
(48)
 
59
(137)
520
(77)
 
(170)
(233)
 
 
 
 
 
 
 
 
 
 
 
Analysis of loans and advances to customers at amortised cost
£bn
 
£bn
 
 
£bn
 
£bn
 
£bn
 
£bn
 
 
£bn
 
£bn
 
Personal Banking
167.1
166.5
 
165.4
164.6
162.4
160.4
 
157.3
155.7
Barclaycard Consumer UK
8.8
8.4
 
8.7
8.6
8.8
8.7
 
9.9
10.7
Business Banking
30.0
32.4
 
34.7
35.4
36.6
36.6
 
38.2
37.5
Total loans and advances to customers at amortised cost
205.9
207.3
 
208.8
208.6
207.8
205.7
 
205.4
203.9
 
 
 
 
 
 
 
 
 
 
 
Analysis of customer deposits at amortised cost
 
 
 
 
 
 
 
 
 
 
Personal Banking
197.0
196.6
 
196.4
193.3
191.0
186.0
 
179.7
173.2
Barclaycard Consumer UK
 
0.1
0.1
 
0.1
0.1
Business Banking
64.5
63.7
 
64.2
63.5
64.4
61.4
 
60.7
58.7
Total customer deposits at amortised cost
261.5
260.3
 
260.6
256.8
255.5
247.5
 
240.5
232.0
 
Barclays International
 
 
 
 
 
 
 
 
 
 
 
Q222
 
Q122
 
 
Q4211
 
Q3211
 
Q2211
 
Q121
 
 
Q420
 
Q320
 
Income statement information
£m
 
£m
 
 
£m
 
£m
 
£m
 
£m
 
 
£m
 
£m
 
Net interest income
1,029
936
 
955
749
811
748
 
614
823
Net trading income
2,766
2,446
 
789
1,515
1,455
1,934
 
1,372
1,528
Net fee, commission and other income
1,321
1,442
 
1,766
1,673
1,553
1,717
 
1,500
1,430
Total income
5,116
4,824
 
3,510
3,937
3,819
4,399
 
3,486
3,781
Credit impairment (charges)/releases
(209)
(101)
 
(23)
18
271
22
 
(291)
(370)
Net operating income
4,907
4,723
 
3,487
3,955
4,090
4,421
 
3,195
3,411
Operating costs
(2,537)
(2,505)
 
(2,160)
(2,310)
(2,168)
(2,438)
 
(2,133)
(2,227)
UK bank levy
 
(134)
 
(240)
Litigation and conduct
(1,319)
(513)
 
(84)
(100)
(140)
(21)
 
(9)
(28)
Total operating expenses
(3,856)
(3,018)
 
(2,378)
(2,410)
(2,308)
(2,459)
 
(2,382)
(2,255)
Other net income
5
8
 
3
15
13
9
 
9
9
Profit before tax
1,056
1,713
 
1,112
1,560
1,795
1,971
 
822
1,165
Attributable profit
783
1,300
 
818
1,191
1,207
1,431
 
441
782
 
 
 
 
 
 
 
 
 
 
 
Balance sheet information
£bn
 
£bn
 
 
£bn
 
£bn
 
£bn
 
£bn
 
 
£bn
 
£bn
 
Loans and advances at amortised cost
167.3
144.8
 
133.8
125.9
121.9
123.5
 
122.7
128.0
Trading portfolio assets
126.9
134.1
 
146.9
144.8
147.1
131.1
 
127.7
122.3
Derivative financial instrument assets
343.5
288.8
 
261.5
257.0
255.4
269.4
 
301.8
295.9
Financial assets at fair value through the income statement
209.3
203.8
 
188.2
200.5
190.4
197.5
 
170.7
178.2
Cash collateral and settlement balances
128.5
132.0
 
88.1
115.9
108.5
109.7
 
97.5
121.8
Other assets
275.1
255.5
 
225.6
231.8
223.5
221.7
 
221.4
261.7
Total assets
1,250.6
1,159.0
 
1,044.1
1,075.9
1,046.8
1,052.9
 
1,041.8
1,107.9
Deposits at amortised cost
307.4
286.1
 
258.8
253.3
245.4
251.2
 
240.5
262.4
Derivative financial instrument liabilities
321.2
277.2
 
256.4
252.3
246.9
260.2
 
300.4
293.3
Loan: deposit ratio
54%
51%
 
52%
50%
50%
49%
 
51%
49%
Risk weighted assets
263.8
245.1
 
230.9
222.7
223.2
230.0
 
222.3
224.7
Period end allocated tangible equity
38.0
35.6
 
33.2
31.8
31.8
32.7
 
30.2
30.5
 
 
 
 
 
 
 
 
 
 
 
Performance measures
 
 
 
 
 
 
 
 
 
 
Return on average allocated tangible equity
8.4%
14.8%
 
9.9%
14.9%
14.9%
17.7%
 
5.8%
10.2%
Average allocated tangible equity (£bn)
37.3
35.1
 
32.9
31.8
32.4
32.3
 
30.5
30.6
Cost: income ratio
75%
63%
 
68%
61%
60%
56%
 
68%
60%
Loan loss rate (bps)
49
28
 
7
(7)
 
90
112
Net interest margin
4.52%
4.15%
 
4.14%
4.02%
3.96%
3.92%
 
3.41%
3.79%
 
 
1
The comparative capital and financial metrics relating to Q221 - Q421 have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 65 and Restatement of financial statements (Note 1) on page 87 for more information.
 
Analysis of Barclays International
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Corporate and Investment Bank
Q222
 
Q122
 
 
Q4211
 
Q3211
 
Q2211
 
Q121
 
 
Q420
 
Q320
 
Income statement information
£m
 
£m
 
 
£m
 
£m
 
£m
 
£m
 
 
£m
 
£m
 
Net interest income
410
385
 
432
279
370
270
 
110
305
Net trading income
2,738
2,450
 
774
1,467
1,494
1,917
 
1,397
1,535
Net fee, commission and other income
885
1,103
 
1,426
1,383
1,115
1,407
 
1,131
1,065
Total income
4,033
3,938
 
2,632
3,129
2,979
3,594
 
2,638
2,905
Credit impairment (charges)/releases
(65)
33
 
73
128
229
43
 
(52)
(187)
Net operating income
3,968
3,971
 
2,705
3,257
3,208
3,637
 
2,586
2,718
Operating costs
(1,870)
(1,921)
 
(1,562)
(1,747)
(1,623)
(1,886)
 
(1,603)
(1,716)
UK bank levy
 
(128)
 
(226)
Litigation and conduct
(1,314)
(318)
 
(59)
(99)
(78)
(1)
 
2
(3)
Total operating expenses
(3,184)
(2,239)
 
(1,749)
(1,846)
(1,701)
(1,887)
 
(1,827)
(1,719)
Other net income
 
1
1
 
2
1
Profit before tax
784
1,732
 
957
1,411
1,507
1,751
 
761
1,000
Attributable profit
579
1,316
 
695
1,085
989
1,263
 
413
627
 
 
 
 
 
 
 
 
 
 
 
Balance sheet information
£bn
 
£bn
 
 
£bn
 
£bn
 
£bn
 
£bn
 
 
£bn
 
£bn
 
Loans and advances at amortised cost
125.8
109.6
 
100.0
93.8
91.0
94.3
 
92.4
96.8
Trading portfolio assets
126.7
134.0
 
146.7
144.7
147.0
130.9
 
127.5
122.2
Derivative financial instruments assets
343.4
288.7
 
261.5
256.9
255.3
269.4
 
301.7
295.9
Financial assets at fair value through the income statement
209.2
203.8
 
188.1
200.4
190.3
197.3
 
170.4
177.9
Cash collateral and settlement balances
127.7
131.2
 
87.2
115.1
107.7
108.8
 
96.7
121.0
Other assets
237.2
222.5
 
195.8
200.4
192.5
190.8
 
194.9
228.9
Total assets
1,170.0
1,089.8
 
979.3
1,011.3
983.8
991.5
 
983.6
1,042.7
Deposits at amortised cost
229.5
214.7
 
189.4
185.8
178.2
185.2
 
175.2
195.6
Derivative financial instrument liabilities
321.2
277.1
 
256.4
252.2
246.8
260.2
 
300.3
293.2
Risk weighted assets
227.6
213.5
 
200.7
192.5
194.3
201.3
 
192.2
193.3
 
 
 
 
 
 
 
 
 
 
 
Performance measures
 
 
 
 
 
 
 
 
 
 
Return on average allocated tangible equity
7.1%
17.1%
 
9.7%
15.6%
14.0%
17.9%
 
6.3%
9.5%
Average allocated tangible equity (£bn)
32.7
30.8
 
28.7
27.8
28.4
28.2
 
26.3
26.4
Cost: income ratio
79%
57%
 
66%
59%
57%
53%
 
69%
59%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Analysis of total income
£m
 
£m
 
 
£m
 
£m
 
£m
 
£m
 
 
£m
 
£m
 
FICC
1,529
1,644
 
546
803
895
1,204
 
812
1,000
Equities
1,411
1,052
 
501
757
777
932
 
542
691
Global Markets
2,940
2,696
 
1,047
1,560
1,672
2,136
 
1,354
1,691
Advisory
236
185
 
287
253
218
163
 
232
90
Equity capital markets
37
47
 
158
186
226
243
 
104
122
Debt capital markets
281
416
 
511
532
429
453
 
418
398
Investment Banking fees
554
648
 
956
971
873
859
 
754
610
Corporate lending
(47)
125
 
176
168
38
206
 
186
232
Transaction banking
586
469
 
453
430
396
393
 
344
372
Corporate
539
594
 
629
598
434
599
 
530
604
Total income
4,033
3,938
 
2,632
3,129
2,979
3,594
 
2,638
2,905
 
 
1
The comparative capital and financial metrics relating to Q221 - Q421 have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 65 and Restatement of financial statements (Note 1) on page 87 for more information.
 
 
Analysis of Barclays International
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Consumer, Cards and Payments
Q222
 
Q122
 
 
Q421
 
Q321
 
Q221
 
Q121
 
 
Q420
 
Q320
 
Income statement information
£m
 
£m
 
 
£m
 
£m
 
£m
 
£m
 
 
£m
 
£m
 
Net interest income
619
551
 
522
471
441
478
 
504
518
Net fee, commission, trading and other income
464
335
 
356
337
399
327
 
344
358
Total income
1,083
886
 
878
808
840
805
 
848
876
Credit impairment (charges)/releases
(144)
(134)
 
(96)
(110)
42
(21)
 
(239)
(183)
Net operating income
939
752
 
782
698
882
784
 
609
693
Operating costs
(667)
(584)
 
(598)
(563)
(545)
(552)
 
(530)
(511)
UK bank levy
 
(6)
 
(14)
Litigation and conduct
(5)
(195)
 
(25)
(1)
(62)
(20)
 
(11)
(25)
Total operating expenses
(672)
(779)
 
(629)
(564)
(607)
(572)
 
(555)
(536)
Other net income
5
8
 
2
15
13
8
 
7
8
Profit/(loss) before tax
272
(19)
 
155
149
288
220
 
61
165
Attributable profit/(loss)
204
(16)
 
123
106
218
168
 
28
155
 
 
 
 
 
 
 
 
 
 
 
Balance sheet information
£bn
 
£bn
 
 
£bn
 
£bn
 
£bn
 
£bn
 
 
£bn
 
£bn
 
Loans and advances at amortised cost
41.5
35.2
 
33.8
32.1
30.9
29.2
 
30.3
31.2
Total assets
80.6
69.2
 
64.8
64.6
63.0
61.4
 
58.2
65.2
Deposits at amortised cost
77.9
71.4
 
69.4
67.5
67.2
66.0
 
65.3
66.8
Risk weighted assets
36.2
31.6
 
30.2
30.2
29.0
28.8
 
30.1
31.4
 
 
 
 
 
 
 
 
 
 
 
Performance measures
 
 
 
 
 
 
 
 
 
 
Return on average allocated tangible equity
17.8%
(1.5)%
 
11.7%
10.5%
21.8%
16.5%
 
2.7%
14.7%
Average allocated tangible equity (£bn)
4.6
4.3
 
4.2
4.0
4.0
4.1
 
4.2
4.2
Cost: income ratio
62%
88%
 
72%
70%
72%
71%
 
65%
61%
Loan loss rate (bps)
132
145
 
105
127
27
 
286
211
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Analysis of total income
£m
 
£m
 
 
£m
 
£m
 
£m
 
£m
 
 
£m
 
£m
 
International Cards and Consumer Bank
691
538
 
552
490
517
533
 
576
600
Private Bank
245
214
 
200
188
214
179
 
174
171
Payments
147
134
 
126
130
109
93
 
98
105
Total income
1,083
886
 
878
808
840
805
 
848
876
 
 
 
 
Head Office
 
 
 
 
 
 
 
 
 
 
 
Q222
 
Q122
 
 
Q421
 
Q321
 
Q221
 
Q121
 
 
Q420
 
Q320
 
Income statement information
£m
 
£m
 
 
£m
 
£m
 
£m
 
£m
 
 
£m
 
£m
 
Net interest income
66
 
(38)
(112)
(64)
(178)
 
(86)
(48)
Net fee, commission and other income
(132)
(43)
 
(11)
2
37
103
 
(85)
(79)
Total income
(132)
23
 
(49)
(110)
(27)
(75)
 
(171)
(127)
Credit impairment releases/(charges)
9
8
 
(5)
(1)
6
 
(31)
(5)
Net operating expenses
(123)
31
 
(54)
(111)
(21)
(75)
 
(202)
(132)
Operating costs
(60)
(85)
 
(152)
(95)
(341)
(71)
 
(213)
(69)
UK bank levy
 
 
(9)
Litigation and conduct
1
(1)
 
(3)
(19)
16
(9)
 
(42)
(23)
Total operating expenses
(59)
(86)
 
(155)
(114)
(325)
(80)
 
(264)
(92)
Other net income/(expenses)
2
(18)
 
11
78
8
123
 
8
10
Loss before tax
(180)
(73)
 
(198)
(147)
(338)
(32)
 
(458)
(214)
Attributable (loss)/profit
(170)
(292)
 
(159)
(134)
120
(25)
 
(381)
(284)
 
 
 
 
 
 
 
 
 
 
 
Balance sheet information
£bn
 
£bn
 
 
£bn
 
£bn
 
£bn
 
£bn
 
 
£bn
 
£bn
 
Total assets
19.8
19.9
 
19.0
18.5
18.3
17.7
 
18.6
19.3
Risk weighted assets1
8.6
11.0
 
11.0
11.8
12.0
10.7
 
10.2
9.8
Period end allocated tangible equity1
1.1
3.6
 
5.5
6.3
5.9
3.3
 
6.8
7.1
 
 
 
 
 
 
 
 
 
 
 
Performance measures1
 
 
 
 
 
 
 
 
 
 
Average allocated tangible equity (£bn)
1.7
3.6
 
5.1
6.5
4.2
4.3
 
7.3
7.6
 
 
 
1
The comparative capital and financial metrics relating to Q221 - Q421 have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 65 and Restatement of financial statements (Note 1) on page 87 for more information.
 
 
 
Performance Management
 
Margins and balances
 
 
Half year ended 30.06.22
 
Half year ended 30.06.21
 
 
Net interest income
 
Average customer assets
 
Net interest margin
 
Net interest income
 
Average customer assets
 
Net interest margin
 
 
£m
 
£m
 
%
 
£m
 
£m
 
%
 
Barclays UK
 
2,732
206,524
 
2.67
 
2,586
 
204,930
 
2.54
 
Barclays International1
 
1,883
 
88,607
 
4.29
 
1,518
 
77,413
 
3.95
 
Total Barclays UK and Barclays International
 
4,615
295,131
3.15
4,104
282,343
2.93
Other2
 
148
 
 
 
(201)
 
 
 
Total Barclays Group
 
4,763
 
 
 
3,903
 
 
 
 
1
Barclays International margins include the lending related investment bank business.
2
Other includes Head Office and the non-lending related investment bank businesses not included in Barclays International margins.
 
 
 
The Group’s combined product and equity structural hedge notional as at 30 June 2022 was £256bn (30 June 2021: £198bn), with an average duration of close to 3 years (2021: average duration close to 3 years). Gross structural hedge contributions of £879m (H121: £689m) and net structural hedge contributions of £83m (H121: £592m) are included in Group net interest income. Gross structural hedge contributions represent the absolute level of interest earned from the fixed receipts on swaps in the structural hedge, while the net structural hedge contributions represent the net interest earned on the difference between the structural hedge rate and prevailing floating rates.
 
Quarterly analysis for Barclays UK and Barclays International
 
Net interest income
 
Average customer assets
 
Net interest margin
 
Three months ended 30.06.22
 
£m
 
£m
 
%
 
Barclays UK
 
1,393
 
205,834
 
2.71
 
Barclays International1
 
1,016
 
92,371
 
4.41
 
Total Barclays UK and Barclays International
 
2,409
 
298,205
 
3.24
 
 
 
 
 
Three months ended 31.03.22
 
 
 
 
Barclays UK
 
1,339
 
207,607
 
2.62
 
Barclays International1
 
867
 
84,838
 
4.15
 
Total Barclays UK and Barclays International
 
2,206
 
292,445
 
3.06
 
 
 
 
 
Three months ended 31.12.21
 
 
 
 
Barclays UK
 
1,313
 
209,064
 
2.49
 
Barclays International1
 
848
 
81,244
 
4.14
 
Total Barclays UK and Barclays International
 
2,161
 
290,308
 
2.95
 
 
 
 
 
Three months ended 30.09.21
 
 
 
 
Barclays UK
 
1,303
 
207,692
 
2.49
 
Barclays International1
 
783
 
77,364
 
4.02
 
Total Barclays UK and Barclays International
 
2,086
 
285,056
 
2.90
 
 
 
 
 
Three months ended 30.06.21
 
 
 
 
Barclays UK
 
1,305
 
205,168
 
2.55
 
Barclays International1
 
763
 
77,330
 
3.96
 
Total Barclays UK and Barclays International
 
2,068
 
282,498
 
2.94
 
 
 
1
Barclays International margins include the lending related investment bank business.
 
 
Risk Management
 
Risk management and principal risks
 
 
The roles and responsibilities of the business groups, Risk and Compliance in the management of risk in the Group are defined in the Enterprise Risk Management Framework. The purpose of the framework is to identify the principal risks of the Group, the process by which the Group sets its appetite for these risks in its business activities, and the consequent limits which it places on related risk taking. The framework identifies nine principal risks: credit risk, market risk, treasury and capital risk, climate risk, operational risk, model risk, conduct risk, reputation risk and legal risk. Further detail on the Group’s principal risks and previously identified material existing and emerging risks and how such risks are managed is available in the Barclays PLC Annual Report 2021 (pages 202 to 223), or online at home.barclays/annualreport. There have been no significant changes to these principal risks or previously identified material existing and emerging risks in the period other than as set out below.
 
Material existing and emerging risks
 
 
Set out below are details of two additional material risks identified in H122 which potentially impact one or more principal risks.
 
Internal control over financial reporting and disclosure controls and procedures
 
The Group is subject to requirements under the Sarbanes-Oxley Act of 2002, as amended, to perform system and process evaluation and testing of its internal control over financial reporting to allow management to assess the effectiveness of its internal controls. In connection with the offer and sale of securities by Barclays Bank PLC in excess of the amounts registered under the 2019 F-3 and Predecessor Shelf (see “Over-issuance of US securities under Barclays Bank PLC's US shelf registration statements” below), management has concluded that the Group had a material weakness in relation to certain aspects of its internal control environment and that, as a consequence, its internal control over financial reporting as at 31 December 2021 was not effective under the applicable Committee of Sponsoring Organizations Framework and its disclosure controls and procedures were not effective as at such date. The material weakness that has been identified relates to a weakness in controls over the identification of external regulatory limits related to securities issuance and monitoring against these limits. As a result of this weakness, Barclays Bank PLC issued securities in excess of the amounts under the US shelf registration statements referred to above.
 
Remediation efforts have begun and the Group is taking steps to strengthen internal controls relating to securities issuance to address the material weakness. However, internal control systems (no matter how well designed) have inherent limitations and may not prevent or detect further misstatements or errors (whether of a similar or different character to the foregoing). If the Group fails to maintain an effective internal control environment or its disclosure controls and procedures are not effective, the Group could suffer material misstatements in its financial statements and fail to meet its reporting obligations, which could cause investors to lose confidence in the Group's reported financial information. This could in turn limit the Group's access to capital markets, negatively impact its results of operations, and lead to a negative impact on the trading price of its securities. Additionally, ineffective internal control over financial reporting could expose the Group to increased risk of fraud or misuse of corporate assets and subject it to potential regulatory investigations and civil or criminal sanctions. Any of the foregoing could have a material adverse effect on Barclays Bank PLC’s and the Group's business, financial condition, results of operations and reputation as a frequent issuer in the securities markets.
 
Over-issuance of US securities under Barclays Bank PLC's US shelf registration statements
 
The Group may be subject to claims for rescission or damages and regulatory enforcement actions in connection with certain sales of securities issued by Barclays Bank PLC materially in excess of the amounts set forth in prior registration statements as set out under “Internal control over financial reporting and disclosure controls and procedures” above.
 
The securities that were issued in excess of these amounts comprise structured notes and exchange traded notes (ETNs). As such, certain offers and sales were not made in compliance with the US Securities Act of 1933, as amended (Securities Act), giving rise to rights of rescission for certain purchasers of the securities. As a result, Barclays Bank PLC has elected to make a rescission offer (Rescission Offer) to eligible purchasers of the relevant affected securities, which it intends to launch on 1 August 2022.
 
As previously disclosed, the Group is conducting a review (the Review), assisted by external counsel, of the facts and circumstances relating to the sale of the relevant affected securities in excess of amounts registered under such US shelf registration statements and, among other things, the control environment related to such sales. The Review is at an advanced stage and reports on its progress have been made to the Group’s management team, the Group Board, and regulators, including the SEC Divisions of Enforcement and Corporation Finance. Such reports have included, among other things: (i) an assessment that the issuance of securities in excess of the maximum aggregate offering price for BBPLC’s 2019 US Shelf resulted from a failure to monitor issuances during the period in which Barclays Bank PLC’s status changed from a “well-known seasoned issuer” to an “ineligible issuer” for US securities law purposes, which required Barclays Bank PLC to pre-register a set amount of securities to be issued under its US Shelf with the SEC; (ii) confirmation that the Review has not identified any evidence of intentional misconduct; and (iii) the discovery that, while the vast majority of the over-issuance occurred under the 2019 US Shelf, a small portion of the over-issuance also occurred under the Predecessor Shelf.
 
The Group is also conducting an internal review involving a five-year look-back at limits in other issuance programmes. Management has assessed as remote the risk of material financial impact associated with issuance limits other than where pre-registration of securities is required; therefore the focus of the review has been on programmes with external regulatory limits related to securities issuance. This review has not identified any other breach of an external regulatory limit in any issuance programme used by a member of the Group. Management has identified an instance where a limit imposed solely for internal governance reasons was exceeded when taking into account a large security held on the Group's own balance sheet issued under a non-SEC registered debt issuance programme which did not have an external limit, although the breach of the internal limit did not give rise to any rights on the part of investors and did not constitute a material weakness. Nevertheless, there can be no assurance that the ongoing internal or external counsel reviews will not identify additional facts and information that could be material to an evaluation of this aspect of the Group's control environment.
 
Under Section 12(a)(1) of the Securities Act, certain purchasers of unregistered securities have a right to recover, upon the tender of such security, the consideration paid for such security with interest, less the amount of any income received, or damages if the purchaser no longer owns the security (Rescission Price). Pursuant to the Rescission Offer, Barclays Bank PLC will offer to repurchase the relevant affected securities at the Rescission Price. Although the Rescission Offer is expected to reduce liability with respect to potential private civil claims, it will not necessarily prevent such claims from being asserted against Barclays Bank PLC and/or its affiliates, including claims under applicable US federal securities laws.
 
Further, the Rescission Offer does not bar the SEC or other authorities from pursuing enforcement actions against Barclays Bank PLC and its affiliates, which are expected to result in fines, penalties and/or other sanctions. The Group is engaged with, and responding to inquiries and requests for information from, various regulators, including the SEC. The SEC’s investigation into this matter is at an advanced stage and the Group has had preliminary discussions with the staff of the SEC’s Division of Enforcement about resolving this matter.
 
As at 30 June 2022, Barclays PLC has recognised a balance sheet provision of £1,757m (December 2021: £220m) in relation to this matter, out of which £1,592m (December 2021: £220m) relates to the over-issuance of structured notes and £165m (December 2021: nil) relates to liabilities that could be incurred arising out of ongoing discussions in respect of a potential SEC resolution. A contingent liability exists in relation to the over-issuance of ETNs due to evidentiary challenges and the high level of trading in the securities. A contingent liability also exists in relation to any potential civil claims or enforcement actions taken against Barclays Bank PLC and its affiliates but Barclays Bank PLC is unable to assess the likelihood of liabilities that may arise out of such claims or actions, there is currently no indication of the exact timing for resolution and it is not practicable to provide an estimate of the financial effects.
 
The final cost of the Rescission Offer will be impacted by a number of factors, including prevailing market conditions. Prior to the completion of the Rescission Offer, the amount of the provision in relation to the over-issuance of structured notes will fluctuate, perhaps materially, due, in part, to the volatility of the market prices for the structured notes subject to the Rescission Offer. While Barclays Bank PLC and/or its affiliates have entered into hedging arrangements designed to minimise the volatility, such arrangements cannot by their very nature completely hedge the exposures, which may mean the final impact of the Rescission Offer may materially differ from the £1,592m provision reflected as at 30 June 2022. In addition, the hedging arrangements may be modified, may not prove effective (in existing or modified form), may expire prior to the end of the Rescission Offer and do not cover any other losses arising out of potential private civil claims or enforcement actions. The provision of £165m in relation to the potential SEC resolution may also be impacted by the ultimate outcome of the ongoing discussions. Any of the foregoing could result in material additional losses for the Group.
 
Any liabilities, claims or actions in connection with the over-issuance of securities under the 2019 F-3 and the Predecessor Shelf could have a material adverse effect on Barclays Bank PLC's and the Group's business, financial condition, results of operations and reputation as a frequent issuer in the securities markets.
 
Management has concluded that, by virtue of the fact that there was a weakness in controls over the identification of external regulatory limits related to securities issuance and monitoring against these limits, the Group had a material weakness in relation to certain aspects of its internal control environment and, as a consequence, its internal control over financial reporting and disclosure controls and procedures as at 31 December 2021 were not effective. Further details on such material weakness are set out under “Internal control over financial reporting and disclosure controls and procedures” above.
 
 
 
Credit Risk
 
Loans and advances at amortised cost by stage
 
The table below presents an analysis of loans and advances at amortised cost by gross exposure, impairment allowance, impairment charge and coverage ratio by stage allocation and business segment as at 30 June 2022. Also included are off-balance sheet loan commitments and financial guarantee contracts by gross exposure, impairment allowance and coverage ratio by stage allocation as at 30 June 2022.
 
Impairment allowance under IFRS 9 considers both the drawn and the undrawn counterparty exposure. For retail portfolios, the total impairment allowance is allocated to the drawn exposure to the extent that the allowance does not exceed the exposure, as expected credit loss (ECL) is not reported separately. Any excess is reported on the liability side of the balance sheet as a provision. For wholesale portfolios, the impairment allowance on the undrawn exposure is reported on the liability side of the balance sheet as a provision.
 
 
Gross exposure
 
 
Impairment allowance
 
Net exposure
 
 
Stage 1
 
Stage 2
 
Stage 3
 
Total
 
 
Stage 1
 
Stage 2
 
Stage 3
 
Total
 
As at 30.06.22
 
£m
 
£m
 
£m
 
£m
 
 
£m
 
£m
 
£m
 
£m
 
£m
 
Barclays UK
160,110
23,805
3,012
186,927
 
218
780
753
1,751
185,176
Barclays International
32,053
3,251
1,674
36,978
 
679
821
826
2,326
34,652
Head Office
3,852
215
688
4,755
 
2
16
346
364
4,391
Total Barclays Group retail
196,015
27,271
5,374
228,660
 
899
1,617
1,925
4,441
224,219
Barclays UK
35,915
2,267
862
39,044
 
131
49
117
297
38,747
Barclays International
120,470
11,916
1,022
133,408
 
254
198
287
739
132,669
Head Office
186
1
23
210
 
21
21
189
Total Barclays Group wholesale1
156,571
14,184
1,907
172,662
 
385
247
425
1,057
171,605
Total loans and advances at amortised cost
352,586
41,455
7,281
401,322
 
1,284
1,864
2,350
5,498
395,824
Off-balance sheet loan commitments and financial guarantee contracts2
373,544
24,429
1,146
399,119
 
275
233
17
525
398,594
Total3
726,130
65,884
8,427
800,441
 
1,559
2,097
2,367
6,023
794,418
 
 
 
 
 
 
 
 
 
 
 
 
As at 30.06.22
 
 
Half year ended 30.06.22
 
 
 
Coverage ratio
 
 
Loan impairment charge/(release) and loan loss rate
 
 
 
Stage 1
 
Stage 2
 
Stage 3
 
Total
 
 
Loan impairment charge/(release)
 
Loan loss rate
 
 
 
%
 
%
 
%
 
%
 
 
£m
 
bps
 
 
Barclays UK
0.1
3.3
25.0
0.9
 
 
14
 
2
 
Barclays International
2.1
25.3
49.3
6.3
 
 
253
 
138
 
Head Office
0.1
7.4
50.3
7.7
 
 
(18)
 
 
Total Barclays Group retail
0.5
5.9
35.8
1.9
 
 
249
 
22
 
Barclays UK
0.4
2.2
13.6
0.8
 
 
36
 
19
 
Barclays International
0.2
1.7
28.1
0.6
 
 
75
 
11
 
Head Office
91.3
10.0
 
 
 
 
Total Barclays Group wholesale1
0.2
1.7
22.3
0.6
 
 
111
 
13
 
Total loans and advances at amortised cost
0.4
4.5
32.3
1.4
 
 
360
 
18
 
Off-balance sheet loan commitments and financial guarantee contracts2
0.1
1.0
1.5
0.1
 
 
(42)
 
 
 
Other financial assets subject to impairment3
 
 
 
 
 
 
23
 
 
 
Total4
0.2
3.2
28.1
0.8
 
 
341
 
 
 
 
1
Includes Wealth UK and Private Banking exposures measured on an individual customer exposure basis, and excludes Business Banking exposures, including lending under the government backed Bounce Back Loan Scheme (BBLS) of £8.1bn that are managed on a collective basis and reported within BUK Retail. The net impact is a difference in total exposure of £4.3bn of balances reported as wholesale loans on page 35 in the Loans and advances at amortised cost by product disclosure.
2
Excludes loan commitments and financial guarantees of £21.1bn carried at fair value.
3
Other financial assets subject to impairment not included in the table above include cash collateral and settlement balances, financial assets at fair value through other comprehensive income and other assets. These have a total gross exposure of £197.3bn and impairment allowance of £149m. This comprises £11m ECL on £195.0bn Stage 1 assets, £2m on £2.1bn Stage 2 fair value through other comprehensive income assets, cash collateral and settlement balances and £136m on £143m Stage 3 other assets.
4
The loan loss rate is 17bps after applying the total impairment charge of £341m.
 
 
Gross exposure
 
 
Impairment allowance
 
Net exposure
 
 
Stage 1
 
Stage 2
 
Stage 3
 
Total
 
 
Stage 1
 
Stage 2
 
Stage 3
 
Total
 
As at 31.12.21
 
£m
 
£m
 
£m
 
£m
 
 
£m
 
£m
 
£m
 
£m
 
£m
 
Barclays UK
160,695
22,779
2,915
186,389
 
261
949
728
1,938
184,451
Barclays International
25,981
2,691
1,566
30,238
 
603
795
858
2,256
27,982
Head Office
3,735
429
705
4,869
 
2
36
347
385
4,484
Total Barclays Group retail
190,411
25,899
5,186
221,496
 
866
1,780
1,933
4,579
216,917
Barclays UK
35,571
1,917
969
38,457
 
153
43
111
307
38,150
Barclays International
92,341
13,275
1,059
106,675
 
187
192
458
837
105,838
Head Office
542
2
21
565
 
19
19
546
Total Barclays Group wholesale1
128,454
15,194
2,049
145,697
 
340
235
588
1,163
144,534
Total loans and advances at amortised cost
318,865
41,093
7,235
367,193
 
1,206
2,015
2,521
5,742
361,451
Off-balance sheet loan commitments and financial guarantee contracts2
312,142
34,815
1,298
348,255
 
217
302
23
542
347,713
Total3
631,007
75,908
8,533
715,448
 
1,423
2,317
2,544
6,284
709,164
 
 
 
 
 
 
 
 
 
 
 
 
As at 31.12.21
 
 
Half year ended 31.12.21
 
 
 
Coverage ratio
 
 
Loan impairment charge/(release) and loan loss rate
 
 
 
Stage 1
 
Stage 2
 
Stage 3
 
Total
 
 
Loan impairment charge/(release)
 
Loan loss rate
 
 
 
%
 
%
 
%
 
%
 
 
£m
 
bps
 
 
Barclays UK
0.2
4.2
25.0
1.0
 
 
(227)
 
 
Barclays International
2.3
29.5
54.8
7.5
 
 
181
 
60
 
Head Office
0.1
8.4
49.2
7.9
 
 
 
 
Total Barclays Group retail
0.5
6.9
37.3
2.1
 
 
(46)
 
 
Barclays UK
0.4
2.2
11.5
0.8
 
 
122
 
32
 
Barclays International
0.2
1.4
43.2
0.8
 
 
(197)
 
 
Head Office
90.5
3.4
 
 
 
 
Total Barclays Group wholesale1
0.3
1.5
28.7
0.8
 
 
(75)
 
 
Total loans and advances at amortised cost
0.4
4.9
34.8
1.6
 
 
(121)
 
 
Off-balance sheet loan commitments and financial guarantee contracts2
0.1
0.9
1.8
0.2
 
 
(514)
 
 
 
Other financial assets subject to impairment3
 
 
 
 
 
 
(18)
 
 
 
Total
0.2
3.1
29.8
0.9
 
 
(653)
 
 
 
 
 
1
Includes Wealth and Private Banking exposures measured on an individual basis, and excludes Business Banking exposures, including BBLS of £9.4bn that are managed on a collective basis and reported within Barclays UK Retail. The net impact is a difference in total exposure of £6.0bn of balances reported as wholesale loans on page 35 in the Loans and advances at amortised cost by product disclosure.
2
Excludes loan commitments and financial guarantees of £18.8bn carried at fair value.
3
Other financial assets subject to impairment not included in the table above include cash collateral and settlement balances, financial assets at fair value through other comprehensive income and other assets. These have a total gross exposure of £155.2bn and impairment allowance of £114m. This comprises £6m ECL on £154.9bn Stage 1 assets, £1m on £157.0bn Stage 2 fair value through other comprehensive income assets, other assets and cash collateral and settlement balances and £107m on £110m Stage 3 other assets.
 
 
Loans and advances at amortised cost by product
 
 
The table below presents a breakdown of loans and advances at amortised cost and the impairment allowance with stage allocation by asset classification.
 
 
 
Stage 2
 
 
 
As at 30.06.22
 
Stage 1
 
Not past due
 
<=30 days past due
 
>30 days past due
 
Total
 
Stage 3
 
Total
 
Gross exposure
 
£m
 
£m
 
£m
 
£m
 
£m
 
£m
 
£m
 
Home loans
 
150,883
16,269
1,700
765
18,734
2,110
171,727
Credit cards, unsecured loans and other retail lending
 
43,628
5,918
303
273
6,494
2,510
52,632
Wholesale loans
 
158,075
15,814
84
329
16,227
2,661
176,963
Total
 
352,586
38,001
2,087
1,367
41,455
7,281
401,322
 
 
 
 
 
 
 
 
Impairment allowance
 
 
 
 
 
 
 
 
Home loans
 
19
29
6
6
41
398
458
Credit cards, unsecured loans and other retail lending
 
860
1,329
100
126
1,555
1,448
3,863
Wholesale loans
 
405
264
2
2
268
504
1,177
Total
 
1,284
1,622
108
134
1,864
2,350
5,498
 
 
 
 
 
 
 
 
Net exposure
 
 
 
 
 
 
 
 
Home loans
 
150,864
16,240
1,694
759
18,693
1,712
171,269
Credit cards, unsecured loans and other retail lending
 
42,768
4,589
203
147
4,939
1,062
48,769
Wholesale loans
 
157,670
15,550
82
327
15,959
2,157
175,786
Total
 
351,302
36,379
1,979
1,233
39,591
4,931
395,824
 
 
 
 
 
 
 
 
Coverage ratio
 
%
%
%
%
%
%
%
Home loans
 
0.2
0.4
0.8
0.2
18.9
0.3
Credit cards, unsecured loans and other retail lending
 
2.0
22.5
33.0
46.2
23.9
57.7
7.3
Wholesale loans
 
0.3
1.7
2.4
0.6
1.7
18.9
0.7
Total
 
0.4
4.3
5.2
9.8
4.5
32.3
1.4
 
 
 
 
 
 
 
 
As at 31.12.21
 
 
 
 
 
 
 
 
Gross exposure
 
£m
£m
£m
£m
£m
£m
£m
Home loans
 
148,058
17,133
1,660
707
19,500
2,122
169,680
Credit cards, unsecured loans and other retail lending
 
37,840
5,102
300
248
5,650
2,332
45,822
Wholesale loans
 
132,967
15,246
306
391
15,943
2,781
151,691
Total
 
318,865
37,481
2,266
1,346
41,093
7,235
367,193
 
 
 
 
 
 
 
 
Impairment allowance
 
 
 
 
 
 
 
 
Home loans
 
19
46
6
7
59
397
475
Credit cards, unsecured loans and other retail lending
 
824
1,493
85
123
1,701
1,504
4,029
Wholesale loans
 
363
248
4
3
255
620
1,238
Total
 
1,206
1,787
95
133
2,015
2,521
5,742
 
 
 
 
 
 
 
 
Net exposure
 
 
 
 
 
 
 
 
Home loans
 
148,039
17,087
1,654
700
19,441
1,725
169,205
Credit cards, unsecured loans and other retail lending
 
37,016
3,609
215
125
3,949
828
41,793
Wholesale loans
 
132,604
14,998
302
388
15,688
2,161
150,453
Total
 
317,659
35,694
2,171
1,213
39,078
4,714
361,451
 
 
 
 
 
 
 
 
Coverage ratio
 
%
%
%
%
%
%
%
Home loans
 
0.3
0.4
1.0
0.3
18.7
0.3
Credit cards, unsecured loans and other retail lending
 
2.2
29.3
28.3
49.6
30.1
64.5
8.8
Wholesale loans
 
0.3
1.6
1.3
0.8
1.6
22.3
0.8
Total
 
0.4
4.8
4.2
9.9
4.9
34.8
1.6
 
 

 
Loans and advances at amortised cost by selected sectors
 
 
The table below presents a breakdown of drawn exposure and impairment allowance for loans and advances at amortised cost with stage allocation for selected industry sectors within the wholesale loans portfolio. As the nature of macroeconomic uncertainty has evolved from the COVID-19 pandemic towards high inflation, supply chain constraints and consumer demand headwinds, so has the selected population under management focus.
 
The gross loans and advances to selected sectors have remained stable over the year. The small increase in provisions is informed by the improved macroeconomic outlook used in the Q222 scenario refresh, offset by management judgments to reflect the risk of uncertainty still prevailing within these sectors. The wholesale portfolio also benefits from a hedge protection programme that enables effective risk management against credit losses. An additional £0.1bn (December 2021: £0.1bn) impairment allowance has been applied to the undrawn exposures not included in the table below.
 
 
Gross exposure
 
Impairment allowance
 
Stage 1
Stage 2
Stage 3
Total
 
Stage 1
Stage 2
Stage 3
Total
As at 30.06.22
£m
£m
£m
£m
 
£m
£m
£m
£m
Autos
914
370
2
1,286
 
10
5
15
Consumer manufacture
3,498
1,587
215
5,300
 
45
27
47
119
Discretionary retail and wholesale
5,811
1,311
240
7,362
 
34
21
45
100
Hospitality and leisure
3,817
1,755
352
5,924
 
33
35
41
109
Passenger travel
807
318
107
1,232
 
11
5
12
28
Real estate
14,001
2,509
550
17,060
 
89
45
107
241
Steel and aluminium manufacturers
610
75
7
692
 
6
1
1
8
Total
29,458
7,925
1,473
38,856
 
228
139
253
620
Total of wholesale exposures (%)
19%
49%
55%
22%
 
56%
52%
50%
53%
 
 
 
 
 
 
 
 
 
 
 
Gross exposure
 
Impairment allowance
 
Stage 1
Stage 2
Stage 3
Total
 
Stage 1
Stage 2
Stage 3
Total
As at 31.12.21
£m
£m
£m
£m
 
£m
£m
£m
£m
Autos
656
295
2
953
 
3
3
6
Consumer manufacture
3,904
1,304
211
5,419
 
18
22
43
83
Discretionary retail and wholesale
5,413
1,197
230
6,840
 
47
20
54
121
Hospitality and leisure
4,348
1,613
384
6,345
 
28
33
44
105
Passenger travel
856
285
143
1,284
 
30
8
40
78
Real estate
13,620
3,314
518
17,452
 
65
53
93
211
Steel and aluminium manufacturers
415
75
6
496
 
2
3
1
6
Total
29,212
8,083
1,494
38,789
 
193
142
275
610
Total of wholesale exposures (%)
22%
51%
54%
26%
 
53%
56%
44%
49%
 
UK Commercial real estate exposure continues to remain well collateralised, however it has been included within the latest selected sector scoping as the broader real estate sector remains under pressure due to pricing and affordability concerns, as well as construction input costs and supply chain issues adding to the uncertainty, in particular across non-investment grade exposures.
 
The coverage ratio for selected sectors has broadly remained consistent at 1.6% as at 30 June 2022. Non-default coverage has marginally increased from 0.9% as at 31 December 2021 to 1.0% as at 30 June 2022.
 
 
 
Movement in gross exposures and impairment allowance including provisions for loan commitments and financial guarantees
 
 
The following tables present a reconciliation of the opening to the closing balance of the exposure and impairment allowance. An explanation of the methodology used to determine credit impairment provisions is included in the Barclays PLC Annual Report 2021 (Page 348). Transfers between stages in the table have been reflected as if they had taken place at the beginning of the year. The movements are measured over a 6-month period.
 
Loans and advances at amortised cost
 
Stage 1
 
Stage 2
 
Stage 3
 
Total
 
 
Gross exposure
 
ECL
 
Gross exposure
 
ECL
 
Gross exposure
 
ECL
 
Gross exposure
 
ECL
 
Home loans
£m
 
£m
 
£m
 
£m
 
£m
 
£m
 
£m
 
£m
 
As at 1 January 2022
148,058
19
19,500
59
2,122
397
169,680
475
Transfers from Stage 1 to Stage 2
(5,725)
(1)
5,725
1
Transfers from Stage 2 to Stage 1
5,131
18
(5,131)
(18)
Transfers to Stage 3
(197)
(234)
(5)
431
5
Transfers from Stage 3
19
1
133
3
(152)
(4)
Business activity in the period1
14,723
4
339
1
1
15,063
5
Refinements to models used for calculation
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes
(4,151)
(22)
(506)
2
(69)
16
(4,726)
(4)
Final repayments
(6,975)
(1,092)
(2)
(210)
(3)
(8,277)
(5)
Disposals
Write-offs2
(13)
(13)
(13)
(13)
As at 30 June 20223
150,883
19
18,734
41
2,110
398
171,727
458
 
 
 
 
 
 
 
 
 
Credit cards, unsecured loans and other retail lending
As at 1 January 2022
37,840
824
5,650
1,701
2,332
1,504
45,822
4,029
Transfers from Stage 1 to Stage 2
(2,572)
(67)
2,572
67
Transfers from Stage 2 to Stage 1
1,689
422
(1,689)
(422)
Transfers to Stage 3
(444)
(11)
(516)
(222)
960
233
Transfers from Stage 3
30
13
49
9
(79)
(22)
Business activity in the period1
8,231
354
294
32
20
5
8,545
391
Refinements to models used for calculation4
43
187
96
326
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes5
1,678
(691)
413
240
94
285
2,185
(166)
Final repayments
(2,673)
(23)
(251)
(27)
(140)
(29)
(3,064)
(79)
Disposals6
(151)
(4)
(28)
(10)
(122)
(69)
(301)
(83)
Write-offs2
(555)
(555)
(555)
(555)
As at 30 June 20223
43,628
860
6,494
1,555
2,510
1,448
52,632
3,863
 
 
1
Business activity in the period does not include additional drawdowns on the existing facility which are reported under 'Net drawdowns, repayments, net re-measurement and movements due to exposure and risk parameter changes'. Business activity reported within Credit cards, unsecured loans and other retail lending portfolio includes GAP portfolio acquisition in US cards of £2.7bn.
2
In H122, gross write-offs amounted to £768m (H121: £1,001m) and post write-off recoveries amounted to £36m (H121: £31m). Net write-offs represent gross write-offs less post write-off recoveries and amounted to £732m (H121: £970m).
3
Other financial assets subject to impairment not included in the table above include cash collateral and settlement balances, financial assets at fair value through other comprehensive income and other assets. These have a total gross exposure of £197.3bn (December 21: £155.2bn) and an impairment allowance of £149m (December 21: £114m). This comprises £11m ECL (December 21: £6m) on £195.0bn stage 1 assets (December 21: £154.9bn), £2m (December 21: £1m) on £2.1bn stage 2 fair value through other comprehensive income assets, other assets and cash collateral and settlement balances (December 21: £0.2bn) and £136m (FY21: £107m) on £143m stage 3 other assets (December 21: £110m).
4
Refinements to models used for calculation reported within Credit cards, unsecured loans and other retail lending portfolio include a £0.3bn movement in US cards. These reflect methodology changes made during the year. Barclays continually review the output of models to determine accuracy of the ECL calculation including review of model monitoring, external benchmarking and experience of model operation over an extended period of time. This ensures that the models used continue to reflect the risks inherent across the businesses.
5
Transfers and risk parameter changes include a £0.2bn (December 21: £0.3bn) net release in ECL arising from a reclassification of £1.4bn (December 21: £1.9bn) gross loans and advances from Stage 2 to Stage 1 in Credit cards, unsecured loans and other retail lending portfolio. The reclassification followed a review of back-testing of results which indicated that accuracy of origination probability of default characteristics required management adjustments to correct. The re-classification was first established in Q220.
6
The £0.3bn disposals reported within Credit cards, unsecured loans and other retail lending portfolio includes £0.2bn sale of NFL portfolio within US cards and £0.1bn of debt sales undertaken during the year.
 
Loans and advances at amortised cost
 
 
 
 
 
 
 
Stage 1
 
Stage 2
 
Stage 3
 
Total
 
 
Gross exposure
 
ECL
 
Gross exposure
 
ECL
 
Gross exposure
 
ECL
 
Gross exposure
 
ECL
 
Wholesale loans
£m
 
£m
 
£m
 
£m
 
£m
 
£m
 
£m
 
£m
 
As at 1 January 2022
132,967
363
15,943
255
2,781
620
151,691
1,238
Transfers from Stage 1 to Stage 2
(5,129)
(29)
5,129
29
Transfers from Stage 2 to Stage 1
5,544
41
(5,544)
(41)
Transfers to Stage 3
(676)
(3)
(405)
(6)
1,081
9
Transfers from Stage 3
114
9
200
17
(314)
(26)
Business activity in the period1
28,927
40
1,670
14
108
14
30,705
68
Refinements to models used for calculation2
(66)
(42)
(374)
(482)
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes3
12,529
79
1,048
70
(634)
555
12,943
704
Final repayments
(16,201)
(29)
(1,783)
(28)
(115)
(48)
(18,099)
(105)
Disposals4
(31)
(46)
(46)
(77)
(46)
Write-offs5
(200)
(200)
(200)
(200)
As at 30 June 20226
158,075
405
16,227
268
2,661
504
176,963
1,177
 
 
 
 
 
 
 
 
 
Reconciliation of ECL movement to impairment charge/(release) for the period
£m
 
Home loans
 
 
 
 
 
 
 
(4)
Credit cards, unsecured loans and other retail lending
 
472
Wholesale loans
 
185
ECL movement excluding assets derecognised due to disposals and write-offs
 
653
Recoveries and reimbursements7
 
(47)
Exchange and other adjustments8
 
(246)
Impairment release on loan commitments and other financial guarantees
 
(42)
Impairment charge on other financial assets6
 
23
Income statement charge for the period
 
341
 
 
1
Business activity in the period does not include additional drawdowns on the existing facility which are reported under 'Net drawdowns, repayments, net re-measurement and movements due to exposure and risk parameter changes'.
2
Refinements to models used for calculation reported within Wholesale loans relates to a £0.5bn movement in Business Banking. This relates to an update in the underlying ECL model that now fully recognises the 100% government guarantee against Barclays Bounce Back Loans exposure.
3
"Net drawdowns, repayments, net re-measurement and movements due to exposure and risk parameter changes" reported within Wholesale loans also include assets of £0.5bn de-recognised due to payment received on defaulted loans from government guarantees issued under government’s Bounce Back Loans Scheme.
4
The £0.1bn disposals reported within Wholesale loans relates to debt sales undertaken during the year.
5
In H122, gross write-offs amounted to £768m (H121: £1,001m) and post write-off recoveries amounted to £36m (H121: £31m). Net write-offs represent gross write-offs less post write-off recoveries and amounted to £732m (H121: £970m).
6
Other financial assets subject to impairment not included in the table above include cash collateral and settlement balances, financial assets at fair value through other comprehensive income and other assets. These have a total gross exposure of £197.3bn (December 21: £155.2bn) and impairment allowance of £149m (December 21: £114m). This comprises £11m ECL (December 21: £6m) on £195.0bn stage 1 assets (December 21: £154.9bn), £2m (December 21: £1m) on £2.1bn stage 2 fair value through other comprehensive income assets, other assets and cash collateral and settlement balances (December 21: £157.0bn) and £136m (December 21: £107m) on £143m stage 3 other assets (December 21: £110m).
7
Recoveries and reimbursements includes a net gain in relation to reimbursements from financial guarantee contracts held with third parties of £11m (H121 loss: £216m) and post write off recoveries of £36m (H121: £31m).
8
Exchange and other adjustments includes foreign exchange and interest and fees in suspense.
 
Loan commitments and financial guarantees
 
Stage 1
 
Stage 2
 
Stage 3
 
Total
 
 
Gross
exposure
 
ECL
 
Gross
exposure
 
ECL
 
Gross
exposure
 
ECL
 
Gross
exposure
 
ECL
 
Home loans
£m
 
£m
 
£m
 
£m
 
£m
 
£m
 
£m
 
£m
 
As at 1 January 2022
10,833
532
3
11,368
Net transfers between stages
39
(39)
Business activity in the period
8,146
8,146
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes
(6,354)
(12)
(6,366)
Limit management and final repayments
(172)
(22)
(194)
As at 30 June 2022
12,492
459
3
12,954
 
 
 
 
 
 
 
 
 
Credit cards, unsecured loans and other retail lending
As at 1 January 2022
122,819
50
5,718
61
218
20
128,755
131
Net transfers between stages
(1,277)
23
935
(18)
342
(5)
Business activity in the period
26,892
1
212
27,104
1
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes
9,385
3
(1,267)
20
(288)
2
7,830
25
Limit management and final repayments
(3,740)
(1)
(209)
(3)
(36)
(3,985)
(4)
As at 30 June 2022
154,079
76
5,389
60
236
17
159,704
153
 
 
 
 
 
 
 
 
 
Wholesale loans
 
 
 
 
 
 
 
 
As at 1 January 2022
178,490
167
28,565
241
1,077
3
208,132
411
Net transfers between stages
9,775
36
(9,709)
(37)
(66)
1
Business activity in the period
37,358
19
2,864
24
1
40,223
43
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes
17,712
(9)
1,510
(22)
140
(5)
19,362
(36)
Limit management and final repayments
(36,362)
(14)
(4,649)
(33)
(245)
1
(41,256)
(46)
As at 30 June 2022
206,973
199
18,581
173
907
226,461
372
 
 
Management adjustments to models for impairment
 
 
Management adjustments to impairment models are applied in order to factor in certain conditions or changes in policy that are not fully incorporated into the impairment models, or to reflect additional facts and circumstances at the period end. Management adjustments are reviewed and incorporated into future model development where applicable.
 
Total management adjustments to impairment allowance are presented by product below:
 
Overview of management adjustments to models for impairment allowance1
 
 
As at 30.06.22
 
As at 31.12.21
 
 
Management adjustments to impairment allowances
 
Proportion of total impairment allowances
 
Management adjustments to impairment allowances
 
Proportion of total impairment allowances
 
 
£m
 
%
 
£m
 
%
 
Home loans
 
76
 
16.6
 
103
 
21.7
 
Credit cards, unsecured loans and other retail lending
 
785
 
19.6
 
1,362
 
32.7
 
Wholesale loans2
 
426
 
27.5
 
21
 
1.3
 
Total
 
1,287
 
21.4
 
1,486
 
23.6
 
 
Management adjustments to models for impairment allowance1
 
 
Impairment allowance pre management adjustments3
 
Economic uncertainty adjustments
 
Other adjustments
 
Total Adjustments
 
Total impairment allowance4
 
 
 
(a)
 
(b)
 
(a+b)
 
 
As at 30.06.22
 
£m
 
£m
 
£m
 
£m
 
£m
 
Home loans
 
382
 
43
 
33
 
76
 
458
 
Credit cards, unsecured loans and other retail lending
 
3,229
 
578
 
207
 
785
 
4,014
 
Wholesale loans
 
1,125
 
417
 
9
 
426
 
1,551
 
Total
 
4,736
 
1,038
 
249
 
1,287
 
6,023
 
 
 
 
 
 
 
As at 31.12.21
 
 
 
 
 
 
Home loans
 
372
 
72
 
31
 
103
 
475
 
Credit cards, unsecured loans and other retail lending
 
2,798
 
1,217
 
145
 
1,362
 
4,160
 
Wholesale loans
 
1,628
 
403
 
(382)
 
21
 
1,649
 
Total
 
4,798
 
1,692
 
(206)
 
1,486
 
6,284
 
 
1
Positive values reflect an increase in impairment allowance and negative values reflect a reduction in the impairment allowance.
2
Proportion of management adjustments to impairment allowances has increased in wholesale loans primarily driven by release of offsetting PMA to recognise BBLS government guarantees of £0.4bn; now captured through the model. Excluding this, proportion of management adjustments to impairment allowances remain materially stable compare to previous year.
3
Includes £4.1bn (December 2021: £4.1bn) of modelled ECL, £0.4bn (December 2021: £0.5bn) of individually assessed impairments and £0.2bn (December 2021: £0.2bn) ECL from non-modelled exposures.
4
Total impairment allowance consists of ECL stock on drawn and undrawn exposure.
 
Economic uncertainty adjustments
 
 
Throughout the COVID-19 pandemic in 2020 and 2021, macroeconomic forecasts anticipated lasting impacts to unemployment levels and customer and client stress. However, the most recent macroeconomic outlook suggests the concerns over the spread of COVID-19 in major economies has receded and normalisation of customer behaviour has been observed, but uncertainty persists: Russia’s invasion of Ukraine is affecting global energy markets and food prices; China’s ‘zero-COVID’ policy is putting pressure on stretched supply chains; and labour markets continue to generate inflationary pressures. Credit deterioration could still occur as emerging supply chain disruption and inflationary pressures challenge economic stability; and economic consensus may not capture the range of arising economic uncertainty.
 
Given this backdrop, COVID-19 related expert judgements have been materially replaced by provisions for customers and clients considered most vulnerable to rising costs and supply chain disruption. This uncertainty continues to be captured in two distinct ways. Firstly, customer uncertainty: the identification of customers and clients who may be more vulnerable to the emerging economic instability; and secondly, model uncertainty: to capture the impact from model limitations and sensitivities to specific macroeconomic parameters which are applied at a portfolio level.
 
The economic uncertainty adjustments of £1.0bn (FY21: £1.7bn) include customer and client uncertainty provisions of £0.8bn (FY21: £1.5bn) and model uncertainty provisions of £0.2bn (FY21: £0.2bn).
 
Customer and client uncertainty provisions include an adjustment of £0.8bn (FY21: £1.5bn) which has been applied to customers and clients considered potentially vulnerable to the emerging economic instability in light of inflationary and supply chain concerns. This adjustment is split between credit cards, unsecured loans and other retail lending £0.5bn (FY21: £0.8bn) and wholesale loans £0.3bn (FY21: £0.3bn). The reduction in the credit cards, unsecured loans and other retail lending-related adjustment is due to unwinding of COVID-19 related expert judgements partially offset by provisions booked for customers and clients considered more vulnerable to rising costs and slowing consumer demand.
 
Furthermore, a previously held 2021 adjustment of £0.4bn to amend probabilities of default (PDs), informed by pre COVID-19 levels, is no longer required as the normalisation of customer behaviour is now captured within the modelled output.
 
Model uncertainty provisions £0.2bn (2021: £0.2bn) informed by modelled provisions following the updated Q222 scenario.
 
Other adjustments
 
 
Other adjustments are operational in nature and are expected to remain in place until they can be corrected in the underlying models. These adjustments result from data limitations and model performance related issues identified through established governance processes. The quantum of adjustments has reduced in response to the macroeconomic variable refresh in Q222 as well as model enhancements made during H122. Material adjustments comprise the following:
 
Home loans: The low average loan to value (LTV) nature of the UK Home Loans portfolio means that modelled ECL estimates are low. An adjustment is made to maintain an appropriate level of ECL informed by model monitoring.
 
Credit cards, unsecured loans and other retail lending: Includes the estimated ECL impact from adoption of the new definition of default under the Capital Requirements Regulation, the Day 1 provision for the GAP portfolio acquisition in US cards, an annual update to the qualitative measures used in high risk account management (HRAM) and adjustments for model inaccuracies informed by model monitoring; partially offset by a reclassification of loans and advances from Stage 2 to Stage 1 in credit cards. The reclassification followed a review of back-testing results which indicated that accuracy of origination probability of default characteristics requires management adjustments to correct and was first established in Q220. This adjustment has been reduced, driven by the improved macroeconomic scenarios in Q222.
 
Wholesale loans: Management adjustments of £(0.4)bn within wholesale loans in 2021 principally comprised an adjustment applied on bounce back loans of £(0.4)bn to reverse out the modelled charge which did not consider the government guarantee when calculating the ECL. This adjustment is no longer needed due to model enhancements.
 
 
Measurement uncertainty
 
Management has applied economic uncertainty and other adjustments to modelled ECL outputs. Economic uncertainty adjustments have been applied to customers and clients considered most vulnerable to rising costs and supply chain disruption. As a result, ECL is higher than would be the case if it were based on forecast economic scenarios alone.
 
The measurement of modelled ECL involves complexity and judgement, including estimation of probabilities of default (PD), loss given default (LGD), a range of unbiased future economic scenarios, estimation of expected lives, estimation of exposures at default (EAD) and assessing significant increases in credit risk. The Group uses a five-scenario model to calculate ECL. An external consensus forecast is assembled from key sources, including HM Treasury (short and medium term forecasts), Bloomberg (based on median of economic forecasts) and the Urban Land Institute (for US House Prices), which forms the Baseline scenario. In addition, two adverse scenarios (Downside 1 and Downside 2) and two favourable scenarios (Upside 1 and Upside 2) are derived, with associated probability weightings. The adverse scenarios are calibrated to a broadly similar severity to Barclays’ internal stress tests and stress scenarios provided by regulators whilst also considering IFRS 9 specific sensitivities and non-linearity. The favourable scenarios are designed to reflect plausible upside risks to the Baseline scenario which are broadly consistent with the economic narrative approved by the Senior Scenario Review Committee. All scenarios are regenerated at a minimum semi-annually. The scenarios include key economic variables, (including GDP, unemployment, House Price Index (HPI) and base rates in both the UK and US markets), and expanded variables using statistical models based on historical correlations. The upside and downside shocks are designed to evolve over a five-year stress horizon, with all five scenarios converging to a steady state after approximately seven years.
 
Scenarios used to calculate the Group’s ECL charge were refreshed in Q222. The current Baseline scenario reflects the latest consensus economic forecasts. Unemployment rates remain low, close to current levels. As inflation expectations drift higher, central banks tighten monetary policy sharply. In 2023, the UK Bank Rate reaches 2.75%, while the US Federal Funds Rate peaks at 3.25%. Rising borrowing charges and falling real wages subtract from growth through lower investment and household consumption. In the Downside 2 scenario, with inflation expectations rising, the central banks have to raise interest rates very sharply. The UK Bank Rate and the US Federal Funds Rate both reach 5.0% in Q223. Higher borrowing costs derail the economy and unemployment peaks in Q124 at 9.2% in the UK and 9.5% in the US. Given already stretched valuations, the sharp increase in mortgage servicing costs sees house prices decrease very sharply. In the Upside 2 scenario, supply disruptions get resolved, while the aggregate demand is supported by a release of household savings. GDP growth accelerates. Recovering labour force participation limits domestic inflationary pressures, while lower energy prices add some downward pressure on prices globally.
 
The methodology for estimating probability weights used in calculating ECL involves simulating a range of future paths for UK and US GDP using historical data. The five scenarios are mapped against the distribution of these future paths, with the median centred around the Baseline such that scenarios further from the Baseline attract a lower weighting. A single set of five scenarios is used across all portfolios and all five weights are normalised to equate to 100%. The same scenarios and weights that are used in the ECL estimation are also used for Barclays’ internal planning purposes. The impacts across the portfolios are different because of the sensitivities of each of the portfolios to specific macroeconomic variables. For example, mortgages are highly sensitive to house prices; credit cards and unsecured consumer loans are highly sensitive to unemployment.
 
The decrease in the Upside scenario weightings and increase in the Baseline weighting were driven by: (i) continued growth in UK/US GDP which resulted in a narrower fan of future GDP paths; and (ii) generally less favourable GDP projections across scenarios, increasing the distance between Upside 2 and Baseline scenario paths. For further details see page 48.
 
COVID-19 related expert judgements have been materially replaced by provisions for customers and clients considered most vulnerable to rising costs and supply chain disruption. The economic uncertainty adjustments of £1.0bn (FY21: £1.7bn) have been applied as overlays to the modelled ECL output. These adjustments consist of a customer and client uncertainty provision of £0.8bn (FY21: £1.5bn) and a model uncertainty provision of £0.2bn (FY21: £0.2bn). For further details, see pages 41 to 35.
 
The tables below show the key consensus macroeconomic variables used in the scenarios (5-year annual paths), the probability weights applied to each scenario and the macroeconomic variables by scenario using ‘specific bases’ i.e. the most extreme position of each variable in the context of the scenario, for example, the highest unemployment for downside scenarios and the lowest unemployment for upside scenarios. The 5-year average table provides additional transparency.
 
Baseline average macroeconomic variables used in the calculation of ECL
 
2022
 
2023
 
2024
 
2025
 
2026
 
As at 30.06.22
 
%
 
%
 
%
 
%
 
%
 
UK GDP1
 
3.9
1.7
1.6
1.6
1.6
UK unemployment2
 
4.0
4.1
3.9
3.9
3.9
UK HPI3
 
4.3
1.0
2.2
2.5
2.8
UK bank rate
 
1.5
2.7
2.4
2.1
2.0
US GDP1
 
3.3
2.2
2.1
2.1
2.1
US unemployment4
 
3.6
3.5
3.5
3.5
3.5
US HPI5
 
4.1
3.4
3.4
3.4
3.4
US federal funds rate
 
1.5
3.2
2.9
2.7
2.5
 
2021
 
2022
 
2023
 
2024
 
2025
 
As at 31.12.21
 
%
 
%
 
%
 
%
 
%
 
UK GDP1
 
6.2
 
4.9
 
2.3
 
1.9
 
1.7
 
UK unemployment2
 
4.8
 
4.7
 
4.5
 
4.3
 
4.2
 
UK HPI3
 
4.7
 
1.0
 
1.9
 
1.9
 
2.3
 
UK bank rate
 
0.1
 
0.8
 
1.0
 
1.0
 
0.8
 
US GDP1
 
5.5
 
3.9
 
2.6
 
2.4
 
2.4
 
US unemployment4
 
5.5
 
4.2
 
3.6
 
3.6
 
3.6
 
US HPI5
 
11.8
 
4.5
 
5.2
 
4.9
 
5.0
 
US federal funds rate
 
0.2
 
0.3
 
0.9
 
1.2
 
1.3
 
 
1
Average Real GDP seasonally adjusted change in year.
2
Average UK unemployment rate 16-year+.
3
Change in year end UK HPI = Halifax All Houses, All Buyers index, relative to prior year end.
4
Average US civilian unemployment rate 16-year+.
5
Change in year end US HPI = FHFA House Price Index, relative to prior year end.
 
Downside 2 average economic variables used in the calculation of ECL
 
2022
 
2023
 
2024
 
2025
 
2026
 
As at 30.06.22
 
%
 
%
 
%
 
%
 
%
 
UK GDP1
 
3.1
(4.8)
(0.4)
4.3
3.6
UK unemployment2
 
5.2
8.4
8.6
6.8
5.9
UK HPI3
 
0.2
(26.2)
(3.6)
17.9
10.2
UK bank rate
 
1.8
4.7
4.3
2.6
2.3
US GDP1
 
2.4
(4.1)
(0.2)
3.4
2.7
US unemployment4
 
4.6
8.0
9.0
7.1
5.8
US HPI5
 
(0.2)
(11.7)
(0.2)
5.5
3.5
US federal funds rate
 
1.8
4.8
4.6
3.6
3.0
 
2021
 
2022
 
2023
 
2024
 
2025
 
As at 31.12.21
 
%
 
%
 
%
 
%
 
%
 
UK GDP1
 
6.2
 
0.2
 
(4.0)
 
2.8
 
4.3
 
UK unemployment2
 
4.8
 
7.2
 
9.0
 
7.6
 
6.3
 
UK HPI3
 
4.7
 
(14.3)
 
(21.8)
 
11.9
 
15.2
 
UK bank rate
 
0.1
 
2.2
 
3.9
 
3.1
 
2.2
 
US GDP1
 
5.5
 
(0.8)
 
(3.5)
 
2.5
 
3.2
 
US unemployment4
 
5.5
 
6.4
 
9.1
 
8.1
 
6.4
 
US HPI5
 
11.8
 
(6.6)
 
(9.0)
 
5.9
 
6.7
 
US federal funds rate
 
0.2
 
2.1
 
3.4
 
2.6
 
2.0
 
 
1
Average Real GDP seasonally adjusted change in year.
2
Average UK unemployment rate 16-year+.
3
Change in year end UK HPI = Halifax All Houses, All Buyers index, relative to prior year end.
4
Average US civilian unemployment rate 16-year+.
5
Change in year end US HPI = FHFA House Price Index, relative to prior year end.
 
 
Downside 1 average economic variables used in the calculation of ECL
 
2022
 
2023
 
2024
 
2025
 
2026
 
As at 30.06.22
 
%
 
%
 
%
 
%
 
%
 
UK GDP1
 
3.5
(1.6)
0.6
3.0
2.6
UK unemployment2
 
4.6
6.2
6.2
5.3
4.9
UK HPI3
 
2.3
(13.2)
(0.8)
10.0
6.5
UK bank rate
 
1.6
3.8
3.4
2.4
2.0
US GDP1
 
2.7
(1.0)
1.1
2.9
2.5
US unemployment4
 
4.1
5.7
6.2
5.3
4.6
US HPI5
 
1.9
(4.4)
1.6
4.4
3.4
US federal funds rate
 
1.7
3.9
3.8
3.2
2.8
 
2021
 
2022
 
2023
 
2024
 
2025
 
As at 31.12.21
 
%
 
%
 
%
 
%
 
%
 
UK GDP1
 
6.2
 
2.8
 
(0.7)
 
2.3
 
2.9
 
UK unemployment2
 
4.8
 
6.2
 
6.8
 
6.0
 
5.3
 
UK HPI3
 
4.7
 
(6.8)
 
(10.5)
 
6.9
 
8.6
 
UK bank rate
 
0.1
 
1.6
 
2.7
 
2.3
 
1.6
 
US GDP1
 
5.5
 
1.6
 
(0.4)
 
2.4
 
2.7
 
US unemployment4
 
5.5
 
5.4
 
6.6
 
6.1
 
5.2
 
US HPI5
 
11.8
 
(1.2)
 
(2.1)
 
4.8
 
5.2
 
US federal funds rate
 
0.2
 
1.3
 
2.3
 
2.1
 
1.8
 
 
 
 
1
Average Real GDP seasonally adjusted change in year.
2
Average UK unemployment rate 16-year+.
3
Change in year end UK HPI = Halifax All Houses, All Buyers index, relative to prior year end.
4
Average US civilian unemployment rate 16-year+.
5
Change in year end US HPI = FHFA House Price Index, relative to prior year end.
 
Upside 2 average economic variables used in the calculation of ECL
 
2022
 
2023
 
2024
 
2025
 
2026
 
As at 30.06.22
 
%
 
%
 
%
 
%
 
%
 
UK GDP1
 
5.0
5.2
3.1
2.4
2.0
UK unemployment2
 
3.8
3.7
3.6
3.6
3.6
UK HPI3
 
6.5
11.2
6.2
4.7
3.7
UK bank rate
 
1.2
1.5
1.4
1.3
1.3
US GDP1
 
4.0
4.9
3.6
3.4
3.4
US unemployment4
 
3.4
3.0
3.1
3.1
3.1
US HPI5
 
5.4
5.5
4.6
4.5
4.5
US federal funds rate
 
1.1
2.2
1.9
1.7
1.5
 
2021
 
2022
 
2023
 
2024
 
2025
 
As at 31.12.21
 
%
 
%
 
%
 
%
 
%
 
UK GDP1
 
6.2
 
7.2
 
4.0
 
2.7
 
2.1
 
UK unemployment2
 
4.8
 
4.5
 
4.1
 
4.0
 
4.0
 
UK HPI3
 
4.7
 
8.5
 
9.0
 
5.2
 
4.2
 
UK bank rate
 
0.1
 
0.2
 
0.5
 
0.5
 
0.3
 
US GDP1
 
5.5
 
5.3
 
4.1
 
3.5
 
3.4
 
US unemployment4
 
5.5
 
3.9
 
3.4
 
3.3
 
3.3
 
US HPI5
 
11.8
 
10.6
 
8.5
 
7.2
 
6.6
 
US federal funds rate
 
0.2
 
0.3
 
0.4
 
0.7
 
1.0
 
 
1
Average Real GDP seasonally adjusted change in year.
2
Average UK unemployment rate 16-year+.
3
Change in year end UK HPI = Halifax All Houses, All Buyers index, relative to prior year end.
4
Average US civilian unemployment rate 16-year+.
5
Change in year end US HPI = FHFA House Price Index, relative to prior year end.
 
 
Upside 1 average economic variables used in the calculation of ECL
 
2022
 
2023
 
2024
 
2025
 
2026
 
As at 30.06.22
 
%
 
%
 
%
 
%
 
%
 
UK GDP1
 
4.5
3.5
2.4
2.0
1.8
UK unemployment2
 
3.9
3.8
3.8
3.8
3.8
UK HPI3
 
5.4
6.3
4.1
3.6
3.2
UK bank rate
 
1.3
2.0
1.6
1.5
1.5
US GDP1
 
3.7
3.7
3.0
2.9
2.9
US unemployment4
 
3.5
3.2
3.3
3.3
3.3
US HPI5
 
4.7
4.4
4.0
3.9
3.9
US federal funds rate
 
1.3
2.4
2.2
1.9
1.8
 
2021
 
2022
 
2023
 
2024
 
2025
 
As at 31.12.21
 
%
 
%
 
%
 
%
 
%
 
UK GDP1
 
6.2
 
6.0
 
3.1
 
2.3
 
1.9
 
UK unemployment2
 
4.8
 
4.6
 
4.3
 
4.2
 
4.1
 
UK HPI3
 
4.7
 
5.0
 
5.0
 
3.9
 
3.3
 
UK bank rate
 
0.1
 
0.6
 
0.8
 
0.8
 
0.5
 
US GDP1
 
5.5
 
4.6
 
3.4
 
2.9
 
2.9
 
US unemployment4
 
5.5
 
4.0
 
3.5
 
3.5
 
3.5
 
US HPI5
 
11.8
 
8.3
 
7.0
 
6.0
 
5.7
 
US federal funds rate
 
0.2
 
0.3
 
0.6
 
1.0
 
1.1
 
 
 
 
1
Average Real GDP seasonally adjusted change in year.
2
Average UK unemployment rate 16-year+.
3
Change in year end UK HPI = Halifax All Houses, All Buyers index, relative to prior year end.
4
Average US civilian unemployment rate 16-year+.
5
Change in year end US HPI = FHFA House Price Index, relative to prior year end.
 
 
Scenario probability weighting
 
Upside 2
 
Upside 1
 
Baseline
 
Downside 1
 
Downside 2
 
 
%
 
%
 
%
 
%
 
%
 
As at 30.06.22
 
 
 
 
 
 
Scenario probability weighting
 
14.0
 
25.6
 
37.8
 
15.2
 
7.4
 
As at 31.12.21
 
 
 
 
 
 
Scenario probability weighting
 
20.9
 
27.2
 
30.1
 
14.8
 
7.0
 
 
 
 
Specific bases show the most extreme position of each variable in the context of the scenario, for example, the highest unemployment for downside scenarios, average unemployment for baseline scenarios and lowest unemployment for upside scenarios. GDP and HPI downside and upside scenario data represents the lowest and highest points relative to the start point in the 20 quarter period.
 
 
Macroeconomic variables (specific bases)1
 
 
Upside 2
 
Upside 1
 
Baseline
 
Downside 1
 
Downside 2
 
As at 30.06.22
 
%
 
%
 
%
 
%
 
%
 
UK GDP2
 
16.8
12.8
2.1
(1.1)
(5.9)
UK unemployment3
 
3.6
3.8
4.0
6.6
9.2
UK HPI4
 
36.7
24.8
2.6
(13.6)
(30.8)
UK bank rate
 
0.8
0.8
2.1
4.0
5.0
US GDP2
 
20.2
16.1
2.4
(0.5)
(5.0)
US unemployment3
 
3.0
3.2
3.5
6.5
9.5
US HPI4
 
27.0
22.9
3.5
(2.6)
(13.4)
US federal funds rate
 
0.3
0.3
2.6
4.1
5.0
 
 
 
 
 
 
As at 31.12.21
 
 
 
 
 
 
UK GDP2
 
21.4
 
18.3
 
3.4
 
(1.6)
 
(1.6)
 
UK unemployment3
 
4.0
 
4.1
 
4.5
 
7.0
 
9.2
 
UK HPI4
 
35.7
 
23.8
 
2.4
 
(12.7)
 
(29.9)
 
UK bank rate
 
0.1
 
0.1
 
0.7
 
2.8
 
4.0
 
US GDP2
 
22.8
 
19.6
 
3.4
 
1.5
 
(1.3)
 
US unemployment3
 
3.3
 
3.5
 
4.1
 
6.8
 
9.5
 
US HPI4
 
53.3
 
45.2
 
6.2
 
2.2
 
(5.0)
 
US federal funds rate
 
0.1
 
0.1
 
0.8
 
2.3
 
3.5
 
 
 
1
UK GDP = Real GDP growth seasonally adjusted; UK unemployment = UK unemployment rate 16-year+; UK HI = Halifax All Houses, All Buyers Index; US GDP = Real GDP growth seasonally adjusted; US unemployment = US civilian unemployment rate 16-year+; US HPI = FHFA House Price Index. 20 quarter period starts from Q122 (2021: Q121).
2
Maximum growth relative to Q421 (2021: Q420), based on 20 quarter period in Upside scenarios; 5-year yearly average Compound Annual Growth Rate (CAGR) in Baseline; minimum growth relative to Q421 (2021: Q420), based on 20 quarter period in Downside scenarios.
3
Lowest quarter in 20 quarter period in Upside scenarios; 5-year average in Baseline; highest quarter 20 quarter period in Downside scenarios.
4
Maximum growth relative to Q421 (2021: Q420), based on 20 quarter period in Upside scenarios; 5-year quarter end CAGR in Baseline; minimum growth relative to Q421 (2021: Q420), based on 20 quarter period in Downside scenarios.
 
Average basis represents the average quarterly value of variables in the 20 quarter period with GDP and HPI based on yearly average and quarterly CAGRs respectively.
 
 
Macroeconomic variables (5-year averages)1
 
 
Upside 2
 
Upside 1
 
Baseline
 
Downside 1
 
Downside 2
 
As at 30.06.22
 
%
 
%
 
%
 
%
 
%
 
UK GDP2
 
3.5
2.8
2.1
1.6
1.1
UK unemployment3
 
3.7
3.8
4.0
5.5
7.0
UK HPI4
 
6.4
4.5
2.6
0.6
(1.5)
UK bank rate
 
1.3
1.6
2.1
2.7
3.1
US GDP2
 
3.9
3.2
2.4
1.6
0.8
US unemployment3
 
3.1
3.3
3.5
5.2
6.9
US HPI4
 
4.9
4.2
3.5
1.4
(0.8)
US federal funds rate
 
1.7
1.9
2.6
3.1
3.6
 
 
 
 
 
 
As at 31.12.21
 
 
 
 
 
 
UK GDP2
 
4.4
 
3.9
 
3.4
 
2.7
 
1.8
 
UK unemployment3
 
4.3
 
4.4
 
4.5
 
5.8
 
7.0
 
UK HPI4
 
6.3
 
4.4
 
2.4
 
0.3
 
(2.0)
 
UK bank rate
 
0.3
 
0.5
 
0.7
 
1.7
 
2.3
 
US GDP2
 
4.4
 
3.9
 
3.4
 
2.4
 
1.3
 
US unemployment3
 
3.9
 
4.0
 
4.1
 
5.7
 
7.1
 
US HPI4
 
8.9
 
7.7
 
6.2
 
3.6
 
1.4
 
US federal funds rate
 
0.5
 
0.6
 
0.8
 
1.5
 
2.1
 
 
1
UK GDP = Real GDP growth seasonally adjusted; UK unemployment = UK unemployment rate 16-year+; UK HPI = Halifax All Houses, All Buyers Index; US GDP = Real GDP growth seasonally adjusted; US unemployment = US civilian unemployment rate 16-year+; US HPI = FHFA House Price Index.
2
5-year yearly average CAGR, starting 2021 (2021: 2020).
3
5-year average. Period based on 20 quarters from Q122 (2021: Q121).
4
5-year quarter end CAGR, starting Q421 (2021: Q420).
 
 
ECL under 100% weighted scenarios for modelled portfolios
 
 
The table below shows the ECL assuming scenarios have been 100% weighted. Model exposures are allocated to a stage based on the individual scenario rather than through a probability-weighted approach as required for Barclays reported impairment allowances. As a result, it is not possible to back solve to the final reported weighted ECL from the individual scenarios as a balance may be assigned to a different stage dependent on the scenario. Model exposure uses exposure at default (EAD) values and is not directly comparable to gross exposure used in prior disclosures. For Credit cards, unsecured loans and other retail lending, an average EAD measure is used (12-month or lifetime, depending on stage allocation in each scenario). Therefore, the model exposure movement into Stage 2 is higher than the corresponding Stage 1 reduction.
 
All ECL using a model is included, with the exception of Treasury assets (£7.7m of ECL). Non-modelled exposures and management adjustments are excluded. Management adjustments can be found in the Management adjustments to models for impairment section.
 
Model exposures allocated to Stage 3 do not change in any of the scenarios as the transition criteria relies only on observable evidence of default as at 30 June 2022 and not on macroeconomic scenarios.
 
The Downside 2 scenario represents a severe global recession with substantial falls in both UK and US GDP. Unemployment in UK markets rises towards 9.2% and US markets rises towards 9.5% and there are substantial falls in asset prices including housing. Under the Downside 2 scenario, model exposure moves between stages as the economic environment weakens. This can be seen in the movement of £22.1bn of model exposure into Stage 2 between the Weighted and Downside 2 scenario. ECL increases in Stage 2 predominantly due to unsecured portfolios as economic conditions deteriorate.
 
 
Scenarios
 
As at 30 June 2022
 
Weighted
 
Upside 2
 
Upside 1
 
Baseline
 
Downside 1
 
Downside 2
 
Stage 1 Model Exposure (£m)
 
 
 
 
 
 
 
Home loans
 
142,668
 
144,569
 
143,881
 
142,882
 
141,536
 
139,553
 
Credit cards, unsecured loans and other retail lending
 
46,225
 
46,906
 
46,692
 
46,446
 
45,324
 
44,057
 
Wholesale loans
 
183,356
 
189,252
 
187,709
 
183,570
 
178,233
 
167,303
 
Stage 1 Model ECL (£m)
 
 
 
 
 
 
 
Home loans
 
3
 
2
 
2
 
2
 
4
 
10
 
Credit cards, unsecured loans and other retail lending
 
341
 
329
 
333
 
338
 
353
 
372
 
Wholesale loans
 
250
 
210
 
224
 
237
 
296
 
329
 
Stage 1 Coverage (%)
 
 
 
 
 
 
 
Home loans
 
Credit cards, unsecured loans and other retail lending
 
0.7
0.7
0.7
0.7
0.8
0.8
Wholesale loans
 
0.1
0.1
0.1
0.1
0.2
0.2
Stage 2 Model Exposure (£m)
 
 
 
 
 
 
 
Home loans
 
18,684
 
16,783
 
17,471
 
18,470
 
19,815
 
21,799
 
Credit cards, unsecured loans and other retail lending
 
8,699
 
7,741
 
8,048
 
8,448
 
9,932
 
11,658
 
Wholesale loans
 
23,702
 
17,806
 
19,349
 
23,489
 
28,825
 
39,755
 
Stage 2 Model ECL (£m)
 
 
 
 
 
 
 
Home loans
 
13
 
8
 
9
 
11
 
20
 
40
 
Credit cards, unsecured loans and other retail lending
 
1,531
 
1,306
 
1,378
 
1,468
 
1,840
 
2,318
 
Wholesale loans
 
463
 
348
 
382
 
438
 
604
 
1,091
 
Stage 2 Coverage (%)
 
 
 
 
 
 
 
Home loans
 
0.1
0.1
0.1
0.1
0.2
Credit cards, unsecured loans and other retail lending
 
17.6
16.9
17.1
17.4
18.5
19.9
Wholesale loans
 
2.0
2.0
2.0
1.9
2.1
2.7
Stage 3 Model Exposure (£m)
 
 
 
 
 
 
 
Home loans
 
1,631
 
1,631
 
1,631
 
1,631
 
1,631
 
1,631
 
Credit cards, unsecured loans and other retail lending
 
1,797
 
1,797
 
1,797
 
1,797
 
1,797
 
1,797
 
Wholesale loans1
 
2,431
 
2,431
 
2,431
 
2,431
 
2,431
 
2,431
 
Stage 3 Model ECL (£m)
 
 
 
 
 
 
 
Home loans
 
313
 
301
 
305
 
309
 
328
 
357
 
Credit cards, unsecured loans and other retail lending
 
1,207
 
1,183
 
1,191
 
1,222
 
1,218
 
1,212
 
Wholesale loans1
 
61
 
56
 
58
 
60
 
66
 
73
 
Stage 3 Coverage (%)
 
 
 
 
 
 
 
Home loans
 
19.2
18.5
18.7
18.9
20.1
21.9
Credit cards, unsecured loans and other retail lending
 
67.2
65.8
66.3
68.0
67.8
67.4
Wholesale loans1
 
2.5
2.3
2.4
2.5
2.7
3.0
Total Model ECL (£m)
 
 
 
 
 
 
 
Home loans
 
329
 
311
 
316
 
322
 
352
 
407
 
Credit cards, unsecured loans and other retail lending
 
3,079
 
2,818
 
2,902
 
3,028
 
3,411
 
3,902
 
Wholesale loans1
 
774
 
614
 
664
 
735
 
966
 
1,493
 
Total Model ECL
 
4,182
 
3,743
 
3,882
 
4,085
 
4,729
 
5,802
 
 
1
Material wholesale loan defaults are individually assessed across different recovery strategies. As a result, ECL of £376m is reported as individually assessed impairments in the table below.
 
Reconciliation to total ECL
 
£m
 
Total model ECL
 
4,182
 
ECL from individually assessed impairments
 
376
 
ECL from non-modelled and other management adjustments1
 
1,465
 
Total ECL
 
6,023
 
 
 
1
Includes £1.3bn post-model adjustments of which £0.1bn is included as part of total model ECL and £0.2bn ECL from non-modelled exposures.
 
The dispersion of results around the Baseline is an indication of uncertainty around the future projections. The disclosure highlights the results of the alternative scenarios enabling the reader to understand the extent of the impact on exposure and ECL from the upside/downside scenarios. Consequently, the use of five scenarios with associated weightings results in a total weighted ECL uplift from the Baseline ECL of 2.4%, largely driven by credit card losses which have more linear loss profiles than UK home loans and wholesale loan positions.
 
Home loans: Total weighted ECL of £329m represents a 2.2% increase over the Baseline ECL (£322m), and coverage ratios remain steady across the Upside scenarios, Baseline and Downside 1 scenario. However, total ECL increases in the Downside 2 scenario to £407m, driven by a significant fall in UK HPI (30.8%) reflecting the non-linearity of the UK portfolio.
 
Credit cards, unsecured loans and other retail lending: Total weighted ECL of £3,079m represents a 1.7% increase over the Baseline ECL (£3,028m) reflecting the range of economic scenarios used, mainly impacted by unemployment and other key retail variables. Total ECL increases to £3,902m under Downside 2 scenario, mainly driven by Stage 2, where coverage rates increase to 19.9% from a weighted scenario approach of 17.6% and circa £3.0bn increase in model exposure that meets the Significant Increase in Credit Risk criteria and transitions from Stage 1 to Stage 2.
 
Wholesale loans: Total weighted ECL of £774m represents an 5.3% increase over the Baseline ECL (£735m) reflecting the range of economic scenarios used, with exposures in the Corporate and Investment Bank particularly sensitive to the Downside 2 scenario.
 
 
 
Scenarios
 
As at 31 December 2021
 
Weighted
 
Upside 2
 
Upside 1
 
Baseline
 
Downside 1
 
Downside 2
 
Stage 1 Model Exposure (£m)
 
 
 
 
 
 
 
Home loans
 
137,279
 
139,117
 
138,424
 
137,563
 
135,544
 
133,042
 
Credit cards, unsecured loans and other retail lending
 
45,503
 
46,170
 
45,963
 
45,751
 
43,131
 
38,820
 
Wholesale loans
 
174,249
 
177,453
 
176,774
 
175,451
 
169,814
 
161,998
 
Stage 1 Model ECL (£m)
 
 
 
 
 
 
 
Home loans
 
4
 
2
 
2
 
3
 
6
 
14
 
Credit cards, unsecured loans and other retail lending
 
324
 
266
 
272
 
279
 
350
 
418
 
Wholesale loans
 
290
 
240
 
262
 
286
 
327
 
350
 
Stage 1 Coverage (%)
 
 
 
 
 
 
 
Home loans
 
Credit cards, unsecured loans and other retail lending
 
0.7
0.6
0.6
0.6
0.8
1.1
Wholesale loans
 
0.2
 
0.1
 
0.1
 
0.2
 
0.2
 
0.2
 
Stage 2 Model Exposure (£m)
 
 
 
 
 
 
 
Home loans
 
22,915
21,076
21,769
22,631
24,649
27,151
Credit cards, unsecured loans and other retail lending
 
7,200
6,260
6,521
6,795
9,708
14,290
Wholesale loans
 
32,256
 
29,052
 
29,732
 
31,054
 
36,692
 
44,507
 
Stage 2 Model ECL (£m)
 
 
 
 
 
 
 
Home loans
 
15
 
10
 
11
 
12
 
22
 
47
 
Credit cards, unsecured loans and other retail lending
 
1,114
 
925
 
988
 
1,058
 
1,497
 
3,295
 
Wholesale loans
 
572
 
431
 
467
 
528
 
851
 
1,510
 
Stage 2 Coverage (%)
 
 
 
 
 
 
 
Home loans
 
0.1
0.1
0.1
0.1
0.2
Credit cards, unsecured loans and other retail lending
 
15.5
14.8
15.2
15.6
15.4
23.1
Wholesale loans
 
1.8
 
1.5
 
1.6
 
1.7
 
2.3
 
3.4
 
Stage 3 Model Exposure (£m)
 
 
 
 
 
 
 
Home loans
 
1,724
1,724
1,724
1,724
1,724
1,724
Credit cards, unsecured loans and other retail lending
 
1,922
1,922
1,922
1,922
1,922
1,922
Wholesale loans1
 
1,811
 
1,811
 
1,811
 
1,811
 
1,811
 
1,811
 
Stage 3 Model ECL (£m)
 
 
 
 
 
 
 
Home loans
 
303
292
295
299
320
346
Credit cards, unsecured loans and other retail lending
 
1,255
1,236
1,245
1,255
1,277
1,297
Wholesale loans1
 
323
 
321
 
322
 
323
 
326
 
332
 
Stage 3 Coverage (%)
 
 
 
 
 
 
 
Home loans
 
17.6
16.9
17.1
17.3
18.6
20.1
Credit cards, unsecured loans and other retail lending
 
65.3
64.3
64.8
65.3
66.4
67.5
Wholesale loans1
 
17.8
 
17.7
 
17.8
 
17.8
 
18.0
 
18.3
 
Total Model ECL (£m)
 
 
 
 
 
 
 
Home loans
 
322
304
308
314
348
407
Credit cards, unsecured loans and other retail lending
 
2,693
2,427
2,505
2,592
3,124
5,010
Wholesale loans1
 
1,185
992
1,051
1,137
1,504
2,192
Total Model ECL
 
4,200
3,723
3,864
4,043
4,976
7,609
 
1
Material wholesale loan defaults are individually assessed across different recovery strategies. As a result, ECL of £524m is reported as individually assessed impairments in the table below.
 
Reconciliation to total ECL1
 
£m
 
Total model ECL
 
4,200
ECL from individually assessed impairments
 
524
ECL from non-modelled and other management adjustments
 
1,560
Total ECL
 
6,284
 
1
Includes £1.5bn of post-model adjustments and £0.2bn ECL from non-modelled exposures.
 
 
Analysis of specific portfolios and asset types
 
 
Secured home loans
 
 
The UK home loan portfolio primarily comprises first lien mortgages and accounts for 93% (December 2021: 93%) of the Group’s total home loans balance.
 
Barclays UK
 
Home loans principal portfolios
 
As at 30.06.22
 
As at 31.12.21
 
Gross loans and advances (£m)
 
159,676
 
158,192
 
90 day arrears rate, excluding recovery book (%)
 
0.1
 
0.1
 
Annualised gross charge-off rates - 180 days past due (%)
 
0.5
 
0.5
 
Recovery book proportion of outstanding balances (%)
 
0.6
 
0.6
 
Recovery book impairment coverage ratio (%)
 
4.6
 
4.2
 
 
 
 
Average marked to market LTV
 
 
 
Balance weighted %
 
50.8
 
50.7
 
Valuation weighted %
 
37.8
 
37.5
 
 
 
 
New lending
 
Half year ended 30.06.22
 
Half year ended 30.06.21
 
New home loan bookings (£m)
 
14,117
 
19,120
 
New home loan proportion > 90% LTV (%)
 
2.6
 
0.9
 
Average LTV on new home loans: balance weighted (%)
 
68.6
 
68.7
 
Average LTV on new home loans: valuation weighted (%)
 
60.4
 
61.3
 
 
Home loans principal portfolios – distribution of balances by LTV1
 
 
Distribution of balances
 
Distribution of impairment allowance
 
Coverage ratio
 
 
Stage 1
 
Stage 2
 
Stage 3
 
Total
 
Stage 1
 
Stage 2
 
Stage 3
 
Total
 
Stage 1
 
Stage 2
 
Stage 3
 
Total
 
Barclays UK
 
%
 
%
 
%
 
%
 
%
 
%
 
%
 
%
 
%
 
%
 
%
 
%
 
As at 30.06.22
 
 
 
 
 
 
 
 
 
 
 
 
 
<=75%
 
79.2
 
10.9
 
0.6
 
90.7
 
6.7
 
17.3
 
34.5
 
58.5
 
 
0.1
 
2.9
 
 
>75% and <=90%
 
8.2
 
0.5
 
 
8.7
 
4.2
 
10.8
 
12.2
 
27.2
 
 
1.2
 
29.1
 
0.2
 
>90% and <=100%
 
0.6
 
 
 
0.6
 
0.4
 
0.6
 
2.2
 
3.2
 
 
2.5
 
72.9
 
0.3
 
>100%
 
 
 
 
 
0.1
 
1.5
 
9.5
 
11.1
 
0.4
 
20.7
 
100.0
 
23.1
 
As at 31.12.21
 
 
 
 
 
 
 
 
 
 
 
 
 
<=75%
 
77.2
 
11.3
 
0.7
 
89.2
 
8.3
 
17.7
 
31.9
 
57.9
 
 
0.1
 
2.4
 
 
>75% and <=90%
 
9.3
 
0.6
 
 
9.9
 
4.8
 
10.7
 
11.7
 
27.2
 
 
1.0
 
22.6
 
0.1
 
>90% and <=100%
 
0.9
 
 
 
0.9
 
0.9
 
1.0
 
2.9
 
4.8
 
0.1
 
1.9
 
87.5
 
0.3
 
>100%
 
 
 
 
 
0.2
 
1.0
 
8.9
 
10.1
 
0.4
 
6.4
 
100.0
 
14.1
 
 
1
Portfolio mark to market based on the most updated valuation including recovery book balances. Updated valuations reflect the application of the latest HPI available as at 30 June 2022.
 
New lending reduced to £14.1bn, a level more consistent with pre-COVID-19 periods, from £19.1bn in H121 when market dynamics drove high levels of new business due to stamp duty relief and property ownership led demand. The proportion of new lending with LTV >85% was 18%, more consistent with levels seen pre-COVID-19, compared to 7% in H121 when high LTV products were gradually being reintroduced following COVID-19 restrictions.
 
Head Office: Italian home loans and advances at amortised cost reduced to £4.6bn (2021: £4.7bn). The portfolio is secured on residential property with an average balance weighted mark to market LTV of 59.0% (2021: 60.4%). 90 day arrears remained stable at 1.3% (2021: 1.3%), gross charge-off rates increased to 0.4% (2021: 0.3%).
 
Credit cards, unsecured loans and other retail lending
 
 
The principal portfolios listed below accounted for 83% (December 2021: 82%) of the Group’s total credit cards, unsecured loans and other retail lending.
Principal portfolios
Gross exposure
 
30 day arrears rate, excluding recovery book
 
90 day arrears rate, excluding recovery book
 
Annualised gross write-off rate
 
Annualised net write-off rate
 
As at 30.06.22
 
£m
 
%
 
%
 
%
 
%
 
Barclays UK
 
 
 
 
 
 
UK cards
 
9,901
1.0
0.2
2.4
2.3
UK personal loans
 
4,188
1.3
0.6
2.0
1.6
Barclays Partner Finance
 
2,459
0.5
0.2
0.8
0.8
Barclays International
 
 
 
 
 
 
US cards
 
23,037
1.4
0.7
2.9
2.7
Germany consumer lending
 
3,993
1.5
0.7
0.7
0.7
 
 
 
 
 
 
As at 31.12.21
 
 
 
 
 
 
Barclays UK
 
 
 
 
 
 
UK cards
 
9,933
1.0
0.2
4.1
4.0
UK personal loans
 
4,011
1.5
0.7
3.5
3.2
Barclays Partner Finance
 
2,471
0.4
0.2
1.4
1.4
Barclays International
 
 
 
 
 
 
US cards
 
17,779
1.6
0.8
4.3
4.2
Germany consumer lending
 
3,559
1.5
0.7
0.9
0.8
 
UK cards: 30 and 90 day arrears rates remained stable at 1.0% and 0.2%, with balances flat at £9.9bn. Gross and net write-off rates returned to more stable levels of 2.4% and 2.3% following the higher rates in 2021 caused by the sharp reductions in overall balances through COVID-19 and heightened debt sale activity.
 
UK personal loans: 30 and 90 day arrears rates reduced by 0.2% and 0.1% to 1.3% and 0.6% respectively. This marginal reduction was driven by the portfolio growing through new lending post the COVID-19 reductions, and these newer vintages performing better than the historical stock. Gross and net write-off rates returned to more stable levels of 2.0% and 1.6% following the higher rates in 2021 caused by the sharp reductions in overall balances through COVID-19 and heightened debt sale activity.
 
Barclays Partner Finance: 30 and 90 day arrears rates remain stable and in line with December 2021.
 
US cards: Balances increased due to the acquisition of the GAP portfolio in June 2022, movement in the USD/GBP exchange rate and core portfolio growth. 30 and 90 day arrears rates improved due to the GAP portfolio acquisition.
 
Germany consumer lending: 30 and 90 day arrears rates were stable. 30 day arrears rates are below pre-COVID levels.
 
 
Government supported loans
 
 
Throughout the COVID-19 pandemic Barclays has supported its customers and clients by participating in the UK government's Bounce Back Loan Scheme (BBLS), Coronavirus Business Interruption Loan Scheme (CBILS), Coronavirus Large Business Interruption Loan Scheme (CLBILS) and the Recovery Loan Scheme (RLS).
 
 
Gross exposure
 
Impairment allowance
 
Impairment coverage
 
Government guaranteed exposure
 
 
Stage 1
 
Stage 2
 
Stage 3
 
Total
 
Modelled impairment
 
Management adjustment
 
Impairment post- management adjustment
 
Pre- management adjustment
 
Post- management adjustment
 
Total
 
As at 30.06.22
 
£m
 
£m
 
£m
 
£m
 
£m
 
£m
 
£m
 
%
 
%
 
£m
 
Barclays UK
 
 
 
 
 
 
 
 
 
 
 
BBLS
 
5,231
 
1,982
 
893
 
8,106
 
22
 
 
22
 
0.3
 
0.3
 
8,083
 
CBILS
 
606
 
234
 
54
 
894
 
18
 
(4)
 
14
 
2.1
 
1.6
 
715
 
RLS
 
17
 
2
 
1
 
20
 
 
 
 
 
 
16
 
Barclays International
 
 
 
 
 
 
 
 
 
 
 
CBILS
 
458
 
145
 
7
 
610
 
3
 
 
3
 
0.5
 
0.5
 
488
 
CLBILS
 
96
 
79
 
6
 
181
 
1
 
 
1
 
0.6
 
0.6
 
145
 
RLS
 
16
 
4
 
1
 
21
 
 
 
 
0.5
 
0.5
 
16
 
Total
 
6,424
 
2,446
 
962
 
9,832
 
44
 
(4)
 
40
 
0.4
 
0.4
 
9,463
 
 
 
 
 
 
 
 
 
 
 
 
As at 31.12.21
 
 
 
 
 
 
 
 
Barclays UK
 
 
 
 
 
 
 
 
 
 
 
BBLS
 
7,881
 
797
 
704
 
9,382
 
396
 
(380)
 
16
 
4.2
 
0.2
 
9,366
 
CBILS
 
900
 
110
 
47
 
1,057
 
12
 
(7)
 
5
 
1.1
 
0.5
 
845
 
RLS
 
11
 
 
1
 
12
 
 
 
 
2.7
 
2.7
 
10
 
Barclays International
 
 
 
 
 
 
 
 
 
 
 
CBILS
 
619
 
146
 
6
 
771
 
5
 
 
5
 
0.6
 
0.6
 
617
 
CLBILS
 
163
 
56
 
2
 
221
 
1
 
 
1
 
0.4
 
0.4
 
177
 
RLS
 
1
 
 
 
1
 
 
 
 
4.7
 
4.7
 
1
 
Total
 
9,575
 
1,109
 
760
 
11,444
 
414
 
(387)
 
27
 
3.6
 
0.2
 
11,016
 
 
The BBLS and CBILS schemes were launched to provide financial support to smaller and medium-sized businesses and CLBILS for larger businesses in the UK who may experience financial difficulties as a result of the COVID-19 outbreak. The RLS aims to help UK businesses access finance as they recover and grow following the COVID-19 pandemic. These loans are guaranteed by the government at 100% for BBLS and 80% for CBILS, CLBILS and RLS (70% for RLS issued post January 1, 2022) as at the balance sheet date.
 
Management adjustment of £(380)m applied in December 2021 has been discontinued following an update in the underlying ECL model that now fully recognises the 100% government guarantee against BBLS exposure within BUK Business Banking. However, we continue to hold the £(4)m (December 2021: £7m) adjustment against CBILS as the 80% government guarantee is not fully recognised in the models. In instances where Barclays has assessed the BBLS exposure to have not met strict assessment criteria, no claim has been made against the government guarantee resulting in an impairment allowance against these loans of £22m (December 2021: £16m) as at the balance sheet date.
 
Additionally, while the government supported loans are covered by guarantees, many BBLS customers have other financing arrangements with Barclays which are not covered by the government guarantee. Noting the elevated levels of delinquency across the BBLS population, Barclays has applied an adjustment of £0.1bn to the £2.6bn gross exposure to BBLS customers outside the scheme.
 
Market Risk
 
Analysis of management value at risk (VaR)
 
 
The table below shows the total management VaR on a diversified basis by asset class. Total management VaR includes all trading positions in Barclays Bank Group and it is calculated with a one-day holding period. VaR limits are applied to total management VaR and by asset class. Additionally, the market risk management function applies VaR sub-limits to material businesses and trading desks.
 
Management VaR (95%) by asset class
 
Half year ended 30.06.22
 
 
Half year ended 31.12.21
 
 
Half year ended 30.06.21
 
 
Average
High
Low
 
Average
High
Low
 
Average
High
Low
 
£m
£m
£m
 
£m
£m
£m
 
£m
£m
£m
Credit risk
16
 
24
 
8
 
 
10
 
13
 
7
 
 
18
30
9
Interest rate risk
 
10
 
19
 
4
 
 
5
 
9
 
4
 
 
8
15
4
Equity risk
 
10
 
29
 
4
 
 
8
 
29
 
4
 
 
10
15
6
Basis risk
 
9
 
24
 
4
 
 
4
 
7
 
3
 
 
7
10
4
Spread risk
 
5
 
10
 
3
 
 
4
 
6
 
3
 
 
4
6
3
Foreign exchange risk
 
10
 
25
 
2
 
 
4
 
16
 
1
 
 
3
6
2
Commodity risk
 
 
1
 
 
 
 
1
 
 
 
1
Inflation risk
 
6
 
17
 
3
 
 
3
 
5
 
2
 
 
2
3
2
Diversification effect1
(39)
n/a
n/a
 
(23)
n/a
n/a
 
(30)
n/a
n/a
Total management VaR
27
43
13
 
15
34
6
 
22
36
13
 
1
Diversification effects recognise that forecast losses from different assets or businesses are unlikely to occur concurrently, hence the expected aggregate loss is lower than the sum of the expected losses from each area. Historical correlations between losses are taken into account in making these assessments. The high and low VaR figures reported for each category did not necessarily occur on the same day as the high and low VaR reported as a whole. Consequently, a diversification effect balance for the high and low VaR figures would not be meaningful and is therefore omitted from the above table.
 
Average management VaR increased 80% to £27m (H221: £15m) driven by elevated market volatility and defensive risk positioning. Risk taking during the period remained within risk appetite.
 
 
Treasury and Capital Risk
 
 
The Group has a comprehensive Key Risk Control Framework for managing its liquidity risk. The liquidity framework meets the PRA standards and is designed to maintain liquidity resources that are sufficient in amount and quality, and a funding profile that is appropriate to meet the Group’s Liquidity Risk Appetite (LRA). The liquidity framework is delivered via a combination of policy formation, review and governance, analysis, stress testing, limit setting and monitoring.
 
Liquidity risk stress testing
 
 
The liquidity risk stress assessment measures the potential contractual and contingent stress outflows under a range of scenarios, which are then used to determine the size of the liquidity pool that is immediately available to meet anticipated outflows if a stress occurs. The short-term scenarios include a 30 day Barclays-specific stress event, a 90 day market-wide stress event and a 30 day combined scenario consisting of both a Barclays specific and market-wide stress event. The Group also runs a long-term liquidity stress test, which measures the anticipated outflows over a 12 month market-wide scenario.
 
The LCR requirement takes into account the relative stability of different sources of funding and potential incremental funding requirements in a stress. The LCR is designed to promote short-term resilience of a bank’s liquidity risk profile by holding sufficient high quality liquid assets to survive an acute stress scenario lasting for 30 days.
 
As at 30 June 2022, the Group held eligible liquid assets in excess of 100% of net stress outflows to its internal and external regulatory requirements.
 
Liquidity coverage ratio
 
 
 
 
As at 30.06.22
 
As at 31.12.21
 
 
£bn
£bn
Eligible liquidity buffer
331
285
Net stress outflows
(212)
(169)
Surplus
119
116
 
 
 
Liquidity coverage ratio
156%
168%
 
The Group plans to maintain its surplus to the internal and regulatory stress requirements at an efficient level, while considering risks to market funding conditions and its liquidity position. The continuous reassessment of these risks may lead to execution of appropriate actions to resize the liquidity pool.
 
 
 
 
Composition of the Group liquidity pool
 
 
 
 
 
As at 30.06.22
 
As at 31.12.21
 
 
Liquidity pool
 
Liquidity pool of which LCR eligible1
 
Liquidity pool
 
 
Cash
 
Level 1
 
Level 2A
 
 
£bn
£bn
£bn
£bn
£bn
Cash and deposits with central banks2
288
284
245
 
 
 
 
 
 
Government bonds3
 
 
 
 
 
AAA to AA-
33
24
1
26
A+ to A-
5
5
2
BBB+ to BBB-
Total government bonds
38
24
6
28
 
 
 
 
 
 
Other
 
 
 
 
 
Government Guaranteed Issuers, PSEs and GSEs
8
6
1
6
International Organisations and MDBs
3
4
5
Covered bonds
4
2
2
6
Other
2
1
Total other
17
12
3
18
 
 
 
 
 
 
Total as at 30 June 2022
343
284
36
9
291
Total as at 31 December 2021
291
243
37
5
 
 
 
 
1
The LCR eligible liquidity pool is adjusted for trapped liquidity and other regulatory deductions. It also incorporates other CRR as amended by CRR II qualifying assets that are not eligible under Barclays’ internal risk appetite.
2
Includes cash held at central banks and surplus cash at central banks related to payment schemes. 99% (December 2021: over 99%) was placed with the Bank of England, US Federal Reserve, European Central Bank, Bank of Japan and Swiss National Bank.
3
Of which over 81% (December 2021: over 82%) comprised UK, US, French, German, Japanese, Swiss and Dutch securities.
 
The Group liquidity pool increased to £343bn as at 30 June 2022 (December 2021: £291bn) driven by continued deposit growth and an increase in wholesale funding, which were partly offset by an increase in business funding consumption. During H122, the month-end liquidity pool ranged from £309bn to £343bn (H221: £290bn to £308bn), and the month-end average balance was £324bn (H221: £296bn). The liquidity pool is held unencumbered and is not used to support payment or clearing requirements. Such requirements are treated as part of our regular business funding. The liquidity pool is intended to offset stress outflows, and comprises the above cash and unencumbered assets.
 
As at 30 June 2022, 64% (December 2021: 58%) of the liquidity pool was located in Barclays Bank PLC, 25% (December 2021: 30%) in Barclays Bank UK PLC and 6% (December 2021: 7%) in Barclays Bank Ireland PLC. The residual portion of the liquidity pool is held outside of these entities, predominantly in US subsidiaries, to meet entity-specific stress outflows and local regulatory requirements. To the extent the use of this residual portion of the liquidity pool is restricted due to local regulatory requirements, it is assumed to be unavailable to the rest of the Group in calculating the LCR.
 
The composition of the pool is subject to limits and controls set by the respective entity Boards and independent liquidity risk, credit risk and market risk functions. In addition, the investment of the liquidity pool is monitored for concentration by issuer, currency and asset type. Given returns generated by these highly liquid assets, the risk and reward profile is continuously managed.
 
Deposit funding
 
As at 30.06.22
 
 
As at 31.12.21
 
 
Loans and advances at amortised cost
 
Deposits at amortised cost
 
Loan: deposit ratio1
 
 
Loan: deposit ratio1
 
Funding of loans and advances
 
£bn
 
£bn
 
%
 
 
%
 
Barclays UK
 
224
 
262
 
85
 
 
85
 
Barclays International
 
167
 
307
 
54
 
 
52
 
Head Office
 
5
 
 
 
 
 
Barclays Group
 
396
 
569
 
70
 
 
70
 
 
1
The loan: deposit ratio is calculated as loans and advances at amortised cost divided by deposits at amortised cost.
 
Funding structure and funding relationships
 
 
The basis for liquidity risk management is a funding structure that reduces the probability of a liquidity stress leading to an inability to meet funding obligations as they fall due. The Group’s overall funding strategy is to develop a diversified funding base (geographically, by type and by counterparty) and maintain access to a variety of alternative funding sources, to provide protection against unexpected fluctuations, while minimising the cost of funding.
 
Within this, the Group aims to align the sources and uses of funding. As such, retail and corporate loans and advances are largely funded by deposits in the relevant entities, with the surplus primarily funding the liquidity pool. The majority of reverse repurchase agreements are matched by repurchase agreements. Derivative liabilities and assets are largely matched. A substantial proportion of balance sheet derivative positions qualify for counterparty netting and the remaining portions are largely offset when netted against cash collateral received and paid. Wholesale debt and equity is used to fund residual assets.
 
These funding relationships as at 30 June 2022 are summarised below:
 
 
 
 
 
 
 
Restated1
 
 
As at 30.06.22
 
As at 31.12.21
 
 
 
As at 30.06.22
 
As at 31.12.21
 
Assets
 
£bn
 
£bn
 
 
Liabilities and equity
 
£bn
 
£bn
 
Loans and advances at amortised cost2
 
381
 
358
 
 
Deposits at amortised cost
 
569
 
519
 
Group liquidity pool
 
343
 
291
 
 
<1 Year wholesale funding
 
84
 
67
 
 
 
 
 
>1 Year wholesale funding
 
97
 
101
 
Reverse repurchase agreements, trading portfolio assets, cash collateral and settlement balances
 
426
 
388
 
 
Repurchase agreements, trading portfolio liabilities, cash collateral and settlement balances
 
387
 
330
 
Derivative financial instruments
 
345
 
263
 
 
Derivative financial instruments
 
321
 
257
 
Other assets3
 
94
 
84
 
 
Other liabilities
 
60
 
40
 
 
 
 
 
Equity
 
71
 
70
 
Total assets
 
1,589
 
1,384
 
 
Total liabilities and equity
 
1,589
 
1,384
 
 
1
2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page 87 for more information. The contractual maturity profile of Senior unsecured (privately placed) has been restated to reflect the impact of the Over-issuance of Securities.
2
Adjusted for liquidity pool debt securities reported at amortised cost of £15bn (December 2021: £3bn).
3
Other assets include fair value assets that are not part of reverse repurchase agreements or trading portfolio assets, and other asset categories.
 
Composition of wholesale funding
 
 
Wholesale funding outstanding (excluding repurchase agreements) was £181.5bn (December 2021: £167.5bn). In H122, the Group issued £3.5bn of MREL eligible instruments from Barclays PLC (the Parent company) in a range of tenors and currencies.
 
Our operating companies also access wholesale funding markets to maintain their stable and diversified funding bases. Barclays Bank PLC continued to issue in the shorter-term and medium-term notes markets. In addition, Barclays Bank UK PLC continued to issue in the shorter-term markets.
 
Wholesale funding of £84.2bn (December 2021: £66.7bn1) matures in less than one year, representing 46% (December 2021: 40%1) of total wholesale funding outstanding. This includes £19.4bn (December 2021: £24.9bn1) related to term funding2.
 
Maturity profile of wholesale funding2,3
 
<1
 
1-3
 
3-6
 
6-12
 
<1
 
1-2
 
2-3
 
3-4
 
4-5
 
>5
 
 
 
month
 
months
 
months
 
months
 
year
 
years
 
years
 
years
 
years
 
years
 
Total
 
 
£bn
 
£bn
 
£bn
 
£bn
 
£bn
 
£bn
 
£bn
 
£bn
 
£bn
 
£bn
 
£bn
 
Barclays PLC (the Parent company)
 
 
 
 
 
 
 
 
 
 
 
 
Senior unsecured (public benchmark)
 
 
 
 
0.2
 
0.2
 
6.9
 
7.7
 
5.5
 
3.5
 
14.0
 
37.8
 
Senior unsecured (privately placed)
 
 
 
 
 
 
0.2
 
 
 
 
1.2
 
1.4
 
Subordinated liabilities
 
 
 
 
 
 
 
1.0
 
1.7
 
 
7.4
 
10.1
 
Barclays Bank PLC (including subsidiaries)
 
 
 
 
 
 
 
 
 
 
 
 
Certificates of deposit and commercial paper
 
9.7
 
11.4
 
18.1
 
10.8
 
50.0
 
0.1
 
2.1
 
 
 
 
52.2
 
Asset backed commercial paper
 
3.7
 
4.5
 
0.2
 
0.2
 
8.6
 
 
 
 
 
 
8.6
 
Senior unsecured (public benchmark)
 
 
 
 
 
 
0.6
 
 
 
 
 
0.6
 
Senior unsecured (privately placed)4
 
7.6
 
1.8
 
1.9
 
3.9
 
15.2
 
6.3
 
7.5
 
2.1
 
3.2
 
20.3
 
54.6
 
Asset backed securities
 
0.6
 
 
 
0.1
 
0.7
 
0.4
 
2.3
 
0.4
 
0.2
 
1.4
 
5.4
 
Subordinated liabilities
 
 
0.1
 
1.2
 
0.2
 
1.5
 
0.1
 
0.1
 
 
0.1
 
 
1.8
 
Barclays Bank UK PLC (including subsidiaries)
 
 
 
 
 
 
 
 
 
 
 
 
Certificates of deposit and commercial paper
 
6.1
 
0.1
 
 
 
6.2
 
 
 
 
 
 
6.2
 
Senior unsecured (public benchmark)
 
 
 
 
 
 
 
 
 
 
0.1
 
0.1
 
Covered Bonds
 
 
 
 
1.8
 
1.8
 
 
 
 
 
0.9
 
2.7
 
Total as at 30 June 2022
 
27.7
 
17.9
 
21.4
 
17.2
 
84.2
 
14.6
 
20.7
 
9.7
 
7.0
 
45.3
 
181.5
 
Of which secured
 
4.3
 
4.5
 
0.2
 
2.1
 
11.1
 
0.4
 
2.3
 
0.4
 
0.2
 
2.3
 
16.7
 
Of which unsecured
 
23.4
 
13.4
 
21.2
 
15.1
 
73.1
 
14.2
 
18.4
 
9.3
 
6.8
 
43.0
 
164.8
 
 
 
 
 
 
 
 
 
 
 
 
 
Total as at 31 December 20211
 
14.1
 
21.7
 
15.5
 
15.4
 
66.7
 
15.4
 
15.1
 
9.9
 
11.4
 
49.0
 
167.5
 
Of which secured
 
2.4
 
6.4
 
0.6
 
0.5
 
9.9
 
1.9
 
2.0
 
0.1
 
0.3
 
2.4
 
16.6
 
Of which unsecured
 
11.7
 
15.3
 
14.9
 
14.9
 
56.8
 
13.5
 
13.1
 
9.8
 
11.1
 
46.6
 
150.9
 
 
1
2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page 87 for more information. The contractual maturity profile of financial liabilities designated at fair value has been restated to reflect the impact of the Over-issuance of Securities. Securities issued by BBPLC in excess of the maximum aggregate offering price registered under Barclays Bank PLC's 2019 F-3 and Predecessor Shelf with a value of £6,997m have been classified as "on demand".
2
The composition of wholesale funds comprises the balance sheet reported financial liabilities at fair value, debt securities in issue and subordinated liabilities. It does not include participation in the central bank facilities reported within repurchase agreements and other similar secured borrowing.
3
Term funding comprises public benchmark and privately placed senior unsecured notes, covered bonds, asset-backed securities and subordinated debt where the original maturity of the instrument is more than 1 year.
4
Includes structured notes of £45.9bn, of which £8.5bn matures within one year.
 
 
Credit ratings
 
 
In addition to monitoring and managing key metrics related to the financial strength of the Group, Barclays also solicits independent credit ratings from Standard & Poor’s Global (S&P), Moody’s, Fitch, and Rating and Investment Information (R&I). These ratings assess the creditworthiness of the Group, its subsidiaries and its branches, and are based on reviews of a broad range of business and financial attributes including capital strength, profitability, funding, liquidity, asset quality, strategy and governance.
 
Barclays Bank PLC
 
Standard & Poor's
 
Moody's
 
Fitch
 
Long-term
 
A / Positive
 
A1 / Stable
 
A+ / Stable
 
Short-term
 
A-1
 
P-1
 
F1
 
 
 
 
 
Barclays Bank UK PLC
 
 
 
 
Long-term
 
A / Positive
 
A1 / Stable
 
A+ / Stable
 
Short-term
 
A-1
 
P-1
 
F1
 
 
 
 
 
Barclays PLC
 
 
 
 
Long-term
 
BBB / Positive
 
Baa2 /Positive
 
A / Stable
 
Short-term
 
A-2
 
P-2
 
F1
 
 
As at 30 June 2022, all solicited ratings and outlooks with all agencies remained unchanged since 31 December 2021.
 
In June 2021, S&P revised the outlooks of Barclays PLC, Barclays Bank PLC and Barclays Bank UK PLC to positive from stable, whilst affirming all ratings. The revisions reflect the view that Barclays is delivering a stronger, more consistent business profile and financial performance.
 
In November 2021, Moody’s revised the outlook of Barclays PLC to positive from stable, whilst affirming all ratings. The revisions reflect Moody’s view that the level and stability of the Group’s earnings could further improve once global macroeconomic conditions normalise, recognising the balanced earnings streams and stable operating costs.
 
In July 2021, Fitch revised the outlooks of Barclays PLC, Barclays Bank PLC and Barclays Bank UK PLC to stable from negative, whilst affirming all ratings. The revisions reflected improved expectations for economic recovery in Barclays’ key markets and the Group’s resilient performance through the pandemic.
 
Barclays also solicits issuer ratings from R&I. In November 2021, R&I upgraded the issuer ratings of Barclays PLC and Barclays Bank PLC by one notch to A and A+ respectively.
 
A credit rating downgrade could result in outflows to meet collateral requirements on existing contracts. Outflows related to credit rating downgrades are included in the LRA stress scenarios and a portion of the liquidity pool is held against this risk. Credit ratings downgrades could also result in reduced funding capacity and increased funding costs.
 
The contractual collateral requirement following one- and two-notch long-term and associated short-term downgrades across all credit rating agencies, would result in outflows of £1bn and £3bn respectively, and are provided for in determining an appropriate liquidity pool size given the Group’s liquidity risk appetite. These numbers do not assume any management or restructuring actions that could be taken to reduce posting requirements. These outflows do not include the potential liquidity impact from loss of unsecured funding, such as from money market funds, or loss of secured funding capacity. However, unsecured and secured funding stresses are included in the LRA stress scenarios and a portion of the liquidity pool is held against these risks.
 
 
 
Regulatory minimum requirements
 
 
Capital
 
 
The Group’s Overall Capital Requirement for CET1 is 10.9% comprising a 4.5% Pillar 1 minimum, a 2.5% Capital Conservation Buffer (CCB), a 1.5% Global Systemically Important Institution (G-SII) buffer, a 2.4% Pillar 2A requirement and a 0% Countercyclical Capital Buffer (CCyB).
 
The Group’s CCyB is based on the buffer rate applicable for each jurisdiction in which the Group has exposures. On 11 March 2020, the Financial Policy Committee (FPC) set the CCyB rate for UK exposures at 0% with immediate effect. The buffer rates set by other national authorities for non-UK exposures are not currently material. Overall, this results in a 0.0% CCyB for the Group. On 13 December 2021, the FPC announced that a CCyB rate of 1% for UK exposures has been re-introduced and will be applicable from 13 December 2022. On 5 July 2022, the FPC announced that the UK CCyB rate will be increased from 1% to 2% and will be applicable from 5 July 2023.
 
The Group’s Pillar 2A requirement as per the PRA’s Individual Capital Requirement was set as a nominal amount. When expressed as a percentage of RWAs this was 4.2% of which at least 56.25% needed to be met with CET1 capital, equating to approximately 2.4% of RWAs. The Pillar 2A requirement is subject to at least annual review and is based on a point in time assessment.
 
The Group’s CET1 target ratio of 13-14% takes into account headroom above requirements which includes a confidential institution-specific PRA buffer. The Group remains above its minimum capital regulatory requirements including the PRA buffer.
 
Leverage
 
The Group is subject to a UK leverage ratio requirement of 3.8%. This comprises the 3.25% minimum requirement, a G-SII additional leverage ratio buffer (G-SII ALRB) of 0.53% and a countercyclical leverage ratio buffer of 0.0%. Although the leverage ratio is expressed in terms of Tier 1 (T1) capital, 75% of the minimum requirement, equating to 2.4375%, needs to be met with CET1 capital. In addition, the G-SII ALRB must be covered solely with CET1 capital. The CET1 capital held against the 0.53% G-SII ALRB was £6.0bn.
 
The Group is also required to disclose an average UK leverage ratio which is based on capital on the last day of each month in the quarter and an exposure measure for each day in the quarter.
 
 
MREL
 
The Group is required to meet the higher of: (i) two times the sum of 8% Pillar 1 and 4.2% Pillar 2A; and (ii) 6.75% of leverage exposures plus capital buffers, including the above mentioned confidential institution-specific PRA buffer. CET1 capital cannot be counted towards both MREL and the capital buffers, meaning that the buffers will effectively be applied above MREL requirements.
 
Significant regulatory updates in the period
 
 
Capital and RWAs
 
On 1 January 2022 the PRA’s implementation of Basel III standards took effect including the re-introduction of the 100% CET1 capital deduction for qualifying software intangible assets and the introduction of the Standardised Approach for Counterparty Credit Risk (SA-CCR) which replaces the Current Exposure Method (CEM) for Standardised derivative exposures as a more risk sensitive approach. In addition, the PRA also implemented IRB roadmap changes which includes revisions to the criteria for definition of default, probability of default (PD) and loss given default (LGD) estimation to ensure supervisory consistency and increase transparency of IRB models.
 
Leverage
 
From 1 January 2022, UK banks became subject to a single UK leverage ratio requirement meaning that the CRR leverage ratio no longer applies. Central bank claims can be excluded from the UK leverage ratio measure as long as they are matched by qualifying liabilities (rather than deposits).
 
References to CRR, as amended by CRR II mean, unless otherwise specified, CRR as amended by CRR II, as it forms part of UK law pursuant to the European Union (Withdrawal) Act 2018. On 31 March 2022, the temporary transitional powers (TTP) available to UK regulators to delay or phase in on-shoring of European Union legislation into UK law ended with full compliance of the on-shored regulations required from 1 April 2022.
 
 
 
 
Impact of Over-issuance of Securities
 
 
Basis of preparation
 
In March 2022, the Group became aware that Barclays Bank PLC had issued securities in excess of the amount it had registered with the SEC under Barclays Bank PLC’s 2019 F-3 and subsequently became aware that securities had also been issued in excess of the amount it had registered with the SEC under the Predecessor Shelf. The securities issued in excess of the registered amount comprised structured products and exchange traded notes. As these securities were not issued in compliance with the Securities Act, a right of rescission has arisen for certain purchasers of the securities. A proportion of these costs associated with the right of rescission are attributable to the financial statements for the year ended 31 December 2021, resulting in the restatement of the 2021 figures in the disclosures below.
 
Prior to the restatement, litigation and conduct charges in the income statement in relation to 2021 were under reported by £220m (pre-tax). This resulted in a CET1 capital decrease of £170m from £47,497m to £47,327m. Both the transitional and fully loaded CET1 ratios remained unchanged at 15.1% and 14.7% respectively. The T1 ratio moved from 19.2% to 19.1% and the total capital ratio moved from 22.3% to 22.2%.
 
The leverage exposure increased £1.9bn to recognise on a regulatory basis, the potential commitment relating to the rescission offer (see 'Other matters' on page 6). This resulted in the UK leverage ratio moving from 5.3% to 5.2% whilst the average UK leverage ratio remained unchanged at 4.9%.
 
Total own funds and eligible liabilities decreased £0.2bn to £108bn, which was in excess of a restated requirement to hold £94bn of own funds and eligible liabilities.
 
 
 
 
 
Restated1
 
Capital ratios2,3,4
 
As at 30.06.22
 
As at 31.03.22
 
As at 31.12.21
 
CET1
 
13.6%
 
13.8%
 
15.1%
 
T1
 
17.1%
 
17.1%
 
19.1%
 
Total regulatory capital
 
19.9%
 
20.1%
 
22.2%
 
 
 
 
 
Capital resources
 
£m
 
£m
 
£m
 
Total equity excluding non-controlling interests per the balance sheet
 
69,627
 
68,465
 
69,052
 
Less: other equity instruments (recognised as AT1 capital)
 
(12,357)
 
(11,119)
 
(12,259)
 
Adjustment to retained earnings for foreseeable ordinary share dividends
 
(595)
 
(968)
 
(666)
 
Adjustment to retained earnings for foreseeable repurchase of shares
 
(568)
 
(1,000)
 
 
Adjustment to retained earnings for foreseeable other equity coupons
 
(32)
 
(39)
 
(32)
 
 
 
 
 
Other regulatory adjustments and deductions
 
 
 
 
Additional value adjustments (PVA)
 
(1,810)
 
(1,864)
 
(1,585)
 
Goodwill and intangible assets
 
(8,232)
 
(8,035)
 
(6,804)
 
Deferred tax assets that rely on future profitability excluding temporary differences
 
(1,010)
 
(938)
 
(1,028)
 
Fair value reserves related to gains or losses on cash flow hedges
 
4,673
 
3,343
 
852
 
Gains or losses on liabilities at fair value resulting from own credit
 
(62)
 
4
 
892
 
Defined benefit pension fund assets
 
(3,785)
 
(3,225)
 
(2,619)
 
Direct and indirect holdings by an institution of own CET1 instruments
 
(20)
 
(20)
 
(50)
 
Adjustment under IFRS 9 transitional arrangements
 
642
 
601
 
1,229
 
Other regulatory adjustments
 
220
 
64
 
345
 
CET1 capital
 
46,691
 
45,269
 
47,327
 
 
 
 
 
AT1 capital
 
 
 
 
Capital instruments and related share premium accounts
 
12,357
 
11,119
 
12,259
 
Qualifying AT1 capital (including minority interests) issued by subsidiaries
 
 
 
637
 
Other regulatory adjustments and deductions
 
(60)
 
(60)
 
(80)
 
AT1 capital
 
12,297
 
11,059
 
12,816
 
 
 
 
 
T1 capital
 
58,988
 
56,328
 
60,143
 
 
 
 
 
T2 capital
 
 
 
 
Capital instruments and related share premium accounts
 
8,442
 
8,334
 
8,713
 
Qualifying T2 capital (including minority interests) issued by subsidiaries
 
1,277
 
1,540
 
1,113
 
Credit risk adjustments (excess of impairment over expected losses)
 
73
 
98
 
73
 
Other regulatory adjustments and deductions
 
(160)
 
(160)
 
(160)
 
Total regulatory capital
 
68,620
 
66,140
 
69,882
 
 
 
 
 
Total RWAs
 
344,516
 
328,830
 
314,136
 
 
1
Capital metrics as at 31 December 2021 have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 65 for more information. The transitional CET1 ratio remains unchanged at 15.1%.
2
CET1, T1 and T2 capital, and RWAs are calculated applying the transitional arrangements of the CRR as amended by CRR II. This includes IFRS 9 transitional arrangements and the grandfathering of CRR II non-compliant capital instruments. December 2021 comparatives include the grandfathering of CRR non-compliant capital instruments.
3
The fully loaded CET1 ratio, as is relevant for assessing against the conversion trigger in Barclays PLC AT1 securities, was 13.4%, with £46.0bn of CET1 capital and £344.3bn of RWAs calculated without applying the transitional arrangements of the CRR as amended by CRR II.
4
The Group’s CET1 ratio, as is relevant for assessing against the conversion trigger in Barclays Bank PLC 7.625% Contingent Capital Notes, was 13.6%. For this calculation CET1 capital and RWAs are calculated applying the transitional arrangements under the CRR as amended by CRR II, including the IFRS 9 transitional arrangements. The benefit of the Financial Services Authority (FSA) October 2012 interpretation of the transitional provisions, relating to the implementation of CRD IV, expired in December 2017.
 
Movement in CET1 capital
 
Three months ended 30.06.22
Six months ended 30.06.22
 
£m
£m
Opening CET1 capital1
45,269
47,327
 
 
 
Profit for the period attributable to equity holders
1,270
2,889
Own credit relating to derivative liabilities
(76)
(97)
Ordinary share dividends paid and foreseen
(291)
(593)
Purchased and foreseeable share repurchase
(1,000)
Other equity coupons paid and foreseen
(192)
(414)
Increase in retained regulatory capital generated from earnings
711
785
 
 
 
Net impact of share schemes
132
(136)
Fair value through other comprehensive income reserve
(550)
(759)
Currency translation reserve
1,333
1,703
Other reserves
11
35
Increase in other qualifying reserves
926
843
 
 
 
Pension remeasurements within reserves
423
1,090
Defined benefit pension fund asset deduction
(560)
(1,166)
Net impact of pensions
(137)
(76)
 
 
 
Additional value adjustments (PVA)
54
(225)
Goodwill and intangible assets
(197)
(1,428)
Deferred tax assets that rely on future profitability excluding those arising from temporary differences
(72)
18
Direct and indirect holdings by an institution of own CET1 instruments
30
Adjustment under IFRS 9 transitional arrangements
41
(587)
Other regulatory adjustments
96
4
Decrease in regulatory capital due to adjustments and deductions
(78)
(2,188)
 
 
 
Closing CET1 capital
46,691
46,691
 
1
Opening balance as at 31 December 2021 has been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 65 for further details.
 
CET1 capital decreased £0.6bn to £46.7bn (December 2021: £47.3bn).
 
CET1 capital decreased by £1.7bn as a result of regulatory changes that took effect from 1 January 2022 including the re-introduction of the 100% CET1 capital deduction for qualifying software intangible assets and a reduction in IFRS9 transitional relief due to the relief applied to the pre-2020 impairment charge reducing to 25% in 2022 from 50% in 2021 and the relief applied to the post-2020 impairment charge reducing to 75% in 2022 from 100% in 2021.
 
£2.9bn of capital generated from profits, after absorbing the £0.6bn net of tax impact of the Over-issuance of Securities, was partially offset by distributions of £2bn comprising:
£1bn for share buybacks announced with FY21 results
£0.6bn accrual towards a FY22 dividend
£0.4bn of equity coupons paid
 
Other significant movements in the period were:
£0.8bn decrease in the fair value through other comprehensive income reserve primarily due to losses on bonds as a result of an increase in yields
£1.7bn increase in the currency translation reserves driven by the appreciation of period end USD against GBP
 
 
RWAs by risk type and business
 
 
Credit risk
 
 
Counterparty credit risk
 
 
Market Risk
 
 
Operational risk
 
Total RWAs
 
 
STD
 
IRB
 
 
STD
 
IRB
 
Settlement Risk
 
CVA
 
 
STD
 
IMA
 
 
 
 
As at 30.06.22
 
£m
 
£m
 
 
£m
 
£m
 
£m
 
£m
 
 
£m
 
£m
 
 
£m
 
£m
 
Barclays UK
 
6,613
 
53,958
 
 
253
 
 
 
76
 
 
236
 
 
 
11,047
 
72,183
 
Corporate and Investment Bank
 
40,055
 
71,737
 
 
18,739
 
22,099
 
440
 
3,357
 
 
17,466
 
28,423
 
 
25,296
 
227,612
 
Consumer, Cards and Payments
 
25,516
 
3,643
 
 
256
 
34
 
 
64
 
 
28
 
195
 
 
6,424
 
36,160
 
Barclays International
 
65,571
 
75,380
 
 
18,995
 
22,133
 
440
 
3,421
 
 
17,494
 
28,618
 
 
31,720
 
263,772
 
Head Office
 
3,488
 
6,069
 
 
 
 
 
 
 
 
 
 
(996)
 
8,561
 
Barclays Group
 
75,672
 
135,407
 
 
19,248
 
22,133
 
440
 
3,497
 
 
17,730
 
28,618
 
 
41,771
 
344,516
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
As at 31.03.22
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Barclays UK
 
6,989
 
54,241
 
 
229
 
 
 
57
 
 
155
 
 
 
11,047
 
72,718
 
Corporate and Investment Bank
 
35,325
 
70,831
 
 
16,422
 
21,047
 
268
 
3,675
 
 
17,068
 
23,551
 
 
25,296
 
213,483
 
Consumer, Cards and Payments
 
21,289
 
3,459
 
 
242
 
12
 
 
37
 
 
110
 
34
 
 
6,424
 
31,607
 
Barclays International
 
56,614
 
74,290
 
 
16,664
 
21,059
 
268
 
3,712
 
 
17,178
 
23,585
 
 
31,720
 
245,090
 
Head Office
 
5,532
 
6,486
 
 
 
 
 
 
 
 
 
 
(996)
 
11,022
 
Barclays Group
 
69,135
 
135,017
 
 
16,893
 
21,059
 
268
 
3,769
 
 
17,333
 
23,585
 
 
41,771
 
328,830
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
As at 31.12.21
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Barclays UK
 
7,195
 
53,408
 
 
426
 
 
 
138
 
 
100
 
 
 
11,022
 
72,289
 
Corporate and Investment Bank
 
29,420
 
64,416
 
 
15,223
 
19,238
 
105
 
2,289
 
 
17,306
 
27,308
 
 
25,359
 
200,664
 
Consumer, Cards and Payments
 
20,770
 
2,749
 
 
215
 
18
 
 
21
 
 
 
57
 
 
6,391
 
30,221
 
Barclays International
 
50,190
 
67,165
 
 
15,438
 
19,256
 
105
 
2,310
 
 
17,306
 
27,365
 
 
31,750
 
230,885
 
Head Office
 
4,733
 
7,254
 
 
 
 
 
 
 
 
 
 
(1,025)
 
10,962
 
Barclays Group
 
62,118
 
127,827
 
 
15,864
 
19,256
 
105
 
2,448
 
 
17,406
 
27,365
 
 
41,747
 
314,136
 
 
 
Movement analysis of RWAs
 
Credit risk
 
Counterparty credit risk
 
Market risk
 
Operational risk
 
Total RWAs
 
 
£m
 
£m
 
£m
 
£m
 
£m
 
Opening RWAs (as at 31.12.21)
 
189,945
 
37,673
 
44,771
 
41,747
 
314,136
 
Book size
 
12,781
 
1,611
 
60
 
24
 
14,476
 
Acquisitions and disposals
 
(209)
 
 
 
 
(209)
 
Book quality
 
(3,101)
 
117
 
 
 
(2,984)
 
Model updates
 
 
 
 
 
 
Methodology and policy
 
3,458
 
3,352
 
 
 
6,810
 
Foreign exchange movements1
 
8,205
 
2,565
 
1,517
 
 
12,287
 
Total RWA movements
 
21,134
 
7,645
 
1,577
 
24
 
30,380
 
Closing RWAs (as at 30.06.22)
 
211,079
 
45,318
 
46,348
 
41,771
 
344,516
 
 
1
Foreign exchange movements does not include foreign exchange for modelled market risk or operational risk.
 
Overall RWAs increased £30.4bn to £344.5bn (December 2021: £314.1bn)
 
Credit risk RWAs increased £21.1bn:
A £12.8bn increase in book size primarily driven by a £7.8bn increase in lending activities mainly within CIB and a £4.5bn temporary increase in RWAs reflecting the hedging arrangements designed to manage the risk of the rescission offer relating to the Over-issuance of Securities, which are expected to reverse after the rescission offer has been completed in Q322
A £0.2bn decrease in acquisitions and disposals primarily driven by partial disposal of Barclays' equity stake in Absa in April 2022, offset by GAP portfolio acquisition
A £3.1bn decrease in book quality primarily driven by the benefit in mortgages from an increase in the House Price Index (HPI)
A £3.5bn increase in methodology and policy as a result of regulatory changes that took effect from 1 January 2022, relating to implementation of IRB roadmap changes partially offset by the reversal of the software intangibles benefit
A £8.2bn increase in FX primarily due to appreciation of period end USD against GBP
 
Counterparty Credit risk RWAs increased £7.6bn:
A £1.6bn increase in book size primarily due to an increase in trading activities within SFTs and derivatives
A £3.4bn increase in methodology and policy as a result of regulatory changes that took effect from 1 January 2022, relating to the introduction of SA-CCR
A £2.6bn increase in FX primarily due to appreciation of period end USD against GBP
 
Market risk RWAs increased £1.6bn:
A £0.1bn increase in book size primarily driven by a £8.4bn increase due to client and trading activities, offset by a £6.9bn decrease in Stressed Value at Risk (SVaR) model adjustment as a result of changes in portfolio composition and a £1.4bn reduction in Structural FX
A £1.5bn increase in FX primarily due to appreciation of period end USD against GBP
 
 
 
 
 
 
Restated1
 
Leverage ratios2,3
 
As at 30.06.22
 
As at 31.03.22
 
As at 31.12.21
 
£m
 
£m
 
£m
 
Average UK leverage ratio
 
4.7%
 
4.8%
 
4.9%
 
Average T1 capital
 
57,689
 
56,701
 
59,739
 
Average UK leverage exposure
 
1,233,537
 
1,179,381
 
1,229,041
 
 
 
 
 
UK leverage ratio
 
5.1%
 
5.0%
 
5.2%
 
 
 
 
 
CET1 capital
 
46,691
 
45,269
 
47,327
 
AT1 capital
 
12,297
 
11,059
 
12,179
 
T1 capital
 
58,988
 
56,328
 
59,506
 
 
 
 
 
UK leverage exposure
 
1,151,214
 
1,123,531
 
1,137,904
 
 
 
 
 
UK leverage exposure
 
 
 
Accounting assets
 
 
 
 
Derivative financial instruments
 
344,855
 
289,822
 
262,572
 
Derivative cash collateral
 
66,909
 
64,836
 
58,177
 
Securities financing transactions (SFTs)
 
193,682
 
186,417
 
170,853
 
Loans and advances and other assets
 
983,784
 
955,020
 
892,683
 
Total IFRS assets
 
1,589,230
 
1,496,095
 
1,384,285
 
 
 
 
 
Regulatory consolidation adjustments
 
(3,546)
 
(3,605)
 
(3,665)
 
 
 
 
 
Derivatives adjustments
 
 
 
 
Derivatives netting
 
(288,727)
 
(235,071)
 
(236,881)
 
Adjustments to collateral
 
(53,328)
 
(52,181)
 
(50,929)
 
Net written credit protection
 
28,102
 
19,729
 
15,509
 
Potential future exposure (PFE) on derivatives
 
85,469
 
85,619
 
137,291
 
Total derivatives adjustments
 
(228,484)
 
(181,904)
 
(135,010)
 
 
 
 
 
SFTs adjustments
 
29,784
 
29,095
 
24,544
 
 
 
 
 
Regulatory deductions and other adjustments
 
(22,758)
 
(22,332)
 
(20,219)
 
 
 
 
 
Weighted off-balance sheet commitments
 
127,400
 
119,933
 
115,047
 
 
 
 
 
Qualifying central bank claims
 
(294,477)
 
(260,196)
 
(210,134)
 
 
 
 
 
Settlement netting
 
(45,935)
 
(53,555)
 
(16,944)
 
 
 
 
 
UK leverage exposure
 
1,151,214
 
1,123,531
 
1,137,904
 
 
1
Capital and leverage metrics as at 31 December 2021 have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 65 for further details.
2
Capital and leverage measures are calculated applying the transitional arrangements of the CRR as amended by CRR II.
3
Fully loaded average UK leverage ratio was 4.6%, with £57.0bn of T1 capital and £1,232.9bn of leverage exposure. Fully loaded UK leverage ratio was 5.1%, with £58.3bn of T1 capital and £1,150.6bn of leverage exposure. Fully loaded UK leverage ratios are calculated without applying the transitional arrangements of the CRR as amended by CRR II.
 
The UK leverage ratio decreased to 5.1% (December 2021: 5.2%) primarily due to a £13.3bn increase in the leverage exposure. The UK leverage exposure increased to £1,151.2bn (December 2021: £1,137.9bn), due to the following significant movements:
 
£36.8bn increase in derivative financial instruments post additional regulatory netting and adjustments for cash collateral primarily driven by client and trading activity in CIB and the application of a 1.4 multiplier introduced under SA-CCR
£34.4bn increase in loans and advances at amortised cost primarily driven by increased lending
£28.1bn increase in SFTs primarily driven by client activity in CIB
£12.6bn increase in net written credit protection primarily driven by the inclusion of credit default swap options from 1 January 2022
£51.8bn decrease in PFE on derivatives primarily driven by increased netting eligibility due to the introduction of SA-CCR
£39.8bn decrease due to an £84.3bn increase in the qualifying central bank claims exemption primarily due to the matching of allowable liabilities rather than deposits introduced under the UK leverage framework review, partially offset by a £44.6bn increase in cash
£20.0bn decrease in trading portfolio assets primarily due to decreases in Equities
 
The average UK Leverage Ratio decreased to 4.7% (December 2021: 4.9%) primarily due to a £2.1bn decrease in average T1 capital largely as a result of regulatory changes effective from 1 January 2022 and the redemption of AT1 instruments in Q122.
 
 
MREL
 
 
 
 
 
 
 
 
MREL requirements including buffers1,2,3,4
 
Total requirement (£m) based on
 
 
Requirement as a percentage of:
 
 
 
 
Restated1
 
 
 
 
Restated1
 
 
As at 30.06.22
 
As at 31.03.22
 
As at 31.12.21
 
 
As at 30.06.22
 
As at 31.03.22
 
As at 31.12.21
 
Requirement based on RWAs (minimum requirement)
98,096
94,947
77,302
 
28.5%
28.9%
24.6%
Requirement based on UK leverage exposure3
 
91,532
89,025
93,975
 
8.0%
7.9%
6.9%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Restated1
 
Own funds and eligible liabilities1,3
 
 
 
 
 
As at 30.06.22
 
As at 31.03.22
 
As at 31.12.21
 
 
 
 
 
 
£m
 
£m
 
£m
 
CET1 capital
 
 
 
 
 
46,691
 
45,269
 
47,327
 
AT1 capital instruments and related share premium accounts5
 
 
 
 
 
12,297
 
11,059
 
12,179
 
T2 capital instruments and related share premium accounts5
 
 
 
 
 
8,355
 
8,272
 
8,626
 
Eligible liabilities
 
 
 
 
 
39,137
 
37,886
 
39,889
 
Total Barclays PLC (the Parent company) own funds and eligible liabilities
 
 
 
106,480
 
102,486
 
108,021
 
 
 
 
 
 
 
 
 
Total RWAs
 
 
 
 
 
344,516
 
328,830
 
314,136
 
Total UK leverage exposure4
 
 
 
 
1,151,214
 
1,123,531
 
1,356,191
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Restated1
 
Own funds and eligible liabilities ratios as a percentage of:1
 
 
 
 
 
As at 30.06.22
 
As at 31.03.22
 
As at 31.12.21
 
Total RWAs
 
 
 
 
 
30.9%
31.2%
34.4%
Total UK leverage exposure4
 
 
 
 
9.2%
9.1%
8.0%
 
As at 30 June 2022, Barclays PLC (the Parent company) held £106.5bn of own funds and eligible liabilities equating to 30.9% of RWAs. This was in excess of the Group's MREL requirement, excluding the PRA buffer, to hold £98.1bn of own funds and eligible liabilities equating to 28.5% of RWAs. The Group remains above its MREL regulatory requirement including the PRA buffer.
 
1
Capital and leverage metrics as at 31 December 2021 have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 65 for further details.
2
Minimum requirement excludes the confidential institution-specific PRA buffer.
3
CET1, T1 and T2 capital, and RWAs are calculated applying IFRS 9 transitional arrangements.
4
As at 31 December 2021, MREL requirements were on a CRR leverage basis which, from 1 January 2022, was no longer applicable for UK banks.
5
Includes other AT1 capital regulatory adjustments and deductions of £60m (December 2021: £80m), and other T2 credit risk adjustments and deductions of £87m (December 2021: £87m).
 
 
Statement of Directors' Responsibilities
 
The Directors (the names of whom are set out below) are required to prepare the financial statements on a going concern basis unless it is not appropriate to do so. In making this assessment, the directors have considered information relating to present and future conditions. Each of the Directors confirm that to the best of their knowledge, the condensed consolidated interim financial statements set out on pages 77 to 86 have been prepared in accordance with International Accounting Standard 34, ‘Interim Financial Reporting’, as adopted by the UK, and that the interim management report herein includes a fair review of the information required by Disclosure Guidance and Transparency Rules 4.2.7R and 4.2.8R namely:
 
an indication of important events that have occurred during the six months ended 30 June 2022 and their impact on the condensed consolidated interim financial statements, and a description of the principal risks and uncertainties for the remaining six months of the financial year
 
any related party transactions in the six months ended 30 June 2022 that have materially affected the financial position or performance of Barclays during that period and any changes in the related party transactions described in the last Annual Report that could have a material effect on the financial position or performance of Barclays in the six months ended 30 June 2022
 
Signed on 27 July 2022 on behalf of the Board by
 
 
C.S. Venkatakrishnan
 
Anna Cross
 
Group Chief Executive
 
Group Finance Director
 
 
Barclays PLC Board of Directors
 
Chairman
 
Executive Directors
 
Non-Executive Directors
 
Nigel Higgins
 
C.S. Venkatakrishnan
 
Mike Ashley
 
 
Anna Cross
 
Robert Berry
 
 
 
Tim Breedon CBE
 
 
 
Mohamed A. El-Erian
 
 
 
Dawn Fitzpatrick
 
 
 
Mary Francis CBE
 
 
 
Crawford Gillies
 
 
 
Brian Gilvary
 
 
 
Diane Schueneman
 
 
 
Julia Wilson
 
 
 
 
 
Independent Review Report to Barclays PLC
 
Conclusion
 
We have been engaged by Barclays PLC ("the company" or "the group") to review the condensed set of financial statements in the Interim Results Announcement for the six months ended 30 June 2022 which comprises:
 
the condensed consolidated income statement and condensed consolidated statement of comprehensive income for the period then ended;
the condensed consolidated balance sheet as at 30 June 2022;
the condensed consolidated statement of changes in equity for the period then ended;
the condensed consolidated cash flow statement for the period then ended; and
the related explanatory notes.
 
Based on our review, nothing has come to our attention that causes us to believe that the condensed set of financial statements in the Interim Results Announcement for the six months ended 30 June 2022 is not prepared, in all material respects, in accordance with IAS 34 Interim Financial Reporting as adopted for use in the UK and the Disclosure Guidance and Transparency Rules (“the DTR”) of the UK’s Financial Conduct Authority (“the UK FCA”).
 
Basis for conclusion
 
We conducted our review in accordance with International Standard on Review Engagements (UK) 2410 Review of Interim Financial Information Performed by the Independent Auditor of the Entity (“ISRE (UK) 2410”) issued for use in the UK. A review of interim financial information consists of making enquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. We read the other information contained in the Interim Results Announcement and consider whether it contains any apparent misstatements or material inconsistencies with the information in the condensed set of financial statements.
 
A review is substantially less in scope than an audit conducted in accordance with International Standards on Auditing (UK) and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.
 
Conclusions relating to going concern
 
Based on our review procedures, which are less extensive than those performed in an audit as described in the Basis for conclusion section of this report, nothing has come to our attention that causes us to believe that the directors have inappropriately adopted the going concern basis of accounting, or that the directors have identified material uncertainties relating to going concern that have not been appropriately disclosed.
 
This conclusion is based on the review procedures performed in accordance with ISRE (UK) 2410. However, future events or conditions may cause the group to cease to continue as a going concern, and the above conclusions are not a guarantee that the group will continue in operation.
 
Directors’ responsibilities
 
The Interim Results Announcement is the responsibility of, and has been approved by, the directors. The directors are responsible for preparing the half-yearly financial report in accordance with the DTR of the UK FCA.
 
As disclosed in note 1, the Basis of preparation, the annual financial statements of the Barclays Group are prepared in accordance with UK-adopted international accounting standards.
 
The directors are responsible for preparing the condensed set of financial statements included in the Interim Results Announcement in accordance with IAS 34 as adopted for use in the UK.
 
In preparing the condensed set of financial statements, the directors are responsible for assessing the group’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the group or to cease operations, or have no realistic alternative but to do so.
 
Our responsibility
 
Our responsibility is to express to the company a conclusion on the condensed set of financial statements in the Interim Results Announcement based on our review. Our conclusion, including our conclusions relating to going concern, are based on procedures that are less extensive than audit procedures, as described in the Basis for conclusion section of this report.
 
The purpose of our review work and to whom we owe our responsibilities
 
This report is made solely to the company in accordance with the terms of our engagement to assist the company in meeting the requirements of the DTR of the UK FCA. Our review has been undertaken so that we might state to the company those matters we are required to state to it in this report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company for our review work, for this report, or for the conclusions we have reached.
 
 
 
 
Stuart Crisp
for and on behalf of KPMG LLP
Chartered Accountants
15 Canada Square
London, E14 5GL
27 July 2022
 
 
 
Condensed Consolidated Financial Statements
 
Condensed consolidated income statement (unaudited)
 
 
 
Restated2
 
Notes1
 
Half year ended 30.06.22
Half year ended 30.06.21
 
 
£m
£m
Interest and similar income
 
7,134
 
5,279
 
Interest and similar expense
 
(2,371)
 
(1,376)
 
Net interest income
 
4,763
 
3,903
 
Fee and commission income
3
 
4,726
 
4,682
 
Fee and commission expense
3
 
(1,302)
 
(976)
 
Net fee and commission income
3
 
3,424
 
3,706
 
Net trading income
 
5,013
 
3,482
 
Net investment income
 
(116)
 
152
 
Other income
 
120
 
72
 
Total income
 
13,204
 
11,315
 
Credit impairment (charges)/releases
 
(341)
 
742
 
Net operating income
 
12,863
 
12,057
 
 
 
 
 
Staff costs
4
(4,583)
 
(4,334)
 
Infrastructure, administration and general expenses
5
 
(2,687)
 
(2,798)
 
Litigation and conduct
15
 
(1,857)
 
(176)
 
Operating expenses
 
(9,127)
 
(7,308)
 
 
 
 
 
Share of post-tax results of associates and joint ventures
 
(3)
 
154
 
Profit on disposal of subsidiaries, associates and joint ventures
 
 
(1)
 
Profit before tax
 
3,733
 
4,902
 
Tax charge
6
(823)
 
(742)
 
Profit after tax
 
2,910
 
4,160
 
 
 
 
 
Attributable to:
 
 
 
Equity holders of the parent
 
2,475
 
3,752
 
Other equity instrument holders
 
414
 
389
 
Total equity holders of the parent
 
2,889
 
4,141
 
Non-controlling interests
7
21
 
19
 
Profit after tax
 
2,910
 
4,160
 
 
 
 
 
Earnings per share
 
p
p
Basic earnings per ordinary share
8
14.8
 
21.9
 
Diluted earnings per ordinary share
8
14.5
 
21.3
 
 
1
For Notes to the Financial Statements see pages 87 to 114.
2
2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page 87 for more information.
 
Condensed consolidated statement of comprehensive income (unaudited)
 
 
 
Restated2
 
 
 
Half year ended 30.06.22
Half year ended 30.06.21
 
Notes1
£m
£m
Profit after tax
 
2,910
4,160
 
 
 
 
Other comprehensive income/(loss) that may be recycled to profit or loss:3
 
 
 
Currency translation reserve
19
1,703
(495)
Fair value through other comprehensive income reserve
19
(913)
(365)
Cash flow hedging reserve
19
(3,818)
(911)
Other comprehensive loss that may be recycled to profit
 
 
(3,028)
(1,771)
 
 
 
 
Other comprehensive income/(loss) not recycled to profit or loss:3
 
 
 
Retirement benefit remeasurements
16
1,090
103
Fair value through other comprehensive income reserve
19
154
115
Own credit
19
855
(47)
Other comprehensive income not recycled to profit
 
 
2,099
171
 
 
 
 
Other comprehensive loss for the period
 
(929)
(1,600)
 
 
 
 
Total comprehensive income for the period
 
1,981
2,560
 
 
 
 
Attributable to:
 
 
 
Equity holders of the parent
 
1,960
2,541
Non-controlling interests
 
21
19
Total comprehensive income for the period
 
1,981
2,560
 
1
For Notes to the Financial Statements see pages 87 to 114.
2
2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page 87 for more information.
3
Reported net of tax.
 
 
Condensed consolidated balance sheet (unaudited)
 
 
 
Restated2
 
 
As at 30.06.22
As at 31.12.21
Assets
Notes1
£m
£m
Cash and balances at central banks
 
283,136
238,574
Cash collateral and settlement balances
 
132,623
92,542
Loans and advances at amortised cost
12
395,824
361,451
Reverse repurchase agreements and other similar secured lending
 
1,639
3,227
Trading portfolio assets
 
127,004
147,035
Financial assets at fair value through the income statement
 
212,723
191,972
Derivative financial instruments
10
344,855
262,572
Financial assets at fair value through other comprehensive income
 
63,194
61,753
Investments in associates and joint ventures
 
911
999
Goodwill and intangible assets
13
 
8,245
8,061
Property, plant and equipment
 
3,582
3,555
Current tax assets
 
551
261
Deferred tax assets
6
5,044
4,619
Retirement benefit assets
16
 
5,233
3,879
Other assets
 
4,666
3,785
Total assets
 
1,589,230
1,384,285
 
 
 
 
Liabilities
 
 
 
Deposits at amortised cost
12
568,670
519,433
Cash collateral and settlement balances
 
124,724
79,371
Repurchase agreements and other similar secured borrowing
 
28,566
28,352
Debt securities in issue
 
115,906
98,867
Subordinated Liabilities
14
11,871
12,759
Trading portfolio liabilities
 
76,638
54,169
Financial liabilities designated at fair value
 
255,136
250,960
Derivative financial instruments
10
321,396
256,883
Current tax liabilities
 
449
689
Deferred tax liabilities
6
5
37
Retirement benefit liabilities
16
309
311
Other liabilities
 
11,538
10,505
Provisions
15
 
3,426
1,908
Total liabilities
 
1,518,634
1,314,244
 
 
 
 
Equity
 
 
 
Called up share capital and share premium
17
4,508
4,536
Other reserves
19
(218)
1,770
Retained earnings
 
52,980
50,487
Shareholders' equity attributable to ordinary shareholders of the parent
 
57,270
56,793
Other equity instruments
18
12,357
12,259
Total equity excluding non-controlling interests
 
69,627
69,052
Non-controlling interests
7
969
989
Total equity
 
70,596
70,041
 
 
 
 
Total liabilities and equity
 
1,589,230
1,384,285
 
 
1
For Notes to the Financial Statements see pages 87 to 114.
2
2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page 87 for more information.
 
 
Condensed consolidated statement of changes in equity (unaudited)
 
 
 
 
 
Restated1
 
Restated1
 
 
Restated1
 
 
Called up share capital and share premium2
 
Other equity instruments2
 
Other reserves2
 
 
 
Retained earnings
 
Total
 
Non-controlling interests3
 
Total equity
 
Half year ended 30.06.22
 
£m
 
£m
 
£m
 
£m
 
£m
 
£m
 
£m
 
Balance as at 1 January 2022
4,536
12,259
1,770
50,487
69,052
989
70,041
Profit after tax
414
2,475
2,889
21
2,910
Currency translation movements
1,703
1,703
1,703
Fair value through other comprehensive income reserve
(759)
(759)
(759)
Cash flow hedges
(3,818)
(3,818)
(3,818)
Retirement benefit remeasurements
1,090
1,090
1,090
Own credit
855
855
855
Total comprehensive income for the period
414
(2,019)
3,565
1,960
21
1,981
Employee share schemes and hedging thereof
33
417
450
450
Issue and redemption of other equity instruments
115
25
140
(20)
120
Other equity instruments coupon paid
(414)
(414)
(414)
Partial disposal of ABSA holding
(39)
39
Vesting of employee share schemes
7
(464)
(457)
(457)
Dividends paid
(664)
(664)
(21)
(685)
Repurchase of shares
(61)
61
(432)
(432)
(432)
Other movements
(17)
2
7
(8)
(8)
Balance as at 30 June 2022
4,508
12,357
(218)
52,980
69,627
969
70,596
 
 
 
 
Half year ended 31.12.2021
 
 
 
 
 
 
 
 
Balance as at 1 July 2021
4,568
11,167
2,856
48,401
66,992
1,064
68,056
Profit after tax
415
2,453
2,868
28
2,896
Currency translation movements
364
364
364
Fair value through other comprehensive income reserve
(38)
(38)
(38)
Cash flow hedges
(1,517)
(1,517)
(1,517)
Retirement benefit remeasurements
540
540
540
Own credit
33
33
33
Total comprehensive income for the period
415
(1,158)
2,993
2,250
28
2,278
Employee share schemes and hedging thereof
35
(54)
(19)
(19)
Issue and redemption of other equity instruments
1,078
6
1,084
(75)
1,009
Other equity instruments coupon paid
(415)
(415)
(415)
Vesting of employee share schemes
(3)
(13)
(16)
(16)
Dividends paid
(339)
(339)
(28)
(367)
Repurchase of shares
(67)
67
(500)
(500)
(500)
Other movements
14
8
(7)
15
15
Balance as at 31 December 2021
4,536
12,259
1,770
50,487
69,052
989
70,041
 
1
2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page 87 for more information.
2
Details of share capital, other equity instruments and other reserves are shown on pages 103 to 104.
3
Details of non-controlling interests are shown on page 92.
 
Condensed consolidated statement of changes in equity (unaudited)
 
 
 
 
 
Restated1
 
Restated1
 
 
Restated1
 
 
Called up share capital and share premium2
 
Other equity instruments2
 
Other reserves2
 
Retained earnings
 
Total
 
Non-controlling interests3
 
Total equity
 
Half year ended 30.06.2021
 
£m
 
£m
 
£m
 
£m
 
£m
 
£m
 
£m
 
Balance as at 1 January 2021
4,637
11,172
4,461
45,527
65,797
1,085
66,882
Profit after tax
389
3,752
4,141
19
4,160
Currency translation movements
(495)
(495)
(495)
Fair value through other comprehensive income reserve
(250)
(250)
(250)
Cash flow hedges
(911)
(911)
(911)
Retirement benefit remeasurements
103
103
103
Own credit
(47)
(47)
(47)
Total comprehensive income for the period
389
(1,703)
3,855
2,541
19
2,560
Employee share schemes and hedging thereof
25
289
314
314
Other equity instruments coupon paid
(389)
(389)
(389)
Vesting of employee share schemes
4
(397)
(393)
(393)
Dividends paid
(173)
(173)
(16)
(189)
Repurchase of shares
(94)
94
(700)
(700)
(700)
Other movements
(5)
(5)
(24)
(29)
Balance as at 30 June 2021
4,568
11,167
2,856
48,401
66,992
1,064
68,056
 
 
 
 
 
 
 
 
 
 
 
 
1.
2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page 87 for more information.
2.
Details of share capital, other equity instruments and other reserves are shown on pages 103 to 104.
3.
Details of non-controlling interests are shown on page 92.
 
 
Condensed consolidated cash flow statement (unaudited)
 
 
Restated1
 
 
Half year ended 30.06.22
Half year ended 30.06.21
 
£m
 
£m
 
Profit before tax
 
3,733
 
4,902
 
Adjustment for non-cash items
 
(7,115)
 
6,977
 
Net (increase)/decrease in loans and advances at amortised cost
 
(17,667)
 
432
 
Net increase in deposits at amortised cost
 
49,237
 
19,859
 
Net increase in debt securities in issue
 
19,748
 
13,041
 
Changes in other operating assets and liabilities
 
14,719
 
(5,559)
 
Corporate income tax paid
 
(401)
 
(712)
 
Net cash from operating activities
 
62,254
 
38,940
 
Net cash from investing activities
 
(14,939)
 
(3,389)
 
Net cash from financing activities
 
(5,500)
 
(2,562)
 
Effect of exchange rates on cash and cash equivalents
 
7,047
 
(5,535)
 
Net increase in cash and cash equivalents
 
48,862
 
27,454
 
Cash and cash equivalents at beginning of the period
 
259,206
 
210,142
 
Cash and cash equivalents at end of the period
 
308,068
 
237,596
 
 
1
2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page 87 for more information.
 
Financial Statement Notes 

 
 
1.
Basis of preparation
 
 
These condensed consolidated interim financial statements ("the financial statements") for the six months ended 30 June 2022 have been prepared in accordance with the Disclosure Guidance and Transparency Rules (DTR) of the UK’s Financial Conduct Authority (FCA) and IAS 34, Interim Financial Reporting, as published by the International Accounting Standards Board (IASB) and adopted by the UK.
 
The condensed consolidated interim financial statements should be read in conjunction with the annual financial statements for the year ended 31 December 2021. The annual financial statements for the year ended 31 December 2021 were prepared in accordance with international accounting standards in conformity with the requirements of the Companies Act 2006 and in accordance with International Financial Reporting Standards (IFRS) and interpretations (IFRICs) as issued by the IASB and adopted by the UK.
 
The accounting policies and methods of computation used in these condensed consolidated interim financial statements are the same as those used in the Barclays PLC Annual Report 2021.
 
 
 
1.
Going concern
 
The financial statements are prepared on a going concern basis, as the Directors are satisfied that the Group and parent company have the resources to continue in business for a period of at least 12 months from approval of the interim financial statements. In making this assessment, the Directors have considered a wide range of information relating to present and future conditions and includes a review of a working capital report (WCR). The WCR is used by the Directors to assess the future performance of the business and that it has the resources in place that are required to meet its ongoing regulatory requirements. The WCR also includes an assessment of the impact of internally generated stress testing scenarios on the liquidity and capital requirement forecasts. The stress tests used were based upon an assessment of reasonably possible downside economic scenarios that the Group could experience.
 
The WCR indicated that the Group had sufficient capital in place to support its future business requirements and remained above its regulatory minimum requirements in the internal stress scenarios.
 
2.
Other disclosures
 
The Credit risk disclosures on pages 33 to 56 form part of these interim financial statements.
 
Restatement of financial statements
 
The comparatives in these condensed consolidated interim financial statements for the six months ended 30 June 2022 (the financial statements) have been restated to reflect both a provision and contingent liability disclosure in respect of the impact of an over-issuance of securities (the Over-issuance of Securities) in excess of the maximum aggregate offering price registered under Barclays Bank PLC’s shelf registration statement on Form F-3, as declared effective by the SEC in August 2019 (2019 F-3) and Barclays Bank PLC’s predecessor shelf registration statement on Form F-3 filed in 2018 (Predecessor Shelf).
 
Due to a historic SEC settlement order, at the time the 2019 F-3 was filed and the Predecessor Shelf was amended, Barclays Bank PLC had ceased to be a “well-known seasoned issuer” (or WKSI) and had become an “ineligible issuer”, as defined in Rule 405 under the Securities Act of 1933, as amended (Securities Act), thus being required to register upfront a certain amount of securities with the SEC.
 
In March 2022, Barclays Bank PLC became aware that it had issued securities in the US materially in excess of the amount it had registered with the SEC under the 2019 F-3 and subsequently became aware that securities had also been issued in excess of the amount it had registered with the SEC under the Predecessor Shelf. The securities that were issued in this period comprise structured notes and exchange traded notes (ETNs). As such, certain offers and sales of these securities were not made in compliance with the Securities Act, giving rise to rights of rescission for certain purchasers of the securities. Under Section 12(a)(1) of the Securities Act, certain purchasers of unregistered securities have a right to recover, upon the tender of such security, the consideration paid for such security with interest, less the amount of any income received, or damages if the purchaser no longer owns the security (the Rescission Price). As a result, Barclays Bank PLC has elected to make a rescission offer to eligible purchasers of the relevant affected securities at the Rescission Price (the Rescission Offer).
 
A proportion of the expected costs associated with the rights of rescission of certain investors are attributable to Barclays PLC’s financial statements for the year ended 31 December 2021. Accordingly, the comparatives in these financial statements have been restated. The restatement impacts the consolidated income statement, the consolidated statement of comprehensive income, the consolidated balance sheet, the consolidated statement of changes in equity, and the consolidated cash flow statement for the year ended 31 December 2021, as well as quarterly and half yearly financial information that is presented within this document. There was no material effect on Barclays PLC’s previously reported financial statements for the year ended 31 December 2020 and 2019.
 
The table below reflects each of the consolidated financial statement line items that were affected by the restatement:
 
Impact on the consolidated income statement
As reported
 
Restatement
 
As restated
Half year ended 30.06.21
£m
 
£m
 
£m
Litigation and conduct
(99)
 
(77)
 
(176)
Operating expenses
(7,231)
 
(77)
 
(7,308)
Profit before tax
 
4,979
 
(77)
 
4,902
Taxation
(759)
 
17
 
(742)
Profit after tax
 
4,220
 
(60)
 
4,160
 
 
 
 
 
 
Year ended 31.12.21
£m
 
£m
 
£m
Litigation and conduct
(177)
 
(220)
 
(397)
Operating expenses
(14,439)
 
(220)
 
(14,659)
Profit before tax
 
8,414
 
(220)
 
8,194
Taxation
(1,188)
 
50
 
(1,138)
Profit after tax
 
7,226
 
(170)
 
7,056
 
 
 
 
 
 
Impact on the consolidated statement of comprehensive income
 
 
 
 
 
Half year ended 30.06.21
£m
 
£m
 
£m
Profit after tax
4,220
 
(60)
 
4,160
Total comprehensive income for the period
2,620
 
(60)
 
2,560
 
 
 
 
 
 
Year ended 31.12.21
£m
 
£m
 
£m
Profit after tax
7,226
 
(170)
 
7,056
Total comprehensive income for the period
5,008
 
(170)
 
4,838
 
 
 
 
 
 
Impact on the cash flow statement
 
 
 
 
 
Half year ended 30.06.21
£m
 
£m
 
£m
Profit before tax
4,979
 
(77)
 
4,902
Adjustment for non-cash items
6,900
 
77
 
6,977
 
 
 
 
 
 
Impact on the consolidated balance sheet
 
 
 
 
 
As at 31.12.21
£m
 
£m
 
£m
Current tax liabilities
739
 
(50)
 
689
Provisions
1,688
 
220
 
1,908
Total liabilities
1,314,074
 
170
 
1,314,244
 
 
 
 
 
 
Retained earnings
50,657
 
(170)
 
50,487
Total equity
70,211
 
(170)
 
70,041
 
 
 
2.
Segmental reporting
 
Analysis of results by business
 
 
 
 
 
 
Barclays
UK
 
Barclays
International
 
Head
Office
 
Barclays
Group
 
Half year ended 30.06.22
£m
 
£m
 
£m
 
£m
 
Total income
 
3,373
 
9,940
 
(109)
 
13,204
 
Credit impairment (charges)/releases
 
(48)
 
(310)
 
17
 
(341)
 
Net operating income/(expenses)
 
3,325
 
9,630
 
(92)
 
12,863
 
Operating costs
 
(2,083)
 
(5,042)
 
(145)
 
(7,270)
 
Litigation and conduct
 
(25)
 
(1,832)
 
 
(1,857)
 
Total operating expenses
 
(2,108)
 
(6,874)
 
(145)
 
(9,127)
 
Other net income/(expenses)1
 
 
13
 
(16)
 
(3)
 
Profit/(loss) before tax
 
1,217
 
2,769
 
(253)
 
3,733
 
 
 
 
 
 
As at 30.06.22
£bn
 
£bn
 
£bn
 
£bn
 
Total assets
 
318.8
 
1,250.6
 
19.8
 
1,589.2
 
 
 
 
 
Restated2
 
 
Restated2
 
 
Barclays
UK
 
Barclays
International
 
Head
Office
 
Barclays
Group
 
Half year ended 30.06.21
£m
 
£m
 
£m
 
£m
 
Total income
 
3,199
 
8,218
 
(102)
 
11,315
 
Credit impairment releases
 
443
 
293
 
6
 
742
 
Net operating income/(expenses)
 
3,642
 
8,511
 
(96)
 
12,057
 
Operating costs
 
(2,114)
 
(4,606)
 
(412)
 
(7,132)
 
Litigation and conduct
 
(22)
 
(161)
 
7
 
(176)
 
Total operating expenses
 
(2,136)
 
(4,767)
 
(405)
 
(7,308)
 
Other net income1
 
 
22
 
131
 
153
 
Profit/(loss) before tax
 
1,506
 
3,766
 
(370)
 
4,902
 
 
 
 
 
 
As at 31.12.21
£bn
 
£bn
 
£bn
 
£bn
 
Total assets
 
321.2
 
1,044.1
 
19.0
 
1,384.3
 
 
 
1
Other net income/(expenses) represents the share of post-tax results of associates and joint ventures, profit (or loss) on disposal of subsidiaries, associates and joint ventures and gains on acquisitions.
2
2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page 87 for more information.
 
Split of income by geographic region1
 
 
 
 
Half year ended 30.06.22
Half year ended 30.06.21
 
£m
 
£m
 
United Kingdom
 
7,972
 
5,895
 
Europe
 
1,311
 
1,222
 
Americas
 
3,200
 
3,608
 
Africa and Middle East
 
31
 
20
 
Asia
 
690
 
570
 
Total
 
13,204
 
11,315
 
 
1
The geographical analysis is based on the location of the office where the transactions are recorded.
 
 
3.
Net fee and commission income
 
 
Fee and commission income is disaggregated below and includes a total for fees in scope of IFRS 15, Revenue from Contracts with Customers:
 
 
Barclays UK
 
Barclays International
 
Head Office
 
Total
 
Half year ended 30.06.22
 
£m
 
£m
 
£m
 
£m
 
Fee type
 
 
 
 
 
Transactional1
 
515
 
1,448
 
 
1,963
 
Advisory
 
83
 
511
 
 
594
 
Brokerage and execution
 
125
 
762
 
 
887
 
Underwriting and syndication
 
 
1,102
 
 
1,102
 
Other
 
29
 
80
 
2
 
111
 
Total revenue from contracts with customers
 
752
 
3,903
 
2
 
4,657
 
Other non-contract fee income
 
 
69
 
 
69
 
Fee and commission income1
 
752
 
3,972
 
2
 
4,726
 
Fee and commission expense
 
(147)
 
(1,153)
 
(2)
 
(1,302)
 
Net fee and commission income
 
605
 
2,819
 
 
3,424
 
 
 
 
Barclays UK
 
Barclays International
 
Head Office
 
Total
 
Half year ended 30.06.21
 
£m
 
£m
 
£m
 
£m
 
Fee type
 
 
 
 
 
Transactional
 
408
 
1,181
 
 
1,589
 
Advisory
 
83
459
1
543
 
Brokerage and execution
 
109
 
553
 
 
662
 
Underwriting and syndication
 
 
1,715
 
 
1,715
 
Other
 
35
 
73
 
3
 
111
 
Total revenue from contracts with customers
 
635
 
3,981
 
4
 
4,620
 
Other non-contract fee income
 
 
62
 
 
62
 
Fee and commission income
 
635
 
4,043
 
4
 
4,682
 
Fee and commission expense1
 
(108)
 
(861)
 
(7)
 
(976)
 
Net fee and commission income
 
527
 
3,182
 
(3)
 
3,706
 
 
1
Barclays has corrected the presentation of the scheme fees incurred when Barclays acts as an “acquirer” as part of the payment transaction cycle. From 2022 onwards, the scheme fees reported under "Barclays International" are presented within fees and commission income under "Transactional" fee type, which had previously been recognised in fees and commission expense. The reclassification into Fee and Commission income is a reduction of £103m for H122. The comparatives have not been restated as the effect is not considered material although the effect would have been a reduction of H121: £88m with no impact on Net fee and commission income. There is no impact on Net assets or Cash flows reported.
 
Transactional fees are service charges on deposit accounts, cash management services and transactional processing fees. These include interchange and merchant fee income generated from credit and bank card usage.
 
Advisory fees are generated from wealth management services and investment banking advisory services related to mergers, acquisitions and financial restructurings.
 
Brokerage and execution fees are earned for executing client transactions with various exchanges and over-the-counter markets and assisting clients in clearing transactions.
 
Underwriting and syndication fees are earned for the distribution of client equity or debt securities and the arrangement and administration of a loan syndication. These include commitment fees to provide loan financing.
 
 
4.
Staff costs
 
 
Half year ended 30.06.22
Half year ended 30.06.21
Compensation costs
£m
£m
Upfront bonus charge
705
824
Deferred bonus charge
280
262
Other incentives
44
6
Performance costs
1,029
1,092
Salaries
2,278
2,117
Social security costs
377
336
Post-retirement benefits
282
275
Other compensation costs
241
223
Total compensation costs
4,207
4,043
 
 
 
Other resourcing costs
 
 
Outsourcing
268
171
Redundancy and restructuring
(15)
23
Temporary staff costs
53
55
Other
70
42
Total other resourcing costs
376
291
 
 
 
Total staff costs
4,583
4,334
 
 
 
Barclays Group compensation costs as a % of total income
31.9%
35.7%
 
No material awards have yet been granted in relation to the 2022 bonus pool as decisions regarding incentive awards are not taken by the Remuneration Committee until the performance for the full year can be assessed. The current year bonus charge for the first six months represents an accrual for estimated costs in accordance with accounting requirements. One of the primary considerations when evaluating the accrual is Group and business level returns, aligning colleague and shareholder interests.
 
The Group has entered into physically settled forward contracts to hedge the settlement of certain share-based payment schemes. The present value of the fixed forward price to be paid under these outstanding contracts is £287m and has been recorded in retained earnings.
 
 
 
 
5.
Infrastructure, administration and general expenses
 
 
Half year ended 30.06.22
Half year ended 30.06.21
Infrastructure costs
£m
£m
Property and equipment
744
 
709
 
Depreciation and amortisation
863
 
832
 
Lease payments
14
 
20
 
Impairment of property, equipment and intangible assets
21
 
304
 
Total infrastructure costs
1,642
 
1,865
 
 
 
 
Administration and general expenses
 
 
Consultancy, legal and professional fees
288
 
262
 
Marketing and advertising
206
 
163
 
Other administration and general expenses
551
 
508
 
Total administration and general expenses
1,045
 
933
 
 
 
 
Total infrastructure, administration and general expenses
2,687
 
2,798
 
 
 
 
6.
Tax
 
 
The tax charge for H122 was £823m (restated1 H121: £742m), representing an effective tax rate (ETR) of 22.0% (restated1 H121: 15.1%). The ETR for H122 includes a charge recognised for the re-measurement of the Group’s UK deferred tax assets (DTAs) due to the enactment of legislation in Q122 which will result in the UK banking surcharge rate being reduced from 8% to 3% effective from 1 April 2023. The ETR excluding the impact of this downward re-measurement of UK DTAs was 12.8%, which includes a 5.8% benefit relating to adjustments in respect of prior years. Included in the H122 tax charge is a credit of £110m (H121: £104m) in respect of payments made on AT1 instruments that are classified as equity for accounting purposes. The H121 ETR included a benefit recognised for the re-measurement of the Group’s UK DTAs as a result of the enactment of legislation to increase the UK corporation tax rate to 25% effective from 1 April 2023.
 
The re-measurement of UK DTAs has resulted in the Group's DTAs decreasing by £318m with a tax charge in the income statement of £346m and a tax credit within other comprehensive income of £28m.
 
In October 2021, the OECD and G20 Inclusive Framework on Base Erosion and Profit Shifting announced plans to introduce a global minimum tax rate of 15%. The model rules were released by the OECD in December 2021 with further guidance published in March 2022. Draft legislation published by the UK government on 20 July 2022 to implement the global minimum tax regime is expected to apply for accounting periods beginning on or after 31 December 2023. The Group is reviewing the published OECD model rules and guidance and will review further guidance as well as new legislation to be released by governments implementing this new tax regime as it is published to assess the potential impact of new legislation.
 
In the USA, the proposed Build Back Better Act was passed by the House of Representatives in 2021 but it was not passed by the Senate and it is uncertain whether various proposals contained in the Act will progress further. The Act included proposals to implement material changes to international tax provisions, including amendments to the Base Erosion and Anti-Abuse Tax and the imposition of an alternative minimum tax based on accounting profits. It is unclear at this time whether any of these proposals could have a significant impact on the Group if enacted. The Group will continue to monitor developments and assess the potential impact of any future legislative changes ultimately enacted.
 
1
2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page 87 for more information.
 
 
As at 30.06.22
 
As at 31.12.21
 
Deferred tax assets and liabilities
 
£m
 
£m
 
UK
 
3,046
 
2,183
 
USA
 
1,530
 
2,006
 
Other territories
 
468
 
430
 
Deferred tax assets
 
5,044
 
4,619
 
Deferred tax liabilities
 
(5)
 
(37)
 
 
 
 
Analysis of deferred tax assets
 
 
 
Temporary differences
 
3,871
 
3,399
 
Tax losses
 
1,173
 
1,220
 
Deferred tax assets
 
5,044
 
4,619
 
 
 
 
 
7.
Non-controlling interests
 
 
Profit attributable to
non-controlling interests
 
Equity attributable to
non-controlling interests
 
Half year ended 30.06.22
 
Half year ended 30.06.21
 
 
As at 30.06.22
 
As at 31.12.21
 
 
£m
£m
 
£m
£m
Barclays Bank PLC issued:
 
 
 
 
 
- Preference shares
15
 
13
 
 
529
 
529
 
- Upper T2 instruments
6
 
3
 
 
438
 
458
 
Other non-controlling interests
 
3
 
 
2
 
2
 
Total
21
 
19
 
 
969
 
989
 
 
 
 
 
8.
Earnings per share
 
 
 
Restated1
 
Half year ended 30.06.22
Half year ended 30.06.21
 
£m
 
£m
 
Profit attributable to ordinary equity holders of the parent
 
2,475
 
3,752
 
 
 
 
 
m
 
m
 
Basic weighted average number of shares in issue
 
16,684
 
17,140
 
Number of potential ordinary shares
 
428
 
467
 
Diluted weighted average number of shares
 
17,112
 
17,607
 
 
 
 
 
p
 
p
 
Basic earnings per ordinary share
 
14.8
 
21.9
 
Diluted earnings per ordinary share
 
14.5
 
21.3
 
 
1
2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page 87 for more information.
 
 
9.
Dividends on ordinary shares
 
 
A half year dividend for 2022 of 2.25p (H121: 2p) per ordinary share will be paid on 16 September 2022 to shareholders on the register on 12 August 2022.
 
 
Half year ended 30.06.22
Half year ended 30.06.21
 
Per share
 
Total
 
Per share
 
Total
 
Dividends paid during the period
 
p
 
£m
 
p
 
£m
 
Full year dividend paid during period
 
4.0
 
664
 
1.0
 
173
 
 
For qualifying American Depositary Receipt (ADR) holders, the half year dividend of 2.25p per ordinary share becomes 9.0p per American Depositary Share (representing 4 shares). The depositary bank will post the half year dividend on 16 September 2022 to ADR holders on the record at close of business on 12 August 2022.
 
The Directors have confirmed their intention to initiate a share buyback of up to £500m after the balance sheet date. The share buyback is expected to commence in the third quarter of 2022. The financial statements for the six months ended 30 June 2022 do not reflect the impact of the proposed share buyback, which will be accounted for as and when shares are repurchased by the Company.
 
10.
Derivative financial instruments
 
 
Contract notional amount
 
Fair value
 
 
 
Assets
 
Liabilities
 
As at 30.06.22
£m
 
 
£m
 
£m
 
Foreign exchange derivatives
 
6,732,093
 
 
135,207
 
(123,662)
 
Interest rate derivatives
 
44,275,712
 
 
130,628
 
(116,541)
 
Credit derivatives
 
1,640,043
 
 
8,128
 
(8,228)
 
Equity and stock index and commodity derivatives
 
2,510,981
 
 
70,066
 
(71,830)
 
Derivative assets/(liabilities) held for trading
 
55,158,829
 
 
344,029
 
(320,261)
 
 
 
 
 
 
Derivatives in hedge accounting relationships
 
 
 
 
 
Derivatives designated as cash flow hedges
 
139,040
 
 
701
 
(21)
 
Derivatives designated as fair value hedges
 
107,809
 
 
106
 
(1,054)
 
Derivatives designated as hedges of net investments
 
4,097
 
 
19
 
(60)
 
Derivative assets/(liabilities) designated in hedge accounting relationships
 
250,946
 
 
826
 
(1,135)
 
 
 
 
 
 
Total recognised derivative assets/(liabilities)
 
55,409,775
 
 
344,855
 
(321,396)
 
 
 
 
 
 
As at 31.12.21
 
 
 
 
Foreign exchange derivatives
 
5,824,856
 
 
76,140
 
(74,437)
 
Interest rate derivatives
 
38,816,432
 
 
125,846
 
(114,803)
 
Credit derivatives
 
1,272,104
 
 
5,682
 
(6,561)
 
Equity and stock index and commodity derivatives
 
1,899,382
 
 
54,010
 
(59,946)
 
Derivative assets/(liabilities) held for trading
 
47,812,774
 
 
261,678
 
(255,747)
 
 
 
 
 
 
Derivatives in hedge accounting relationships
 
 
 
 
 
Derivatives designated as cash flow hedges
 
114,313
 
 
798
 
(3)
 
Derivatives designated as fair value hedges
 
102,815
 
 
59
 
(1,129)
 
Derivatives designated as hedges of net investments
 
2,423
 
 
37
 
(4)
 
Derivative assets/(liabilities) designated in hedge accounting relationships
 
219,551
 
 
894
 
(1,136)
 
 
 
 
 
 
Total recognised derivative assets/(liabilities)
 
48,032,325
 
 
262,572
 
(256,883)
 
 
The IFRS netting posted against derivative assets was £55bn including £12bn of cash collateral netted (December 2021: £24bn including £4bn cash collateral netted) and £55bn for liabilities including £12bn of cash collateral netted (December 2021: £24bn including £4bn of cash collateral netted). Derivative asset exposures would be £306bn (December 2021: £237bn) lower than reported under IFRS if netting were permitted for assets and liabilities with the same counterparty or for which the Group holds cash collateral of £40bn (December 2021: £35bn). Similarly, derivative liabilities would be £293bn (December 2021: £235bn) lower reflecting counterparty netting and cash collateral placed of £26bn (December 2021: £32bn). In addition, non-cash collateral of £13bn (December 2021: £6bn) was held in respect of derivative assets and £3bn (December 2021: £2bn) was placed in respect of derivative liabilities. Collateral amounts are limited to net on balance sheet exposure so as to not include over-collateralisation.
 
 
11.
Fair value of financial instruments
 
 
This section should be read in conjunction with Note 17, Fair value of financial instruments of the Barclays PLC Annual Report 2021 which provides more detail about accounting policies adopted, valuation methodologies used in calculating fair value and the valuation control framework which governs oversight of valuations. There have been no changes in the accounting policies adopted or the valuation methodologies used.
 
Valuation
 
 
The following table shows the Group’s assets and liabilities that are held at fair value disaggregated by valuation technique (fair value hierarchy) and balance sheet classification:
 
 
Valuation technique using
 
 
 
Quoted market prices
 
Observable inputs
 
Significant unobservable inputs
 
 
 
(Level 1)
 
(Level 2)
 
(Level 3)
 
Total
 
As at 30.06.22
 
£m
 
£m
 
£m
 
£m
 
Trading portfolio assets
 
58,419
 
64,329
 
4,256
 
127,004
 
Financial assets at fair value through the income statement
 
1,115
 
202,026
 
9,582
 
212,723
 
Derivative financial instruments
 
11,653
 
329,329
 
3,873
 
344,855
 
Financial assets at fair value through other comprehensive income
 
22,455
 
40,696
 
43
 
63,194
 
Investment property
 
 
 
5
 
5
 
Total assets
 
93,642
 
636,380
 
17,759
 
747,781
 
 
 
 
 
 
Trading portfolio liabilities
 
(47,870)
 
(28,686)
 
(82)
 
(76,638)
 
Financial liabilities designated at fair value
 
(193)
 
(254,496)
 
(447)
 
(255,136)
 
Derivative financial instruments
 
(12,674)
 
(304,343)
 
(4,379)
 
(321,396)
 
Total liabilities
 
(60,737)
 
(587,525)
 
(4,908)
 
(653,170)
 
 
 
 
 
 
As at 31.12.21
 
 
 
 
 
Trading portfolio assets
 
80,926
 
63,828
 
2,281
 
147,035
 
Financial assets at fair value through the income statement
 
5,093
 
177,167
 
9,712
 
191,972
 
Derivative financial instruments
 
6,150
 
252,412
 
4,010
 
262,572
 
Financial assets at fair value through other comprehensive income
 
22,009
 
39,706
 
38
 
61,753
 
Investment property
 
 
 
7
 
7
 
Total assets
 
114,178
 
533,113
 
16,048
 
663,339
 
 
 
 
 
 
Trading portfolio liabilities
 
(27,529)
 
(26,613)
 
(27)
 
(54,169)
 
Financial liabilities designated at fair value
 
(174)
 
(250,376)
 
(410)
 
(250,960)
 
Derivative financial instruments
 
(6,571)
 
(244,253)
 
(6,059)
 
(256,883)
 
Total liabilities
 
(34,274)
 
(521,242)
 
(6,496)
 
(562,012)
 
 
The following table shows the Group’s Level 3 assets and liabilities that are held at fair value disaggregated by product type:
 
 
As at 30.06.22
 
As at 31.12.21
 
 
Assets
 
Liabilities
 
Assets
 
Liabilities
 
 
£m
 
£m
 
£m
 
£m
 
Interest rate derivatives
 
1,573
 
(1,849)
 
1,091
 
(1,351)
 
Foreign exchange derivatives
 
786
 
(560)
 
376
 
(374)
 
Credit derivatives
 
234
 
(615)
 
323
 
(709)
 
Equity derivatives
 
1,280
 
(1,355)
 
2,220
 
(3,625)
 
Corporate debt
 
1,171
 
(13)
 
1,205
 
(21)
 
Reverse repurchase and repurchase agreements
 
178
 
(188)
 
13
 
(172)
 
Non-asset backed loans
 
8,660
 
 
6,405
 
 
Asset backed securities
 
291
 
 
558
 
 
Equity cash products
 
422
 
(3)
 
393
 
 
Private equity investments
 
1,297
 
(8)
 
1,095
 
(6)
 
Other1
 
1,867
 
(317)
 
2,369
 
(238)
 
Total
 
17,759
 
(4,908)
 
16,048
 
(6,496)
 
 
1
Other includes commercial real estate loans, funds and fund-linked products, asset backed loans, issued debt, commercial paper, government sponsored debt and investment property.
 
Assets and liabilities reclassified between Level 1 and Level 2
 
 
During the period, there were no material transfers between Level 1 and Level 2 (period ended 31 December 2021: no material transfers between Level 1 and Level 2).
 
Level 3 movement analysis
 
 
The following table summarises the movements in the balances of Level 3 assets and liabilities during the period. The table shows gains and losses and includes amounts for all financial assets and liabilities that are held at fair value transferred to and from Level 3 during the period. Transfers have been reflected as if they had taken place at the beginning of the period.
 
Asset and liability moves between Level 2 and Level 3 are primarily due to i) an increase or decrease in observable market activity related to an input or ii) a change in the significance of the unobservable input, with assets and liabilities classified as Level 3 if an unobservable input is deemed significant.
 
Level 3 movement analysis
 
 
 
 
 
 
 
Total gains and (losses) in the period recognised in the income statement
 
Total gains or (losses) recognised in OCI
 
Transfers
 
 
 
As at 01.01.22
 
Purchases
 
Sales
 
Issues
 
Settle-ments
 
Trading income
 
Other income
 
In
 
Out
 
As at 30.06.22
 
 
£m
 
£m
 
£m
 
£m
 
£m
 
£m
 
£m
 
£m
 
£m
 
£m
 
£m
 
Corporate debt
389
90
(144)
(17)
54
43
(11)
404
Non-asset backed loans
758
2,448
(459)
11
50
(113)
2,695
Asset backed securities
454
72
(80)
(297)
(20)
100
(66)
163
Equity cash products
303
21
(56)
24
52
(17)
327
Other
377
326
(42)
(5)
56
39
(84)
667
Trading portfolio assets
2,281
2,957
(781)
(319)
125
284
(291)
4,256
 
 
 
 
 
 
 
 
 
 
 
 
Non-asset backed loans
5,647
1,847
(757)
(484)
(334)
52
(9)
5,962
Equity cash products
90
3
2
95
Private equity investments
1,095
99
(16)
(1)
84
(26)
59
(4)
1,290
Other
2,880
4,817
(5,579)
(156)
11
182
99
(19)
2,235
Financial assets at fair value through the income statement
9,712
6,763
(6,352)
(641)
(236)
158
210
(32)
9,582
 
 
 
 
 
 
 
 
 
 
 
 
Private equity investments
1
6
7
Asset backed securities
38
(2)
36
Assets at fair value through other comprehensive income
38
(1)
6
43
 
 
 
 
 
 
 
 
 
 
 
 
Investment property
7
(1)
(1)
5
 
 
 
 
 
 
 
 
 
 
 
 
Trading portfolio liabilities
(27)
(35)
3
(29)
6
(82)
 
 
 
 
 
 
 
 
 
 
 
 
Financial liabilities designated at fair value
(410)
(5)
(13)
47
(22)
(81)
37
(447)
 
 
 
 
 
 
 
 
 
 
 
 
Interest rate derivatives
(260)
25
(4)
(305)
(9)
271
6
(276)
Foreign exchange derivatives
2
(9)
273
(65)
25
226
Credit derivatives
(386)
(36)
5
60
(99)
20
55
(381)
Equity derivatives
(1,405)
(83)
171
980
(1)
(9)
272
(75)
Net derivative financial instruments1
(2,049)
(94)
5
218
849
(10)
217
358
(506)
 
 
 
 
 
 
 
 
 
 
 
 
Total
9,552
9,586
(7,126)
(13)
(695)
687
147
(1)
636
78
12,851
 
1
Derivative financial instruments are represented on a net basis. On a gross basis, derivative financial assets were £3,873m and derivative financial liabilities were £4,379m.
 
Level 3 movement analysis
 
 
As at 01.01.21
 
Purchases
 
Sales
 
Issues
 
Settle-
ments
 
Total gains and (losses) in the period recognised in the income statement
 
Total gains or (losses) recognised in OCI
 
Transfers
 
As at 30.06.21
 
 
Trading income
 
Other income
 
In
 
Out
 
 
£m
 
£m
 
£m
 
£m
 
£m
 
£m
 
£m
 
£m
 
£m
 
£m
 
£m
 
Corporate debt
151
 
305
 
(87)
 
 
 
25
 
 
 
40
 
(11)
 
423
 
Non-asset backed loans
709
 
620
 
(131)
 
 
(84)
 
13
 
 
 
124
 
(106)
 
1,145
 
Asset backed securities
686
 
112
 
(294)
 
 
 
(10)
 
 
 
43
 
(48)
 
489
 
Equity cash products
214
 
13
 
(17)
 
 
 
32
 
 
 
29
 
(9)
 
262
 
Other
103
 
21
 
 
 
(51)
 
(1)
 
 
 
162
 
(1)
 
233
 
Trading portfolio assets
1,863
 
1,071
 
(529)
 
 
(135)
 
59
 
 
 
398
 
(175)
 
2,552
 
 
 
 
 
 
 
 
 
 
 
 
 
Non-asset backed loans
5,580
 
698
 
(299)
 
 
(687)
 
(119)
 
 
 
69
 
(48)
 
5,194
 
Equity cash products
326
 
160
 
(194)
 
 
 
(171)
 
18
 
 
1
 
 
140
 
Private equity investments
874
 
106
 
(9)
 
 
(8)
 
(5)
 
92
 
 
 
(71)
 
979
 
Other
1,726
 
2,291
 
(2,389)
 
 
(162)
 
(19)
 
1
 
 
16
 
 
1,464
 
Financial assets at fair value through the income statement
8,506
3,255
(2,891)
(857)
(314)
111
86
(119)
7,777
 
 
 
 
 
 
 
 
 
 
 
 
Non-asset backed loans
106
 
 
 
 
 
 
 
 
 
(106)
 
 
Asset backed securities
47
 
4
 
 
 
(5)
 
 
 
2
 
 
 
48
 
Assets at fair value through other comprehensive income
153
4
(5)
2
(106)
48
 
 
 
 
 
 
 
 
 
 
 
 
Investment property
10
 
 
(2)
 
 
 
 
 
 
 
 
8
 
 
 
 
 
 
 
 
 
 
 
 
 
Trading portfolio liabilities
(28)
 
(3)
 
14
 
 
 
(7)
 
 
 
 
7
 
(17)
 
 
 
 
 
 
 
 
 
 
 
 
 
Financial liabilities designated at fair value
(355)
98
7
(2)
(78)
18
(312)
 
 
 
 
 
 
 
 
 
 
 
 
Interest rate derivatives
(2)
 
9
 
 
 
33
 
(121)
 
4
 
 
21
 
(297)
 
(353)
 
Foreign exchange derivatives
1
 
 
 
 
58
 
(6)
 
 
 
3
 
(34)
 
22
 
Credit derivatives
(155)
 
(117)
 
2
 
 
(5)
 
12
 
(1)
 
 
1
 
(1)
 
(264)
 
Equity derivatives
(1,614)
 
(315)
 
(1)
 
 
(32)
 
(221)
 
(1)
 
 
28
 
808
 
(1,348)
 
Net derivative financial instruments1
(1,770)
(423)
1
54
(336)
2
53
476
(1,943)
 
 
 
 
 
 
 
 
 
 
 
 
Total
8,379
 
3,904
 
(3,407)
 
 
(845)
 
(591)
 
111
 
2
 
459
 
101
 
8,113
 
 
1
Derivative financial instruments are represented on a net basis. On a gross basis, derivative financial assets were £3,657m and derivative financial liabilities were £5,600m.
 
Unrealised gains and losses on Level 3 financial assets and liabilities
 
 
The following table discloses the unrealised gains and losses recognised in the period arising on Level 3 financial assets and liabilities held at the period end.
 
 
Half year ended 30.06.22
 
Half year ended 30.06.21
 
 
Income statement
 
Other compre hensive income
 
Total
 
Income statement
 
Other compre hensive income
 
Total
 
 
Trading income
 
Other income
 
Trading income
 
Other income
 
 
£m
 
£m
 
£m
 
£m
 
£m
 
£m
 
£m
 
£m
 
Trading portfolio assets
 
121
 
 
 
121
 
35
 
 
 
35
 
Financial assets at fair value through the income statement
 
(165)
 
(22)
 
 
(187)
 
(201)
 
114
 
 
(87)
 
Financial assets at fair value through other comprehensive income
 
 
 
(1)
 
(1)
 
 
 
 
 
Investment properties
 
 
(1)
 
 
(1)
 
 
 
 
 
Trading portfolio liabilities
 
(35)
 
 
 
(35)
 
(6)
 
 
 
(6)
 
Financial liabilities designated at fair value
 
(14)
 
 
 
(14)
 
7
 
 
 
7
 
Net derivative financial instruments
 
862
 
(1)
 
 
861
 
(367)
 
 
 
(367)
 
Total
 
769
 
(24)
 
(1)
 
744
 
(532)
 
114
 
 
(418)
 
 
Valuation techniques and sensitivity analysis
 
 
Sensitivity analysis is performed on products with significant unobservable inputs (Level 3) to generate a range of reasonably possible alternative valuations. The sensitivity methodologies applied take account of the nature of valuation techniques used, as well as the availability and reliability of observable proxy and historical data and the impact of using alternative models.
 
Current year valuation and sensitivity methodologies are consistent with those described within Note 17, Fair value of financial instruments in the Barclays PLC Annual Report 2021.
 
Sensitivity analysis of valuations using unobservable inputs
 
 
 
 
 
 
 
 
 
 
 
As at 30.06.22
 
As at 31.12.21
 
 
Favourable changes
 
Unfavourable changes
 
Favourable changes
 
Unfavourable changes
 
 
Income statement
 
Equity
 
Income statement
 
Equity
 
Income statement
 
Equity
 
Income statement
 
Equity
 
 
£m
 
£m
 
£m
 
£m
 
£m
 
£m
 
£m
 
£m
 
Interest rate derivatives
75
 
 
(108)
 
 
51
 
 
(79)
 
 
Foreign exchange derivatives
15
 
 
(22)
 
 
20
 
 
(28)
 
 
Credit derivatives
111
 
 
(115)
 
 
111
 
 
(103)
 
 
Equity derivatives
107
 
 
(112)
 
 
187
 
 
(195)
 
 
Corporate debt
36
 
 
(35)
 
 
38
 
 
(28)
 
 
Non-asset backed loans
298
 
 
(334)
 
 
165
 
 
(256)
 
 
Equity cash products
73
 
 
(129)
 
 
42
 
 
(61)
 
 
Private equity investments
272
 
1
 
(286)
 
(1)
 
246
 
 
(236)
 
 
Other1
27
 
 
(36)
 
 
20
 
 
(19)
 
 
Total
1,014
 
1
 
(1,177)
 
(1)
 
880
 
 
(1,005)
 
 
 
1
Other includes commercial real estate loans, funds and fund-linked products, asset backed loans, issued debt, commercial paper, government sponsored debt and investment property.
 
The effect of stressing unobservable inputs to a range of reasonably possible alternatives, alongside considering the impact of using alternative models, would be to increase fair values by up to £1,015m (December 2021: £880m) or to decrease fair values by up to £1,178m (December 2021: £1,005m) with substantially all the potential effect impacting profit and loss rather than reserves.
 
Significant unobservable inputs
 
 
The valuation techniques and significant unobservable inputs for assets and liabilities recognised at fair value and classified as Level 3 are consistent with Note 17, Fair value of financial instruments in the Barclays PLC Annual Report 2021.
 
Fair value adjustments
 
 
Key balance sheet valuation adjustments are quantified below:
 
 
As at 30.06.22
 
As at 31.12.21
 
 
£m
 
£m
 
Exit price adjustments derived from market bid-offer spreads
 
(539)
 
(506)
 
Uncollateralised derivative funding
 
(82)
 
(127)
 
Derivative credit valuation adjustments
 
(388)
 
(212)
 
Derivative debit valuation adjustments
 
208
 
91
 
 
Exit price adjustments derived from market bid-offer spreads increased by £33m to £539m as a result of movements in market bid offer spreads.
Uncollateralised derivative funding decreased by £45m to £82m as a result of reduction in uncollateralised funding exposure due to increases in interest rates which offset impact of wider funding spreads.
Derivative credit valuation adjustments increased by £176m to £388m as a result of widening input counterparty credit spreads
Derivative debit valuation adjustments increased by £117m to £208m as a result of widening input own credit spreads
 
Portfolio exemption
 
 
The Group uses the portfolio exemption in IFRS 13, Fair Value Measurement to measure the fair value of groups of financial assets and liabilities. Instruments are measured using the price that would be received to sell a net long position (i.e. an asset) for a particular risk exposure or to transfer a net short position (i.e. a liability) for a particular risk exposure in an orderly transaction between market participants at the balance sheet date under current market conditions. Accordingly, the Group measures the fair value of the group of financial assets and liabilities consistently with how market participants would price the net risk exposure at the measurement date.
 
Unrecognised gains as a result of the use of valuation models using unobservable inputs
 
 
The amount that has yet to be recognised in income that relates to the difference between the transaction price (the fair value at initial recognition) and the amount that would have arisen had valuation models using unobservable inputs been used on initial recognition, less amounts subsequently recognised, is £117m (December 2021: £133m) for financial instruments measured at fair value and £221m (December 2021: £230m) for financial instruments carried at amortised cost. There are additions and FX gains of £19m (December 2021: £59m) and amortisation and releases of £35m (December 2021: £42m) for financial instruments measured at fair value and additions of £nil (December 2021: £nil) and amortisation and releases of £9m (December 2021: £17m) for financial instruments carried at amortised cost.
 
Third party credit enhancements
 
 
Structured and brokered certificates of deposit issued by the Group are insured up to $250,000 per depositor by the Federal Deposit Insurance Corporation (FDIC) in the United States. The FDIC is funded by premiums that Barclays and other banks pay for deposit insurance coverage. The carrying value of these issued certificates of deposit that are designated under the IFRS 9 fair value option includes this third party credit enhancement. The on balance sheet value of these brokered certificates of deposit amounted to £3,065m (December 2021: £790m).
 
 
 
 
Comparison of carrying amounts and fair values for assets and liabilities not held at fair value
 
 
Valuation methodologies employed in calculating the fair value of financial assets and liabilities measured at amortised cost are consistent with those described within Note 17, Fair value of financial instruments in the Barclays PLC Annual Report 2021.
 
The following table summarises the fair value of financial assets and liabilities measured at amortised cost on the Group’s balance sheet.
 
 
As at 30.06.22
 
As at 31.12.21
 
 
Carrying amount
 
Fair value
 
Carrying amount
 
Fair value
 
Financial assets
£m
£m
£m
£m
Loans and advances at amortised cost
395,824
 
396,475
 
361,451
 
362,424
 
Reverse repurchase agreements and other similar secured lending
1,639
 
1,639
 
3,227
 
3,227
 
 
 
 
 
 
Financial liabilities
 
 
 
 
Deposits at amortised cost
(568,670)
 
(568,715)
 
(519,433)
 
(519,436)
 
Repurchase agreements and other similar secured borrowing
(28,566)
 
(28,569)
 
(28,352)
 
(28,358)
 
Debt securities in issue
(115,906)
 
(115,777)
 
(98,867)
 
(100,657)
 
Subordinated liabilities
(11,871)
 
(11,799)
 
(12,759)
 
(13,334)
 
 
 
 
 
12.
Loans and advances and deposits at amortised cost
 
 
As at 30.06.22
 
As at 31.12.21
 
 
£m
 
£m
 
Loans and advances at amortised cost to banks
12,532
9,698
Loans and advances at amortised cost to customers
337,220
319,922
Debt securities at amortised cost
46,072
31,831
Total loans and advances at amortised cost
395,824
361,451
 
 
 
Deposits at amortised cost from banks
29,891
17,819
Deposits at amortised cost from customers
538,779
501,614
Total deposits at amortised cost
568,670
519,433
 
 
 
 
13.
Goodwill and intangible assets
 
 
Goodwill and intangible assets are allocated to business operations according to business segments as follows:
 
 
As at 30.06.22
 
As at 31.12.21
 
 
Goodwill
 
Intangibles
 
Total
 
Goodwill
 
Intangibles
 
Total
 
 
£m
 
£m
 
£m
 
£m
 
£m
 
£m
 
Barclays UK
 
3,560
 
1,247
 
4,807
 
3,560
 
1,233
 
4,793
 
Barclays International
 
308
3,079
3,387
291
2,930
3,221
Head Office
 
44
7
51
42
5
47
Total
 
3,912
4,333
8,245
3,893
4,168
8,061
 
The Group performed an impairment review to assess the recoverability of its goodwill and intangible asset balances as at 31 December 2021. The outcome of this review is disclosed on pages 382-385 of the Barclays PLC Annual Report 2021. No impairment was recognised as a result of the review as value in use exceeded carrying amount. A review of the Group's goodwill and intangible assets as at 30 June 2022 did not identify the presence of impairment.
 
 
 
 
14.
Subordinated liabilities
 
 
Half year ended 30.06.22
 
Year ended 31.12.21
 
 
£m
 
£m
 
Opening balance as at 1 January
12,759
16,341
Issuances
259
1,890
Redemptions
(1,180)
(4,807)
Other
33
(665)
Closing balance
11,871
12,759
 
Issuances of £259m comprise £128m USD Floating Rate Notes, £89m ZAR Floating Rate Notes and £42m EUR Floating Rate Notes issued externally by Barclays subsidiaries.
 
 
Redemptions of £1,180m comprise £1,039m notes issued externally by Barclays Bank PLC, £74m USD Floating Rate Notes issued externally by a Barclays subsidiary and £67m GBP Undated Subordinated Loan Notes (secured) issued externally by a Barclays securitisation special purpose vehicle (SPV). £1,039m notes issued externally by Barclays Bank PLC comprise £838m EUR 6.625% Fixed Rate Subordinated Notes, £147m USD 6.86% Callable Perpetual Core Tier One Notes, £42m EUR Subordinated Floating Rate Notes and £12m GBP 6% Callable Perpetual Core Tier One Notes.
 
 
Other movements predominantly comprise foreign exchange movements and fair value hedge adjustments.
 
 
 
 
 
15.
Provisions
 
 
 
Restated1
 
 
As at 30.06.22
 
As at 31.12.21
 
 
£m
 
£m
 
Customer redress
 
1,985
530
Legal, competition and regulatory matters
 
418
226
Redundancy and restructuring
 
216
326
Undrawn contractually committed facilities and guarantees
 
526
542
Onerous contracts
 
5
Sundry provisions
 
281
279
Total
 
3,426
1,908
 
1
2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page 87 for more information.
 
Over-issuance of securities
 
As at 30 June 2022, Barclays PLC has recognised a balance sheet provision of £1,757m (December 2021: £220m) in relation to the Over-issuance of Securities (see Basis of preparation on page 87 for more information), out of which £1,592m (December 2021: £220m) is due to the over-issuance of structured notes (within Customer redress) and £165m (December 2021: nil) relates to liabilities that could be incurred arising out of ongoing discussions in respect of a potential SEC resolution (within Legal, competition and regulatory matters).
 
The amount of the provision in relation to the rescission rights of investors in over-issued structured notes is determined by (among other things) the market value of the structured notes subject to the Rescission Offer, participation rates in such Rescission Offer, prevailing interest rates, and movements in foreign exchange rates. The majority of the structured notes subject to the Rescission Offer provide an equity linked return to investors. As such, the value of these notes is highly sensitive to movements in the price of individual securities and a range of indices.
 
The increase in the provision of £1,372m predominantly reflects a reduction in the market value of the structured notes and additional accrued interest that would be payable to investors on rescission. The US equity markets have been volatile during the first half of 2022, with significant reductions in the value of US equity indices such as the S&P 500 from the year end 2021 levels, which has led to a reduction in the market value of the structured notes, and increased the size of the provision. The provision does not include the impact of market hedges that have been entered into subsequent to the year-end and were initiated from the end of the first quarter of 2022 to reduce the net volatility to the income statement. When determining these market hedges, consideration was given to changes in the rescission costs which would arise from volatility in the market along with the positioning of the Markets business.
 
The structured notes also accrue interest on a monthly basis (at current prevailing interest rates and participation rate assumptions this is c£34m a month) until the Rescission Price has been paid. The provision also assumes that not all structured note investors whose securities are out of the money will accept the Rescission Offer. If all investors were to accept the Rescission Offer, the provision would increase by c£60m.
 
The remaining increase in the provision of £165m results from Barclays PLC’s estimate of the potential SEC resolution.
 
 
 
 
16.
Retirement benefits
 
 
As at 30 June 2022, the Group’s IAS 19 net pension surplus across all schemes was £4.9bn (December 2021: £3.6bn). The UK Retirement Fund (UKRF), which is the Group’s main scheme, had an IAS 19 net pension surplus of £5.2bn (December 2021: £3.8bn). The movement for the UKRF was driven by an overall increase in AA corporate bond yields (used for discounting future liabilities), a reduction in long-term expected price inflation assumption and the payment of deficit reduction contributions. These movements were partially offset by the fall in the value of UKRF's assets and the impact of high recent inflation on the liabilities.
 
UKRF funding valuations
 
The latest annual update as at 30 September 2021 showed the funding position had improved to a surplus of £0.6bn from a deficit of £0.9bn shown at 30 September 2020. The improvement was mainly due to £0.7bn of deficit reduction contributions and favourable asset returns, partially offset by higher expected long term price inflation. The deficit recovery plan agreed at the last triennial valuation requires deficit reduction contributions from Barclays Bank PLC of £294m in 2022 and £286m in 2023. The deficit reduction contributions are in addition to the regular contributions to meet the Group’s share of the cost of benefits accruing over each year. £147m of the 2022 deficit reduction contributions were paid in April, with the remaining £147m due in September. The next triennial actuarial valuation of the UKRF is due to be completed in 2023 with an effective date of 30 September 2022.
 
During 2019 and 2020, the UKRF, the Group’s main pension scheme, subscribed for non-transferable listed senior fixed rate notes for £1.25bn issued by entities consolidated within the Group under IFRS 10. As a result of these transactions, the CET1 impact of the 2019 and 2020 deficit contributions was deferred until 2023, 2024 and 2025 upon maturity of the notes. Following the PRA’s statement on 13 April 2022, Barclays is planning to unwind these transactions and to agree the terms and timing of this unwind with the UKRF Trustee as part of the next triennial actuarial valuation as at 30 September 2022. Upon unwind, this would result in a c.30bps reduction to the CET1 ratio potentially being accelerated to Q4 2022 from 2023, 2024 and 2025.
 
 
 
 
17.
Called up share capital
 
 
Ordinary share capital
 
Share premium
 
Total share capital and share premium
 
Half year ended 30.06.22
 
£m
 
£m
 
£m
 
Opening balance as at 1 January
 
4,188
 
348
 
4,536
 
Issue of shares under employee share schemes
 
6
 
27
 
33
 
Repurchase of shares
 
(61)
 
 
(61)
 
Closing balance
 
4,133
 
375
 
4,508
 
 
Called up share capital comprises 16,531m (December 2021: 16,752m) ordinary shares of 25p each. The decrease is mainly due to the repurchase of 244m shares as part of the £1.0bn share buyback announced in the FY21 results, partially offset by an increase due to the issuance of shares under employee share schemes.
 
 
 
 
18.
Other equity instruments
 
 
Half year ended 30.06.22
 
Year ended 31.12.21
 
 
£m
 
£m
 
Opening balance as at 1 January
 
12,259
 
11,172
 
Issuances
 
1,247
 
1,078
 
Redemptions
 
(1,132)
 
 
Securities held by the Group
 
(17)
 
9
 
Closing balance
 
12,357
 
12,259
 
 
Other equity instruments of £12,357m (December 2021: £12,259m) comprise AT1 securities issued by Barclays PLC. There was one issuance and one redemption in the six months to 30 June 2022.
 
The AT1 securities are perpetual securities with no fixed maturity and are structured to qualify as AT1 instruments under prevailing capital rules applicable as at the relevant issue date. AT1 securities are undated and are redeemable, at the option of Barclays PLC, in whole on (i) the initial call date, or on any fifth anniversary after the initial call date or (ii) any day falling in a named period ending on the initial reset date, or on any fifth anniversary after the initial reset date. In addition, the AT1 securities are redeemable, at the option of Barclays PLC, in whole in the event of certain changes in the tax or regulatory treatment of the securities. Any redemptions require the prior consent of the PRA.
 
All Barclays PLC AT1 securities will be converted into ordinary shares of Barclays PLC, at a pre-determined price, should the fully loaded CET1 ratio of the Group fall below 7%.
 
 
 
 
19.
Other reserves
 
 
As at 30.06.22
As at 31.12.21
 
£m
£m
Currency translation reserve
 
4,443
2,740
Fair value through other comprehensive income reserve
 
(1,081)
(283)
Cash flow hedging reserve
 
(4,671)
(853)
Own credit reserve
 
(103)
(960)
Other reserves and treasury shares
1,194
1,126
Total
 
(218)
1,770
 
Currency translation reserve
 
The currency translation reserve represents the cumulative gains and losses on the retranslation of the Group’s net investment in foreign operations, net of the effects of hedging.
 
As at 30 June 2022, there was a credit balance of £4,443m (December 2021: £2,740m credit) in the currency translation reserve. The £1,703m credit movement principally reflects the weakening of GBP against USD during the period.
 
Fair value through other comprehensive income reserve
 
The fair value through other comprehensive income reserve represents the changes in the fair value of fair value through other comprehensive income investments since initial recognition.
 
As at 30 June 2022, there was a debit balance of £1,081m (December 2021: £283m debit) in the fair value through other comprehensive income reserve. The loss of £798m is principally driven by a loss of £1,237m from the decrease in fair value of bonds due to increasing bond yields, £5m of net gains transferred to the income statement and £39m of gains transferred to retained earnings on sale of 7.45% equity stake in Absa Group Limited. This is partially offset by a gain of £153m due to an increase in the Absa Group Limited share price and a tax credit of £326m.
 
Cash flow hedging reserve
 
The cash flow hedging reserve represents the cumulative gains and losses on effective cash flow hedging instruments that will be recycled to the income statement when the hedged transactions affect profit or loss.
 
As at 30 June 2022, there was a debit balance of £4,671m (December 2021: £853m debit) in the cash flow hedging reserve. The decrease of £3,818m principally reflects a £4,747m decrease in the fair value of interest rate swaps held for hedging purposes as major interest rate forward curves increased and £429m of gains transferred to the income statement. This is partially offset by a tax credit of £1,358m.
 
Own credit reserve
 
The own credit reserve reflects the cumulative own credit gains and losses on financial liabilities at fair value. Amounts in the own credit reserve are not recycled to profit or loss in future periods.
 
As at 30 June 2022, there was a debit balance of £103m (December 2021: £960m debit) in the own credit reserve. The movement of £857m principally reflects a £1,258m gain from the widening of Barclays’ funding spreads partially offset by a tax charge of £403m.
 
Other reserves and treasury shares
 
Other reserves relate to redeemed ordinary and preference shares issued by the Group. Treasury shares relate to Barclays PLC shares held principally in relation to the Group’s various share schemes.
 
As at 30 June 2022, there was a credit balance of £1,194m (December 2021: £1,126m credit) in other reserves and treasury shares. This is driven by an increase of £61m due to the repurchase of 244m shares as part of the £1.0bn share buyback and a £7m increase in the treasury shares balance held in relation to employee share schemes.
 
 
 
 
20.
Contingent liabilities and commitments
 
 
As at 30.06.22
As at 31.12.21
Contingent liabilities and financial guarantees
£m
 
£m
 
Guarantees and letters of credit pledged as collateral security
 
16,463
 
15,549
 
Performance guarantees, acceptances and endorsements
 
5,877
 
5,797
 
Total
 
22,340
 
21,346
 
 
 
 
Commitments
 
 
 
Documentary credits and other short-term trade related transactions
 
1,888
 
1,584
 
Standby facilities, credit lines and other commitments
 
396,038
 
344,127
 
Total
 
397,926
 
345,711
 
 
Further details on contingent liabilities, where it is not practicable to disclose an estimate of the potential financial effect on Barclays relating to legal and competition and regulatory matters can be found in Note 21.
 
 
 
 
21.
Legal, competition and regulatory matters
 
 
The Group faces legal, competition and regulatory challenges, many of which are beyond our control. The extent of the impact of these matters cannot always be predicted but may materially impact our operations, financial results, condition and prospects. Matters arising from a set of similar circumstances can give rise to either a contingent liability or a provision, or both, depending on the relevant facts and circumstances.
 
The recognition of provisions in relation to such matters involves critical accounting estimates and judgments in accordance with the relevant accounting policies applicable to Note 15, Provisions. We have not disclosed an estimate of the potential financial impact or effect on the Group of contingent liabilities where it is not currently practicable to do so. Various matters detailed in this note seek damages of an unspecified amount. While certain matters specify the damages claimed, such claimed amounts do not necessarily reflect the Group’s potential financial exposure in respect of those matters.
 
Matters are ordered under headings corresponding to the financial statements in which they are disclosed.
 
1. Barclays PLC and Barclays Bank PLC
 
Investigations into certain advisory services agreements
 
 
FCA proceedings
 
In 2008, Barclays Bank PLC and Qatar Holdings LLC entered into two advisory service agreements (the Agreements). The Financial Conduct Authority (FCA) conducted an investigation into whether the Agreements may have related to Barclays PLC’s capital raisings in June and November 2008 (the Capital Raisings) and therefore should have been disclosed in the announcements or public documents relating to the Capital Raisings. In 2013, the FCA issued warning notices (the Notices) finding that Barclays PLC and Barclays Bank PLC acted recklessly and in breach of certain disclosure-related listing rules, and that Barclays PLC was also in breach of Listing Principle 3. The financial penalty provided in the Notices is £50m. Barclays PLC and Barclays Bank PLC continue to contest the findings. Following the conclusion of the Serious Fraud Office (SFO) proceedings against certain former Barclays executives resulting in their acquittals, the FCA proceedings, which were stayed, have resumed. A hearing took place before the Regulatory Decisions Committee in the first quarter of 2022 and a decision is expected in the second half of 2022.
 
Investigations into LIBOR and other benchmarks and related civil actions
 
 
Regulators and law enforcement agencies, including certain competition authorities, from a number of governments have conducted investigations relating to Barclays Bank PLC’s involvement in allegedly manipulating certain financial benchmarks, such as LIBOR. Various individuals and corporates in a range of jurisdictions have threatened or brought civil actions against the Group and other banks in relation to the alleged manipulation of LIBOR and/or other benchmarks.
 
USD LIBOR civil actions
 
The majority of the USD LIBOR cases, which have been filed in various US jurisdictions, have been consolidated for pre-trial purposes in the US District Court in the Southern District of New York (SDNY). The complaints are substantially similar and allege, among other things, that Barclays PLC, Barclays Bank PLC, Barclays Capital Inc. (BCI) and other financial institutions individually and collectively violated provisions of the US Sherman Antitrust Act (Antitrust Act), the US Commodity Exchange Act (CEA), the US Racketeer Influenced and Corrupt Organizations Act (RICO), the Securities Exchange Act of 1934 and various state laws by manipulating USD LIBOR rates.
 
Putative class actions and individual actions seek unspecified damages with the exception of one lawsuit, in which the plaintiffs are seeking no less than $100m in actual damages and additional punitive damages against all defendants, including Barclays Bank PLC. Some of the lawsuits also seek trebling of damages under the Antitrust Act and RICO. Barclays Bank PLC has previously settled certain claims. Two class action settlements, where Barclays Bank PLC has respectively paid $7.1m and $20m, have received final court approval. Barclays Bank PLC also settled two further matters for $7.5m, and $1.95m respectively.
 
Sterling LIBOR civil actions
 
In 2016, two putative class actions filed in the SDNY against Barclays Bank PLC, BCI and other Sterling LIBOR panel banks alleging, among other things, that the defendants manipulated the Sterling LIBOR rate in violation of the Antitrust Act, CEA and RICO, were consolidated. The defendants’ motion to dismiss the claims was granted in 2018. The plaintiffs have appealed the dismissal.
 
Japanese Yen LIBOR civil actions
 
In 2012, a putative class action was filed in the SDNY against Barclays Bank PLC and other Japanese Yen LIBOR panel banks by a lead plaintiff involved in exchange-traded derivatives and members of the Japanese Bankers Association’s Euroyen Tokyo Interbank Offered Rate (Euroyen TIBOR) panel. The complaint alleges, among other things, manipulation of the Euroyen TIBOR and Yen LIBOR rates and breaches of the CEA and the Antitrust Act. In 2014, the court dismissed the plaintiff’s antitrust claims, and, in 2020, the court dismissed the plaintiff’s remaining CEA claims. The plaintiff has appealed the lower court’s dismissal of such claims.
 
In 2015, a second putative class action, making similar allegations to the above class action, was filed in the SDNY against Barclays PLC, Barclays Bank PLC and BCI. Barclays and the plaintiffs have reached a settlement of $17.75m for both actions, which is subject to court approval.
 
SIBOR/SOR civil action
 
In 2016, a putative class action was filed in the SDNY against Barclays PLC, Barclays Bank PLC, BCI and other defendants, alleging manipulation of the Singapore Interbank Offered Rate (SIBOR) and Singapore Swap Offer Rate (SOR). The plaintiffs and remaining defendants (which includes Barclays Bank PLC) have reached a joint settlement to resolve this matter for $91m, which has received preliminary court approval. A final court approval hearing has been scheduled for November 2022. The financial impact of Barclays’ share of the joint settlement is not expected to be material to the Group’s operating results, cash flows or financial position.
 
ICE LIBOR civil actions
 
In 2019, several putative class actions were filed in the SDNY against a panel of banks, including Barclays PLC, Barclays Bank PLC, BCI, other financial institution defendants and Intercontinental Exchange Inc. and certain of its affiliates (ICE), asserting antitrust claims that defendants manipulated USD LIBOR through defendants’ submissions to ICE. These actions have been consolidated. The defendants’ motion to dismiss was granted in 2020 and the plaintiffs appealed. In February 2022, the dismissal was affirmed on appeal. The plaintiffs have not sought U.S. Supreme Court review. This matter is now concluded.
 
In August 2020, an ICE LIBOR-related action was filed by a group of individual plaintiffs in the US District Court for the Northern District of California on behalf of individual borrowers and consumers of loans and credit cards with variable interest rates linked to USD ICE LIBOR. The plaintiffs' motion seeking, among other things, preliminary and permanent injunctions to enjoin the defendants from continuing to set LIBOR or enforce any financial instrument that relies in whole or in part on USD LIBOR was denied. The defendants have moved to dismiss the case.
 
Non-US benchmarks civil actions
 
There remains one claim, issued in 2017, against Barclays Bank PLC and other banks in the UK in connection with alleged manipulation of LIBOR. Proceedings have also been brought in a number of other jurisdictions in Europe, Argentina and Israel relating to alleged manipulation of LIBOR and EURIBOR. Additional proceedings in other jurisdictions may be brought in the future.
 
Credit Default Swap civil action
 
 
A putative antitrust class action is pending in New Mexico federal court against Barclays Bank PLC, BCI and various other financial institutions. The plaintiffs, the New Mexico State Investment Council and certain New Mexico pension funds, allege that the defendants conspired to manipulate the benchmark price used to value Credit Default Swap (CDS) contracts at settlement (i.e. the CDS final auction price). The plaintiffs allege violations of US antitrust laws and the CEA, and unjust enrichment under state law. The defendants have moved to dismiss the case.
 
Foreign Exchange investigations and related civil actions
 
 
In 2015, the Group reached settlements totalling approximately $2.38bn with various US federal and state authorities and the FCA in relation to investigations into certain sales and trading practices in the Foreign Exchange market.
 
The European Commission announced two settlements in May 2019 and the Group paid penalties totalling approximately €210m. In June 2019, the Swiss Competition Commission announced two settlements and the Group paid penalties totalling approximately CHF27m. In December 2021, the European Commission announced a final settlement which required the Group to pay penalties totalling approximately €54m, which amount has been provided for in previous periods. The financial impact of any ongoing investigations is not expected to be material to the Group’s operating results, cash flows or financial position.
 
Various individuals and corporates in a range of jurisdictions have threatened or brought civil actions against the Group and other banks in relation to alleged manipulation of Foreign Exchange markets.
 
FX opt out civil action
 
In 2018, Barclays Bank PLC and BCI settled a consolidated action filed in the SDNY, alleging manipulation of Foreign Exchange markets (Consolidated FX Action), for a total amount of $384m. Also in 2018, a group of plaintiffs who opted out of the Consolidated FX Action filed a complaint in the SDNY against Barclays PLC, Barclays Bank PLC, BCI and other defendants. Some of the plaintiffs' claims were dismissed in 2020.
 
Retail basis civil action
 
In 2015, a putative class action was filed against several international banks, including Barclays PLC and BCI, on behalf of a proposed class of individuals who exchanged currencies on a retail basis at bank branches (Retail Basis Claims). The SDNY has ruled that the Retail Basis Claims are not covered by the settlement agreement in the Consolidated FX Action. The Court subsequently dismissed all Retail Basis Claims against the Group and all other defendants. The plaintiffs have filed an amended complaint.
 
Non-US FX civil actions
 
Legal proceedings have been brought or are threatened against Barclays PLC, Barclays Bank PLC, BCI and Barclays Execution Services Limited (BX) in connection with alleged manipulation of Foreign Exchange in the UK, a number of other jurisdictions in Europe, Israel, Brazil and Australia. Additional proceedings may be brought in the future.
 
The above-mentioned proceedings include two purported class actions filed against Barclays PLC, Barclays Bank PLC, BX, BCI and other financial institutions in the UK Competition Appeal Tribunal (CAT) in 2019 following the settlements with the European Commission described above. The CAT refused to certify these claims in the first quarter of 2022 although the claimants are seeking permission to appeal. Also in 2019, a separate claim was filed in the UK in the High Court of Justice (High Court), and subsequently transferred to the CAT, by various banks and asset management firms against Barclays Bank PLC and other financial institutions alleging breaches of European and UK competition laws related to FX trading.
 
Metals related civil actions
 
 
A number of US civil complaints, each on behalf of a proposed class of plaintiffs, have been consolidated and transferred to the SDNY. The complaints allege that Barclays Bank PLC and other members of The London Gold Market Fixing Ltd. manipulated the prices of gold and gold derivative contracts in violation of the Antitrust Act and other federal laws. The parties have reached a joint settlement to resolve this matter for $50m, which has received preliminary court approval, with the final court approval hearing scheduled for August 2022. The financial impact of Barclays’ share of the joint settlement is not expected to be material to the Group’s operating results, cash flows or financial position. A separate US civil complaint by a proposed class of plaintiffs against a number of banks, including Barclays Bank PLC, BCI and BX, alleging manipulation of the price of silver in violation of the CEA, the Antitrust Act and state antitrust and consumer protection laws, has been dismissed as against the Barclays entities. The plaintiffs have the option to seek the court’s permission to appeal.
 
Civil actions have also been filed in Canadian courts against Barclays PLC, Barclays Bank PLC, Barclays Capital Canada Inc. and BCI on behalf of proposed classes of plaintiffs alleging manipulation of gold and silver prices.
 
US residential mortgage related civil actions
 
 
There are two pending US Residential Mortgage-Backed Securities (RMBS) related civil actions arising from unresolved repurchase requests submitted by Trustees for certain RMBS, alleging breaches of various loan-level representations and warranties (R&Ws) made by Barclays Bank PLC and/or a subsidiary acquired in 2007. In one action, the Barclays defendants’ motion for summary judgment was granted in June 2022 and the plaintiffs’ R&W breach claim was dismissed. The plaintiffs may appeal. The other repurchase action is pending.
 
Barclays Bank PLC has reached settlements to resolve two other repurchase actions, which have received final court approval. Payment of the settlement amount of one of those repurchase actions was completed in the first quarter of 2022, and the other will be completed in the third quarter of 2022. The financial impact of the settlements is not expected to be material to the Group’s operating results, cash flows or financial position.
 
In 2020, a civil litigation claim was filed in the New Mexico First Judicial District Court by the State of New Mexico against six banks, including BCI, on behalf of two New Mexico state pension funds and the New Mexico State Investment Council relating to legacy RMBS purchases. As to BCI, the complaint alleges that the funds purchased approximately $22m in RMBS underwritten by BCI. The parties have reached a joint settlement to resolve this matter for $32.5m. The settlement was paid in April 2022. The financial impact of BCI’s share of the joint settlement is not material to the Group’s operating results, cash flows or financial position.
 
Government and agency securities civil actions
 
 
Treasury auction securities civil actions
 
Consolidated putative class action complaints filed in US federal court against Barclays Bank PLC, BCI and other financial institutions under the Antitrust Act and state common law allege that the defendants (i) conspired to manipulate the US Treasury securities market and/or (ii) conspired to prevent the creation of certain platforms by boycotting or threatening to boycott such trading platforms. The court dismissed the consolidated action in March 2021. The plaintiffs filed an amended complaint. The defendants’ motion to dismiss the amended complaint was granted in March 2022. The plaintiffs are appealing this decision.
 
In addition, certain plaintiffs have filed a related, direct action against BCI and certain other financial institutions, alleging that defendants conspired to fix and manipulate the US Treasury securities market in violation of the Antitrust Act, the CEA and state common law.
 
Supranational, Sovereign and Agency bonds civil actions
 
Civil antitrust actions have been filed in the SDNY and Federal Court of Canada in Toronto against Barclays Bank PLC, BCI, BX, Barclays Capital Securities Limited and, with respect to the civil action filed in Canada only, Barclays Capital Canada, Inc. and other financial institutions alleging that the defendants conspired to fix prices and restrain competition in the market for US dollar-denominated Supranational, Sovereign and Agency bonds.
 
In one of the actions filed in the SDNY, the court granted the defendants’ motion to dismiss the plaintiffs’ complaint. The dismissal was affirmed on appeal; however, the district court subsequently informed the parties of a potential conflict. The motion to dismiss were assigned to a new district court judge and the plaintiffs have moved to vacate the dismissal order. The plaintiffs have voluntarily dismissed the other SDNY action. In the Federal Court of Canada action, the plaintiffs reached settlements with a small number of banks in 2020 (not including Barclays Capital Canada, Inc.). The plaintiffs have commenced the class certification process. There is no court scheduled deadline and the action remains at an early stage.
 
Variable Rate Demand Obligations civil actions
 
Civil actions have been filed against Barclays Bank PLC and BCI and other financial institutions alleging the defendants conspired or colluded to artificially inflate interest rates set for Variable Rate Demand Obligations (VRDOs). VRDOs are municipal bonds with interest rates that reset on a periodic basis, most commonly weekly. Two actions in state court have been filed by private plaintiffs on behalf of the states of Illinois and California. Three putative class action complaints have been consolidated in the SDNY. In the consolidated SDNY class action, certain of the plaintiffs’ claims were dismissed in November 2020 and defendants’ motion for partial dismissal of the amended consolidated complaint was granted in part and denied in part in June 2022. In the California action, the plaintiffs’ claims were dismissed in June 2021. The plaintiffs have appealed the dismissal.
 
Odd-lot corporate bonds antitrust class action
 
 
In 2020, BCI, together with other financial institutions, were named as defendants in a putative class action. The complaint alleges a conspiracy to boycott developing electronic trading platforms for odd-lots and price fixing. The plaintiffs demand unspecified money damages. The defendants’ motion to dismiss was granted in 2021 and the plaintiffs have appealed the dismissal. The district court subsequently informed the parties of a potential conflict and the case was reassigned to a new district court judge. The plaintiffs have filed a motion seeking a ruling that would vacate the dismissal and allow the plaintiffs to file an amended complaint if the appeals court remands the case for further proceedings.
 
Interest rate swap and credit default swap US civil actions
 
 
Barclays PLC, Barclays Bank PLC and BCI, together with other financial institutions that act as market makers for interest rate swaps (IRS) are named as defendants in several antitrust class actions which were consolidated in the SDNY in 2016. The complaints allege the defendants conspired to prevent the development of exchanges for IRS and demand unspecified money damages.
 
In 2018, trueEX LLC filed an antitrust class action in the SDNY against a number of financial institutions including Barclays PLC, Barclays Bank PLC and BCI based on similar allegations with respect to trueEX LLC’s development of an IRS platform. In 2017, Tera Group Inc. filed a separate civil antitrust action in the SDNY claiming that certain conduct alleged in the IRS cases also caused the plaintiff to suffer harm with respect to the Credit Default Swaps market. In 2018 and 2019, respectively, the court dismissed certain claims in both cases for unjust enrichment and tortious interference but denied motions to dismiss the federal and state antitrust claims, which remain pending.
 
BDC Finance L.L.C.
 
 
In 2008, BDC Finance L.L.C. (BDC) filed a complaint in the Supreme Court of the State of New York (NY Supreme Court), demanding damages of $298m, alleging that Barclays Bank PLC had breached a contract in connection with a portfolio of total return swaps governed by an ISDA Master Agreement (the Master Agreement). Following a trial, the court ruled in 2018 that Barclays Bank PLC was not a defaulting party, which was affirmed on appeal. In April 2021, the trial court entered judgement in favour of Barclays Bank PLC for $3.3m and as yet to be determined legal fees and costs. BDC appealed. In January 2022, the appellate court reversed the trial court’s summary judgment decision in favour of Barclays Bank PLC and remanded the case to the lower court for further proceedings, with the trial scheduled to commence in the fourth quarter of 2022.
 
In 2011, BDC’s investment advisor, BDCM Fund Adviser, L.L.C. and its parent company, Black Diamond Capital Holdings, L.L.C. also sued Barclays Bank PLC and BCI in Connecticut State Court for unspecified damages allegedly resulting from Barclays Bank PLC’s conduct relating to the Master Agreement, asserting claims for violation of the Connecticut Unfair Trade Practices Act and tortious interference with business and prospective business relations. This case is currently stayed.
 
Civil actions in respect of the US Anti-Terrorism Act
 
 
There are a number of civil actions, on behalf of more than 4,000 plaintiffs, filed in US federal courts in the US District Court in the Eastern District of New York (EDNY) and SDNY against Barclays Bank PLC and a number of other banks. The complaints generally allege that Barclays Bank PLC and those banks engaged in a conspiracy to facilitate US dollar-denominated transactions for the Iranian Government and various Iranian banks, which in turn funded acts of terrorism that injured or killed the plaintiffs or the plaintiffs’ family members. The plaintiffs seek to recover damages for pain, suffering and mental anguish under the provisions of the US Anti-Terrorism Act, which allow for the trebling of any proven damages.
 
The court granted the defendants’ motions to dismiss three out of the six actions in the EDNY. The plaintiffs have appealed in one action. The remaining actions are stayed pending a decision on the appeal. Out of the two actions in the SDNY, the court also granted the defendants’ motion to dismiss the first action, which is stayed pending a decision on the EDNY appeal. The second SDNY action is stayed, pending any appeal on the dismissal of the first.
 
Shareholder derivative action
 
 
In November 2020, a purported Barclays shareholder filed a putative derivative action in New York state court against BCI and a number of current and former members of the Board of Directors of Barclays PLC and senior executives or employees of the Group. The shareholder filed the claim on behalf of nominal defendant Barclays PLC, alleging that the individual defendants harmed the company through breaches of their duties, including under the Companies Act 2006. The plaintiff seeks damages on behalf of Barclays PLC for the losses that Barclays PLC allegedly suffered as a result of these alleged breaches. An amended complaint was filed in April 2021, which BCI and certain other defendants moved to dismiss. The motion to dismiss was granted in April 2022. The plaintiffs are appealing the decision.
 
Derivative transactions civil action
 
 
In 2021, Vestia (a Dutch housing association) brought a claim against Barclays Bank PLC in the UK in the High Court in relation to a series of derivative transactions entered into with Barclays Bank PLC between 2008 and 2011, seeking damages of £329m. Barclays Bank PLC is defending the claim and has made a counterclaim.
 
Timeshare loans, skilled person review, and associated matters
 
 
In August 2020, the FCA granted an application by Clydesdale Financial Services Limited (CFS), which trades as Barclays Partner Finance and houses Barclays’ point-of-sale finance business, for a validation order with respect to certain loans to customers brokered between April 2014 and April 2016 by Azure Services Limited (ASL), a timeshare operator, which did not, at the point of sale, hold the necessary broker licence. As a condition to the validation order, the FCA required CFS to undertake a skilled person review of the assessment of affordability processes for the loans brokered by ASL (ASL Loans) as well as CFS’ policies and procedures for assessing affordability and oversight of brokers more generally, and dictated a remediation methodology in the event that ASL Loans did not pass the affordability test. CFS voluntarily agreed to remediate the ASL Loans, in accordance with the FCA’s methodology and the remediation exercise is substantively complete. The remaining scope of the skilled person review is also complete. The skilled person made a number of observations, some of which were adverse, about both current and historic affordability practices as well as current oversight practices. CFS is not required to conduct a full back book review but, following a review of certain cohorts of loans to determine historic affordability and/or broker oversight practices that may have caused customer harm, where harm is identified, CFS’ intention is to remediate. To date CFS has identified a number of areas for remediation but the scoping exercise is ongoing. Separately, and notwithstanding this, CFS decided in March 2022 to extend the proactive remediation of ASL Loans beyond those brokered between April 2014 to April 2016 to include the full portfolio of ASL Loans brokered between 2006 and 2018. In the first quarter of 2022, a customer remediation provision of £181m has been recognised in relation to the remediation of the ASL Loans originated outside the April 2014 to April 2016 period. This provision represents the best estimate as at 30 June 2022.
 
CFS continues to review complaints about other legacy partner finance loans, however, it is not currently possible to predict the outcome of this review or the financial impact on the Group.
 
Over-issuance of securities in the US
 
 
Barclays Bank PLC maintains a US shelf registration statement with the Securities and Exchange Commission (SEC) in order to issue securities to US investors. In May 2017, Barclays Bank PLC was the subject of an SEC settlement order as a result of which it lost its status as a “well-known seasoned issuer” (or WKSI) and was required to register a specified amount of securities to be issued under any US shelf registration statements filed with the SEC.
 
On 10 March 2022, executive management became aware that Barclays Bank PLC had issued securities materially in excess of the set amount under its 2019 US shelf registration statement (2019 F-3) and subsequently became aware that securities had also been issued in excess of the set amount under the predecessor US shelf registration statement (the Predecessor Shelf). The securities that have been over-issued comprise structured notes and exchange traded notes (ETNs). Securities issued in excess of the amount registered are considered to be “unregistered securities” for the purposes of US securities laws, with certain purchasers of those securities having a right to recover, upon the tender of such security to Barclays Bank PLC, the consideration paid for such security with interest, less the amount of any income received, or to recover damages from Barclays Bank PLC if the purchaser no longer owns the security and had sold the security at a loss (the Rescission Price). Barclays Bank PLC is expected to launch a rescission offer on 1 August 2022, by which Barclays Bank PLC will offer to repurchase the relevant affected securities for the rescission price (the Rescission Offer). Although the Rescission Offer is expected to reduce liability with respect to potential private civil claims, it will not necessarily prevent such claims from being asserted against Barclays Bank PLC and/or its affiliates, including claims under applicable US federal securities laws.
 
Further, the Rescission Offer does not bar the SEC and other regulators from pursuing enforcement actions against Barclays Bank PLC and its affiliates, which are expected to result in fines, penalties and/or other sanctions. The Group is engaged with, and responding to inquiries and requests for information from, various regulators, including the SEC. The SEC’s investigation into this matter is at an advanced stage and the Group has had preliminary discussions with the staff of the SEC's Division of Enforcement about resolving this matter.
 
As at 30 June 2022, Barclays PLC has recognised a balance sheet provision of £1,757m (December 2021: £220m) in relation to this matter, out of which £1,592m (December 2021: £220m) relates to the over-issuance of structured notes and £165m (December 2021: nil) relates to liabilities that could be incurred arising out of ongoing discussions in respect of a potential SEC resolution.
 
A contingent liability exists in relation to the over-issuance of ETNs due to evidentiary challenges and the high level of trading in the securities. A contingent liability also exists in relation to any potential civil claims or enforcement actions taken against Barclays Bank PLC and/or its affiliates, but Barclays Bank PLC is unable to assess the likelihood of liabilities that may arise out of such claims or actions. Any liabilities, claims or actions in connection with the over-issuance of securities under its 2019 F-3 and the Predecessor Shelf could have an adverse effect on Barclays Bank PLC’s and the Group’s business, financial condition, results of operations and reputation as a frequent issuer in the securities markets.
 
Investigation into the use of unapproved communications platforms 
 
 
In July 2022, Barclays Bank PLC and BCI reached an agreement in principle with the staff of the SEC's Division of Enforcement and the staff of the Commodity Futures Trading Commission (CFTC) in connection with investigations by the SEC and the CFTC of Barclays Bank PLC, BCI and other financial institutions as part of a financial industry sweep regarding compliance with record-keeping obligations in connection with business-related communications sent over unapproved electronic messaging platforms. The SEC and the CFTC found that Barclays Bank PLC and BCI failed to comply with their respective record keeping rules, where such communications were sent or received by employees over electronic messaging channels that had not been approved by the bank for business use by employees. The proposed resolution with the SEC and the CFTC, will include Barclays Bank PLC and BCI paying a combined $125m civil monetary penalty to the SEC and a $75m civil monetary penalty to the CFTC. There will also be non-financial components to the settlements which have yet to be finalised and agreed with the SEC and CFTC. Subject to final agreement of the terms of the settlements and related documentation, as well as the SEC's and CFTC's approval, the civil monetary penalties are expected to be paid during the third quarter of 2022.
 
2. Barclays PLC, Barclays Bank PLC and Barclays Bank UK PLC
 
HM Revenue & Customs (HMRC) assessments concerning UK Value Added Tax
 
 
In 2018, HMRC issued notices that have the effect of removing certain overseas subsidiaries that have operations in the UK from Barclays’ UK VAT group, in which group supplies between members are generally free from VAT. The notices have retrospective effect and correspond to assessments of £181m (inclusive of interest), of which Barclays would expect to attribute an amount of approximately £128m to Barclays Bank UK PLC and £53m to Barclays Bank PLC. HMRC’s decision has been appealed to the First Tier Tribunal (Tax Chamber).
 
Local authority civil actions concerning LIBOR
 
 
Following settlement by Barclays Bank PLC of various governmental investigations concerning certain benchmark interest rate submissions referred to above in ‘Investigations into LIBOR and other benchmarks and related civil actions’, in the UK, certain local authorities brought claims in 2018 against Barclays Bank PLC and Barclays Bank UK PLC asserting that they entered into loans between 2006 and 2008 in reliance on misrepresentations made by Barclays Bank PLC in respect of its conduct in relation to LIBOR. Barclays Bank PLC and Barclays Bank UK PLC were successful in their applications to strike out the claims. The claims have been settled on terms such that the parties have agreed not to pursue these claims further and to bear their own costs. The financial impact of the settlements is not material to the Group’s operating results, cash flows or financial position.
 
3. Barclays PLC
 
Alternative trading systems
 
 
In 2020, a claim was brought against Barclays PLC in the UK in the High Court by various shareholders regarding Barclays PLC’s share price based on the allegations contained within a complaint by the New York State Attorney General (NYAG) in 2014. Such claim was settled in 2016, as previously disclosed. The more recent claim seeks unquantified damages and Barclays is defending the claim. The NYAG complaint was filed against Barclays PLC and BCI in the NY Supreme Court alleging, among other things, that Barclays PLC and BCI engaged in fraud and deceptive practices in connection with LX, BCI’s SEC-registered alternative trading system.
 
General
 
 
The Group is engaged in various other legal, competition and regulatory matters in the UK, the US and a number of other overseas jurisdictions. It is subject to legal proceedings brought by and against the Group which arise in the ordinary course of business from time to time, including (but not limited to) disputes in relation to contracts, securities, debt collection, consumer credit, fraud, trusts, client assets, competition, data management and protection, intellectual property, money laundering, financial crime, employment, environmental and other statutory and common law issues.
 
The Group is also subject to enquiries and examinations, requests for information, audits, investigations and legal and other proceedings by regulators, governmental and other public bodies in connection with (but not limited to) consumer protection measures, compliance with legislation and regulation, wholesale trading activity and other areas of banking and business activities in which the Group is or has been engaged. The Group is cooperating with the relevant authorities and keeping all relevant agencies briefed as appropriate in relation to these matters and others described in this note on an ongoing basis.
 
At the present time, Barclays PLC does not expect the ultimate resolution of any of these other matters to have a material adverse effect on the Group’s financial position. However, in light of the uncertainties involved in such matters and the matters specifically described in this note, there can be no assurance that the outcome of a particular matter or matters (including formerly active matters or those matters arising after the date of this note) will not be material to Barclays PLC’s results, operations or cash flow for a particular period, depending on, among other things, the amount of the loss resulting from the matter(s) and the amount of profit otherwise reported for the reporting period.
 
 
 
 
22.
Related party transactions
 
 
Related party transactions in the half year ended 30 June 2022 were similar in nature to those disclosed in the Barclays PLC Annual Report 2021. No related party transactions that have taken place in the half year ended 30 June 2022 have materially affected the financial position or the performance of the Group during this period.
 
 
23.
 Interest rate benchmark reform
 
 
Following the financial crisis, the reform and replacement of benchmark interest rates such as LIBOR became a priority for global regulators. The FCA and other global regulators instructed market participants to prepare for the cessation of GBP, EUR, CHF, JPY LIBOR and the 1-week and 2-month USD settings of LIBOR after the end of 2021, The remaining USD LIBOR settings are scheduled to cease immediately after 30 June 2023.
 
How the Group is managing the transition to alternative benchmark rates
 
Barclays established a Group-wide LIBOR Transition Programme, further detail on the transition programme is available in the Barclays PLC Annual Report 2021 (Page 417). This Programme oversaw transition for GBP, EUR, CHF and JPY LIBOR exposures and continues to work to transition the remaining residual of unremediated exposures off of synthetic rates, in addition to overseeing USD LIBOR transition in preparation for the 30 June 2023 cessation.
 
The majority of GBP, EUR, CHF and JPY exposures have now transitioned off of LIBOR and good progress has been made with the unremediated exposures reported at year-end 2021. A small residual population of GBP, EUR and JPY contracts remain unremediated at the end of H1 2022. The majority of these have now reset onto GBP and JPY Synthetic LIBOR rates. We continue to work with clients to bilaterally transition these trades and have raised potential risks regarding note holder consent for securitised products and Local Authority consent for Public Finance Initiative (PFI) loan deals with our regulators.
 
The Barclays Group-wide LIBOR Transition Programme has also commenced focus on the transition of USD LIBOR exposures impacted by the 30 June 2023 cessation timeline. As with GBP, EUR, CHF and JPY LIBOR, USD LIBOR transition approaches will vary by product and nature of counterparty. H122 saw focused efforts to transition uncommitted lending exposure with further wide scale client engagement for other products due to commence in H222. Both active conversion of exposures and inclusion of fallback provisions will be leveraged for bilateral derivative and non-derivatives products. For cleared derivatives, Barclays is working with central clearing counterparties (CCPs) on transition which is expected to follow a market wide, standardised approach to reform similar to the CCP-led conversions in 2021.
 
The Group met the Q121 Federal Reserve Bank of New York milestone to cease new use of US dollar LIBOR, with limited exceptions. The Group has put in place controls so that any exceptions or exemptions are approved.
 
 
 
 
24.
Barclays PLC parent company balance sheet
 
 
As at 30.06.22
 
As at 31.12.21
 
Assets
 
£m
 
£m
 
Investment in subsidiaries
 
63,633
 
62,528
 
Loans and advances to subsidiaries
 
20,369
 
22,072
 
Financial assets at fair value through the income statement
 
24,052
 
25,091
 
Derivative financial instruments
 
5
 
4
 
Other assets
 
235
 
68
 
Total assets
 
108,294
 
109,763
 
 
 
 
Liabilities
 
 
 
Deposits at amortised cost
 
545
 
488
 
Debt securities in issue
 
22,389
 
25,658
 
Subordinated liabilities
 
10,070
 
9,301
 
Financial liabilities designated at fair value
 
16,888
 
16,319
 
Derivative financial instruments
 
540
 
43
 
Other liabilities
 
104
 
117
 
Total liabilities
 
50,536
 
51,926
 
 
 
 
Equity
 
 
 
Called up share capital
 
4,133
 
4,188
 
Share premium account
 
375
 
348
 
Other equity instruments
 
12,347
 
12,241
 
Other reserves
 
616
 
555
 
Retained earnings
 
40,287
 
40,505
 
Total equity
 
57,758
 
57,837
 
 
 
 
Total liabilities and equity
 
108,294
 
109,763
 
 
Investment in subsidiaries
 
The investment in subsidiaries of £63,633m (December 2021: £62,528m) predominantly relates to investments in the ordinary shares of Barclays Bank PLC of £36,340m (December 2021: £35,590m) and their AT1 securities of £9,849m (December 2021: £9,493m), as well as investments in the ordinary shares of Barclays Bank UK PLC of £14,245m (December 2021: £14,245m) and their AT1 securities of £2,570m (December 2021: £2,570m). Barclays PLC considers the carrying value of its investment in subsidiaries to be fully recoverable.
 
Loans and advances to subsidiaries
 
During the period, loans and advances to subsidiaries decreased by £1,703m to £20,369m (December 2021: £22,072m). The decrease was driven by the maturity of £2,296m intragroup loans to Barclays Bank PLC and the maturity of £836m intragroup loans to Barclays Bank UK PLC. There was also a £397m share buyback which took place in Q222. This was partially offset by a foreign exchange impact of £1,326m due to depreciation of GBP against major currencies (although the FX impact is offset across the balance sheet liabilities) and £1,010m dividend receipts from Barclays Bank UK PLC.
 
Financial assets and liabilities designated at fair value
 
Financial liabilities designated at fair value of £16,888m (December 2021: £16,319m) comprise material issuances during the period of €2,250m Fixed Rate Resetting Senior Callable Notes and $400m Zero Coupon Callable Notes. The proceeds raised through these transactions were used to invest in subsidiaries of Barclays PLC which are included within the financial assets designated at fair value through the income statement balance of £24,052m (December 2021: £25,091m).
 
Subordinated liabilities and debt securities in issue
 
During the period, subordinated liabilities have increased to £10,070m (December 2021: £9,301m) largely driven by foreign exchange impact of £819m due to depreciation of GBP against major currencies. Debt securities in issue of £22,389m (December 2021: £25,658m) have reduced in the year due to the maturity of senior issuances.
 
Called up share capital and share premium
 
Called up share capital and share premium of Barclays PLC is £4,508m (December 2021: £4,536m). The decrease in the year is primarily due to 244m shares repurchased with a total nominal value of £61m. This decrease was offset by £33m of shares issued under employee share schemes.
 
Other equity instruments
 
Other equity instruments comprises AT1 securities issued by Barclays PLC. The increase in the year of £106m is driven by one issuance (principal amount of £1,250m) and one redemption (principal amount of $1,500m).
 
Other reserves
 
As at 30 June 2022, there was a balance of £616m (December 2021: £555m) in other reserves. The increase is due to the repurchase of shares as part of the share buyback.
 
 
 
 
Management of internal investments, loans and advances
 
Barclays PLC retains the discretion to manage the nature of its internal investments in subsidiaries according to their regulatory and business needs. Barclays PLC may invest capital and funding into Barclays Bank PLC, Barclays Bank UK PLC and other Group subsidiaries such as Barclays Execution Services Limited and the US Intermediate Holding Company (IHC).
 
 
 
Appendix: Non-IFRS Performance Measures
 
 
 
The Group’s management believes that the non-IFRS performance measures included in this document provide valuable information to the readers of the financial statements as they enable the reader to identify a more consistent basis for comparing the businesses’ performance between financial periods, and provide more detail concerning the elements of performance which the managers of these businesses are most directly able to influence or are relevant for an assessment of the Group. They also reflect an important aspect of the way in which operating targets are defined and performance is monitored by management.
 
However, any non-IFRS performance measures in this document are not a substitute for IFRS measures and readers should consider the IFRS measures as well.
 
Non-IFRS performance measures glossary
 
Measure
 
Definition
 
Loan: deposit ratio
 
Loans and advances at amortised cost divided by deposits at amortised cost. The components of the calculation have been included on the page 52.
 
Period end allocated tangible equity
 
Allocated tangible equity is calculated as 13.5% (2021: 13.5%) of RWAs for each business, adjusted for capital deductions, excluding goodwill and intangible assets, reflecting the assumptions the Group uses for capital planning purposes. Head Office allocated tangible equity represents the difference between the Group’s tangible shareholders’ equity and the amounts allocated to businesses.
 
Average tangible shareholders’ equity
 
Calculated as the average of the previous month’s period end tangible equity and the current month’s period end tangible equity. The average tangible shareholders’ equity for the period is the average of the monthly averages within that period.
 
Average allocated tangible equity
 
Calculated as the average of the previous month’s period end allocated tangible equity and the current month’s period end allocated tangible equity. The average allocated tangible equity for the period is the average of the monthly averages within that period.
 
Return on average tangible shareholders’ equity
 
Annualised profit after tax attributable to ordinary equity holders of the parent, as a proportion of average shareholders’ equity excluding non-controlling interests and other equity instruments adjusted for the deduction of intangible assets and goodwill. The components of the calculation have been included on pages 116 to 120.
 
Return on average allocated tangible equity
 
Annualised profit after tax attributable to ordinary equity holders of the parent, as a proportion of average allocated tangible equity. The components of the calculation have been included on pages 116 to 122.
 
Cost: income ratio
 
Total operating expenses divided by total income.
 
Loan loss rate
 
Quoted in basis points and represents total annualised impairment charges divided by gross loans and advances held at amortised cost at the balance sheet date. The components of the calculation have been included on page 33. Quoted as zero when credit impairment is a net release.
 
Net interest margin
 
Annualised net interest income divided by the sum of average customer assets. The components of the calculation have been included on page 29.
 
Tangible net asset value per share
 
Calculated by dividing shareholders’ equity, excluding non-controlling interests and other equity instruments, less goodwill and intangible assets, by the number of issued ordinary shares. The components of the calculation have been included on page 123.
 
 
 
Returns
 
 
Return on average tangible equity is calculated as profit after tax attributable to ordinary equity holders of the parent as a proportion of average tangible equity, excluding non-controlling and other equity interests for businesses. Allocated tangible equity has been calculated as 13.5% (2021: 13.5%) of RWAs for each business, adjusted for capital deductions, excluding goodwill and intangible assets, reflecting the assumptions the Group uses for capital planning purposes. Head Office average allocated tangible equity represents the difference between the Group’s average tangible shareholders’ equity and the amounts allocated to businesses.
 
 
Profit/(loss) attributable to ordinary equity holders of the parent
 
 
Average tangible equity
 
 
Return on average tangible equity
 
Half year ended 30.06.22
£m
 
 
£bn
 
 
%
 
Barclays UK
854
 
10.0
 
17.0
    Corporate and Investment Bank
1,895
 
31.8
 
11.9
    Consumer, Cards and Payments
188
 
4.4
 
8.5
Barclays International
2,083
 
36.2
 
11.5
Head Office
(462)
 
2.7
 
n/m
Barclays Group
2,475
 
48.9
 
10.1
 
 
 
 
 
 
Half year ended 30.06.211
 
 
 
 
 
Barclays UK
1,019
 
9.9
 
20.6
    Corporate and Investment Bank
2,252
 
28.3
 
15.9
    Consumer, Cards and Payments
386
 
4.0
 
19.1
Barclays International
2,638
 
 
32.3
 
 
16.3
 
Head Office
95
 
 
4.3
 
 
n/m
 
Barclays Group
3,752
 
 
46.5
 
 
16.1
 
 
 
1
2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page 87 for more information.
 
 
 
 
 
 
 
 
 
 
Half year ended 30.06.22
 
Barclays UK
 
Corporate and Investment Bank
 
Consumer, Cards and Payments
 
Barclays International
 
Head Office
 
Barclays Group
 
Return on average tangible shareholders' equity
£m
 
£m
 
£m
 
£m
 
£m
 
£m
 
Attributable profit/(loss)
854
1,895
188
2,083
(462)
2,475
 
 
 
 
 
 
 
 
£bn
 
£bn
 
£bn
 
£bn
 
£bn
 
£bn
 
Average shareholders' equity
13.6
31.8
5.3
37.1
6.3
57.0
Average goodwill and intangibles
(3.6)
(0.9)
(0.9)
(3.6)
(8.1)
Average tangible shareholders' equity
 
10.0
 
31.8
 
4.4
 
36.2
 
2.7
 
48.9
 
 
 
 
 
 
 
 
Return on average tangible shareholders' equity
17.0%
11.9%
8.5%
11.5%
n/m
10.1%
 
 
 
Half year ended 30.06.211
 
Barclays UK
 
Corporate and Investment Bank
 
Consumer, Cards and Payments
 
Barclays International
 
Head Office
 
Barclays Group
 
Return on average tangible shareholders' equity
£m
 
£m
 
£m
 
£m
 
£m
 
£m
 
Attributable profit
1,019
2,252
386
2,638
95
3,752
 
 
 
 
 
 
 
 
£bn
£bn
£bn
£bn
£bn
£bn
Average shareholders' equity
13.5
28.3
4.6
32.9
8.0
54.4
Average goodwill and intangibles
(3.6)
(0.6)
(0.6)
(3.7)
(7.9)
Average tangible shareholders' equity
 
9.9
 
28.3
 
4.0
 
32.3
 
4.3
 
46.5
 
 
 
 
 
 
 
 
Return on average tangible shareholders' equity
20.6%
15.9%
19.1%
16.3%
n/m
16.1%
 
 
 
Performance measures excluding the Over-issuance of Securities
 
Profit attributable to ordinary equity holders of the parent
 
 
 
 
 
Half year ended 30.06.22 £m
 
Attributable profit
 
 
 
 
 
2,475
Post-tax impact of the Over-issuance of Securities
 
 
 
 
 
581
Profit attributable to ordinary equity holders of the parent excluding the Over-issuance of Securities
 
 
 
 
 
3,056
 
 
 
 
 
 
 
Return on average tangible shareholders' equity
 
 
 
 
 
£bn
 
Average tangible shareholders' equity
 
 
 
 
 
48.9
 
 
 
 
 
 
 
Return on average tangible shareholders' equity excluding the Over-issuance of Securities
 
 
 
 
 
12.5 %
 
 
1.
2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page 87 for more information.
 
Barclays Group
 
 
 
 
 
 
 
 
 
 
Return on average tangible shareholders' equity
 
Q222
 
Q122
 
 
Q4211
 
Q3211
 
Q2211
 
Q121
 
 
Q420
 
Q320
 
£m
 
£m
 
 
£m
 
£m
 
£m
 
£m
 
 
£m
 
£m
 
Attributable profit
1,071
1,404
 
1,079
1,374
2,048
1,704
 
220
611
 
 
 
 
 
 
 
 
 
 
 
 
£bn
 
£bn
 
£bn
£bn
£bn
 
£bn
 
£bn
£bn
Average shareholders' equity
57.1
56.9
 
56.1
56.5
54.4
54.4
 
55.7
56.4
Average goodwill and intangibles
(8.1)
(8.1)
 
(8.1)
(8.2)
(7.9)
(7.9)
 
(8.1)
(8.1)
Average tangible shareholders' equity
49.0
48.8
 
48.0
48.3
46.5
46.5
 
47.6
48.3
 
 
 
 
 
 
 
 
 
 
 
Return on average tangible shareholders' equity
8.7%
11.5%
 
9.0%
11.4%
17.6%
14.7%
 
1.8%
5.1%
 
 
 
 
Barclays UK
 
 
 
 
 
 
 
 
 
 
Return on average allocated tangible equity
 
Q222
 
Q122
 
 
Q421
 
Q321
 
Q221
 
Q121
 
 
Q420
 
Q320
 
£m
 
£m
 
 
£m
 
£m
 
£m
 
£m
 
 
£m
 
£m
 
Attributable profit
458
396
 
420
317
721
298
 
160
113
 
 
 
 
 
 
 
 
 
 
 
 
£bn
£bn
 
£bn
£bn
£bn
 
£bn
 
£bn
£bn
Average allocated equity
13.6
13.7
 
13.6
13.6
13.5
13.5
 
13.4
13.7
Average goodwill and intangibles
(3.6)
(3.6)
 
(3.6)
(3.6)
(3.6)
(3.6)
 
(3.6)
(3.6)
Average allocated tangible equity
10.0
10.1
 
10.0
10.0
9.9
9.9
 
9.8
10.1
 
 
 
 
 
 
 
 
 
 
 
Return on average allocated tangible equity
18.4%
15.6%
 
16.8%
12.7%
29.1%
12.0%
 
6.5%
4.5%
 
1.
2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page 87 for more information.
 
 
Barclays International
 
 
 
 
 
 
 
 
 
 
Return on average allocated tangible equity
 
Q222
 
Q122
 
 
Q4211
 
Q3211
 
Q2211
 
Q121
 
 
Q420
 
Q320
 
£m
 
£m
 
 
£m
 
£m
 
£m
 
£m
 
 
£m
 
£m
 
Attributable profit
783
1,300
 
818
1,191
1,207
1,431
 
441
782
 
 
 
 
 
 
 
 
 
 
 
 
£bn
£bn
 
£bn
£bn
£bn
 
£bn
 
£bn
£bn
Average allocated equity
38.2
36.0
 
33.8
32.7
33.0
32.8
 
31.1
31.2
Average goodwill and intangibles
(0.9)
(0.9)
 
(0.9)
(0.9)
(0.6)
(0.5)
 
(0.6)
(0.6)
Average allocated tangible equity
37.3
35.1
 
32.9
31.8
32.4
32.3
 
30.5
30.6
 
 
 
 
 
 
 
 
 
 
 
Return on average allocated tangible equity
8.4%
14.8%
 
9.9%
14.9%
14.9%
17.7%
 
5.8%
10.2%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Corporate and Investment Bank
 
 
 
 
 
 
 
 
 
Return on average allocated tangible equity
 
Q222
 
Q122
 
 
Q4211
 
Q3211
 
Q2211
 
Q121
 
 
Q420
 
Q320
 
£m
 
£m
 
 
£m
 
£m
 
£m
 
£m
 
 
£m
 
£m
 
Attributable profit
579
1,316
 
695
1,085
989
1,263
 
413
627
 
 
 
 
 
 
 
 
 
 
 
 
£bn
£bn
 
£bn
£bn
£bn
 
£bn
 
£bn
£bn
Average allocated equity
32.7
30.8
 
28.7
27.8
28.4
28.2
 
26.3
26.4
Average goodwill and intangibles
 
 
Average allocated tangible equity
32.7
30.8
 
28.7
27.8
28.4
28.2
 
26.3
26.4
 
 
 
 
 
 
 
 
 
 
 
Return on average allocated tangible equity
7.1%
17.1%
 
9.7%
15.6%
14.0%
17.9%
 
6.3%
9.5%
 
 
Consumer, Cards and Payments
 
 
 
 
 
 
 
 
 
Return on average allocated tangible equity
 
Q222
 
Q122
 
 
Q421
 
Q321
 
Q221
 
Q121
 
 
Q420
 
Q320
 
£m
 
£m
 
 
£m
 
£m
 
£m
 
£m
 
 
£m
 
£m
 
Attributable profit/(loss)
204
(16)
 
123
106
218
168
 
28
155
 
 
 
 
 
 
 
 
 
 
 
 
£bn
£bn
 
£bn
£bn
£bn
 
£bn
 
£bn
£bn
Average allocated equity
5.5
5.2
 
5.1
4.9
4.6
4.6
 
4.8
4.8
Average goodwill and intangibles
(0.9)
(0.9)
 
(0.9)
(0.9)
(0.6)
(0.5)
 
(0.6)
(0.6)
Average allocated tangible equity
4.6
4.3
 
4.2
4.0
4.0
4.1
 
4.2
4.2
 
 
 
 
 
 
 
 
 
 
 
Return on average allocated tangible equity
17.8%
(1.5)%
 
11.7%
10.5%
21.8%
16.5%
 
2.7%
14.7%
 
 
 
1.
2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page 87 for more information.
 
 
 
Tangible net asset value per share
As at 30.06.22
Restated1 
As at 31.12.21
Restated1
As at 30.06.21
 
£m
£m
£m
Total equity excluding non-controlling interests
69,627
69,052
66,992
Other equity instruments
(12,357)
(12,259)
(11,167)
Goodwill and intangibles
(8,245)
(8,061)
(8,196)
Tangible shareholders' equity attributable to ordinary shareholders of the parent
49,025
48,732
47,629
 
 
 
 
 
m
m
m
Shares in issue
16,531
16,752
 
16,998
 
 
 
 
 
 
p
p
p
Tangible net asset value per share
297
291
 
280
 
 
1.
2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page 87 for more information.
 
 
 
 
Shareholder Information
 
 
 
 
 
 
 
 
 
Results timetable1
 
 
Date
 
 
 
Ex-dividend date
 
 
 
11 August 2022
 
Dividend record date
 
 
12 August 2022
 
Cut off time of 5:00pm (UK time) for the receipt of Dividend Re-investment Programme (DRIP) Application Form Mandate
 
26 August 2022
 
Dividend payment date
 
 
16 September 2022
 
Q322 Results Announcement
 
 
26 October 2022
 
 
 
 
 
 
 
For qualifying US and Canadian resident ADR holders, the half year dividend of 2.25p per ordinary share becomes 9.0p per ADS (representing four shares). The ex-dividend, dividend record and dividend payment dates for ADR holders are as shown above
 
 
 
 
 
 
 
 
 
 
% Change3
Exchange rates2
30.06.22
31.12.21
30.06.21
 
31.12.21
30.06.21
Period end - USD/GBP
1.22
1.35
1.38
 
(10)%
(12)%
6 month average - USD/GBP
1.30
1.36
1.39
 
(4)%
(6)%
3 month average - USD/GBP
1.26
1.35
1.40
 
(7)%
(10)%
Period end - EUR/GBP
1.16
1.19
1.17
 
(3)%
(1)%
6 month average - EUR/GBP
1.19
1.17
1.15
 
2%
3%
3 month average - EUR/GBP
1.18
1.18
1.16
 
2%
 
 
 
 
 
 
 
Share price data
 
 
 
 
 
 
Barclays PLC (p)
153.12
187.00
171.12
 
 
 
Barclays PLC number of shares (m)4
16,531
16,752
16,998
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For further information please contact
 
 
 
 
 
 
 
 
 
 
 
 
 
Investor relations
Media relations
Chris Manners +44 (0) 20 7773 2136
Tom Hoskin +44 (0) 20 7116 4755
 
 
 
 
 
 
 
 
 
 
 
 
 
 
More information on Barclays can be found on our website: home.barclays
 
 
 
 
 
 
 
 
 
 
 
Registered office
 
 
 
 
 
 
1 Churchill Place, London, E14 5HP, United Kingdom. Tel: +44 (0) 20 7116 1000. Company number: 48839.
 
 
 
 
 
 
 
 
Registrar
 
 
 
 
 
 
Equiniti, Aspect House, Spencer Road, Lancing, West Sussex, BN99 6DA, United Kingdom.
 
Tel: 0371 384 20555 from the UK or +44 121 415 7004 from overseas.
 
 
 
 
 
 
 
 
American Depositary Receipts (ADRs)
 
 
 
 
 
 
EQ Shareowner Services
P.O. Box 64854
St. Paul, MN 55164-0854
United States of America
shareowneronline.com
 
 
 
 
 
Toll Free Number: +1 800-990-1135
 
 
 
 
 
 
Outside the US +1 651-453-2128
 
 
 
 
 
 
 
 
 
 
 
 
 
Delivery of ADR certificates and overnight mail
 
 
 
 
 
 
EQ Shareowner Services, 1110 Centre Pointe Curve, Suite 101, Mendota Heights, MN 55120-4100, USA.
 
1
Note that this date is provisional and subject to change.
2
The average rates shown above are derived from daily spot rates during the year.
3
The change is the impact to GBP reported information.
4
The number of shares of 16,531m is different from the 16,509m quoted in the 1 July 2022 RNS because the share buyback transactions executed on the 29 and 30 June 2022 did not settle until 1 July 2022 and 4 July 2022.
5
Lines open 8.30am to 5.30pm (UK time), Monday to Friday, excluding UK public holidays in England and Wales.